Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,29786,-0.150798680721809,0.0034949162644949,-0.157648716600219,-0.143948644843399,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,24951,0.1397881497628,0.00353302032278716,0.132863429930138,0.146712869595463,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.146932862326157,0.00206573231535601,0.142884026988059,0.150981697664255,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,28797,-0.471149454186148,0.00802030894108109,-0.486869259710667,-0.45542964866163,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.245806092722197,0.00544784570835784,-0.256483870310578,-0.235128315133815,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.145947973101496,0.00368211814745718,-0.153164924670512,-0.13873102153248,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,29443,-0.181725142672924,0.00279310028753831,-0.187199619236499,-0.176250666109349,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.197710767713677,0.0043359874489602,-0.206209303113639,-0.189212232313715,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.146006417991783,0.00199521827296401,0.142095790176773,0.149917045806792,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.0808310057866194,0.0018740896227602,0.0771577901260094,0.0845042214472294,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.133031005134471,0.00265956646871258,-0.138243755413148,-0.127818254855795,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,29347,-0.125112874206077,0.00269884008489957,-0.13040260077248,-0.119823147639674,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,24111,-0.294933160944853,0.0063665208373939,-0.307411541786145,-0.282454780103561,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.268984845415527,0.00595970804574776,-0.280665873185192,-0.257303817645861,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.314941713517636,0.00810496675155659,0.299055978684585,0.330827448350687,1.11253692925362e-308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,24951,0.0628257868174305,0.00166678686314615,0.059558884565664,0.0660926890691969,1.97291056611061e-302
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0726204720794792,0.00198367951382191,-0.0765084839265702,-0.0687324602323883,6.36223129975925e-287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,29454,-0.125492983273504,0.00364936410514782,-0.132645736919594,-0.118340229627414,4.14999064624334e-254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,29400,-0.23348087213658,0.00680088890338753,-0.246810614387219,-0.22015112988594,2.7610851995076e-253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.3188051780332,0.00928882209897738,-0.337011269347196,-0.300599086719204,3.3875237002835e-253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.150207478758721,0.00442757742198077,-0.158885530505804,-0.141529427011639,2.01873345401683e-247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.111939354715729,0.00342825398504573,-0.118658732526418,-0.105219976905039,6.82836044661363e-229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,29478,0.101838751598179,0.00315149396927872,0.0956618234183926,0.108015679777965,3.76000741995606e-225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.114574372096397,0.00357335289087985,-0.121578143762521,-0.107570600430272,9.37935078280717e-222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,29478,-0.131134031601939,0.00413548391584494,-0.139239580076995,-0.123028483126883,5.13941624778755e-217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,28931,-0.168855934344823,0.00533661794038633,-0.17931570550798,-0.158396163181665,4.89443640515584e-216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0695436911263504,0.00220189071680164,-0.0738593969312816,-0.0652279853214192,2.61034310098426e-215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.110766036443591,0.00353449850777597,-0.117693653518832,-0.10383841936835,4.22608994737833e-212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.168480050404158,0.00541543250674365,-0.179094298117376,-0.157865802690941,4.12903511648202e-209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.106770042336988,0.00346852459959319,-0.113568350552191,-0.0999717341217857,9.11933303068004e-205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,28774,-0.105777368535027,0.00345777081362843,-0.112554599329738,-0.099000137740315,2.80453656565206e-202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,24966,0.138126094697321,0.00453575956954654,0.129236005941009,0.147016183453632,5.04230907373232e-200
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,29545,0.05650846622164,0.00186448165870963,0.0528540821705692,0.0601628502727109,1.00370491597538e-198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,29301,-0.15147758334741,0.00507246809350775,-0.161419620810686,-0.141535545884135,4.72990363168158e-193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0709035155458875,0.00239218930623396,0.066214824505669,0.0755922065861061,2.73390435179238e-190
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0690066132421004,0.00234455319546256,-0.073601937505207,-0.0644112889789938,1.07574614121731e-187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0621798706453225,0.00212951096347536,0.0580060291569108,0.0663537121337342,8.64312135409814e-185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,29559,-0.0639337936329772,0.0021923008459799,-0.0682307032910978,-0.0596368839748566,2.36022068700352e-184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.105086536047835,0.00360362525616998,0.0980234305457423,0.112149641549929,2.74323127255596e-184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,29786,-0.0551395431135944,0.00190613355163074,-0.0588755648747906,-0.0514035213523981,1.75754337489925e-181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.062218579925926,0.00216041821514685,-0.0664529996276138,-0.0579841602242382,2.58862647814592e-179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,24195,-0.156360101513464,0.00545041843746433,-0.167042921650894,-0.145677281376034,5.19736996377471e-178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.130694530182856,0.00457820305068837,-0.139667808162205,-0.121721252203507,8.00993953425982e-177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.0786230724537922,0.00277585071776775,-0.084063739860617,-0.0731824050469674,3.81633405391241e-174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.149003714069425,0.00530617751360409,-0.159403821996089,-0.138603606142761,3.30829748814027e-171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.0981143558927483,0.00351817882676494,-0.105009986393208,-0.091218725392289,5.56158368468723e-169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.171007194321965,0.00615961955948123,-0.183080048658548,-0.158934339985382,4.29319439369963e-167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,27442,-0.0748351543680101,0.00274108738936962,-0.0802076856511745,-0.0694626230848456,6.00426000110847e-162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0620978660823961,0.00227625336173245,-0.0665593226713917,-0.0576364094934005,7.11942924111638e-162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.21582670540308,0.00797488537062537,-0.231457480729506,-0.200195930076655,2.30557192379781e-159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.0810390018518343,0.00299520735689403,-0.0869096082713466,-0.075168395432322,2.72080808326749e-159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.124520014330394,0.00466045111148871,-0.133654498508912,-0.115385530151876,2.08831271956612e-155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.117214436608938,0.00439554409294301,-0.125829703031106,-0.10859917018677,7.81273792008321e-155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.0844708158182934,0.00318126863021943,-0.0907061023335235,-0.0782355293030634,1.51087829064165e-153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,29566,-0.0598541612858245,0.00225590397416992,-0.0642757330751976,-0.0554325894964515,2.58305221696585e-153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0521045131144004,0.00198523371774587,0.0482134550276185,0.0559955712011823,4.19168167351198e-150
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.259377068637866,0.00993184658072552,-0.278843487936088,-0.239910649339644,1.26487461996316e-148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.147036157788467,0.00563757771805617,-0.158085810115857,-0.135986505461077,3.08259718521534e-148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0627110617640031,0.00240668176870729,-0.0674281580306694,-0.0579939654973368,5.42138466602608e-148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.126339709400741,0.00485867957791909,-0.135862721373462,-0.11681669742802,4.31038430221667e-147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0377043435303147,0.00146053474988162,0.0348416954205467,0.0405669916400826,2.39946973627372e-145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,29349,-0.139345068355191,0.00541469468202656,-0.149957869931963,-0.128732266778419,1.9264711627752e-144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,29584,-0.0591068683899188,0.00230778699713029,-0.0636301309042941,-0.0545836058755434,4.09569324094292e-143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0617547448460921,0.00241890749287764,-0.0664958035321322,-0.0570136861600519,3.19573810984884e-142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0512109651808987,0.00201591611622686,-0.0551621607687034,-0.0472597695930941,7.71105711591842e-141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,24381,-0.0692692962753613,0.00272379669713266,-0.0746079378017413,-0.0639306547489813,7.84151550248761e-141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.108269475109506,0.00427451947520617,-0.11664753328091,-0.0998914169381015,5.23971753674822e-140
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.14550589272536,0.00574743454670051,-0.156770864436893,-0.134240921013827,1.24500639890539e-139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0627468497571009,0.00248808880977026,0.0578701956899512,0.0676235038242506,1.38025634410888e-138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0575994674099701,0.00229179946922494,-0.062091394369651,-0.0531075404502892,6.19275201588064e-138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0334745652998604,0.00133654262888655,0.0308549417472428,0.0360941888524781,5.27731208679065e-137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0554190334230992,0.00221383500111637,-0.0597581500252873,-0.0510799168209111,7.02066592294418e-137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0740914350057833,0.00297248265954965,-0.0799175010185006,-0.0682653689930659,9.629223684036e-136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.102507807182189,0.0041379230877035,-0.110618136434088,-0.0943974779302899,4.1636791230944e-134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0503502949628951,0.00205745561495214,-0.0543829079682013,-0.046317681957589,5.95397887216407e-131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.0970316094049469,0.00399562529198013,-0.104863034977228,-0.0892001838326658,5.69100098608065e-129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.08805934347602,0.00364037427414077,-0.0951944770533359,-0.0809242098987041,5.12823225333607e-128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,29683,-0.0328012049499987,0.00135753052996021,-0.0354619647887207,-0.0301404451112767,9.50995106360389e-128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.137415186900238,0.00568732213499209,-0.148562338284822,-0.126268035515653,9.91864164101602e-128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,29786,-0.0427173216439221,0.00177115356875755,-0.0461887826386869,-0.0392458606491573,2.67696970404425e-127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0539170632366703,0.0022460351367849,-0.0583192921047687,-0.0495148343685719,3.95521802917029e-126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,29349,-0.074154660929836,0.00309013998515063,-0.0802113353007313,-0.0680979865589408,4.89019337525825e-126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0604065957858364,0.0025389739359078,-0.0653829847002157,-0.0554302068714571,1.04759840673459e-123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0589495977672929,0.00249471601201067,-0.0638392411508338,-0.054059954383752,2.56575165395041e-122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.126978416043451,0.00537388605336264,-0.137511232708042,-0.11644559937886,2.71357707782615e-122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0697482375801168,0.0029637731427763,-0.0755572329399584,-0.0639392422202753,2.55075898695821e-121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0815380248173981,0.00346527932603697,-0.0883299722964306,-0.0747460773383657,2.6602407837999e-121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0593167343825977,0.00254584742103045,-0.0643065953278174,-0.054326873437378,8.99877293970141e-119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,29786,-0.0475416457651341,0.0020495347885333,-0.0515587339506594,-0.0435245575796088,5.52987598185753e-118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0406096316312851,0.0017576694855238,0.0371645994396584,0.0440546638229117,4.50443633144122e-117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,29545,-0.0283295664702089,0.00122902756714501,-0.0307384605018131,-0.0259206724386047,1.56009869318521e-116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0511283579576823,0.00222296052636328,-0.0554853605893543,-0.0467713553260103,7.48083131779503e-116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.0516499257096913,0.00225014559621623,0.0472396403411075,0.0560602110782751,1.37684607548124e-115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.155995086057281,0.00682883941361116,-0.169379611307959,-0.142610560806603,1.80341609329304e-114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0829035005322998,0.00365705954272525,-0.0900713372360413,-0.0757356638285583,1.33224933704312e-112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0400368528774238,0.00177040905335309,-0.0435068546219959,-0.0365668511328518,4.35738886514503e-112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.0806189259556436,0.00357428123634932,-0.0876245171788883,-0.0736133347323989,1.11093494300326e-111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,29750,0.0819148125960766,0.00365016323567352,0.0747604926541565,0.0890691325379967,1.28941516677942e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0702603940284506,0.00313705269643776,-0.0764090173134686,-0.0641117707434326,3.52311195541193e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.0715140121713103,0.003201942473421,-0.0777898194192155,-0.0652382049234051,1.42539660771653e-109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0583941373206809,0.00262579220973376,-0.0635406900517591,-0.0532475845896028,1.11610904410813e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0350926186893797,0.00158235300718747,-0.0381940305834672,-0.0319912067952923,4.32541729490931e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.121654784332274,0.00549846946551232,-0.132431784484678,-0.11087778417987,1.37394429488807e-107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,29478,-0.113208462355716,0.00515229972694577,-0.12330696982053,-0.103109954890902,3.77109131736627e-106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,29544,-0.0453468999379816,0.00207256940811187,-0.0494091359778809,-0.0412846638980824,2.79534771200515e-105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.045372817990931,0.00207589222342446,0.041304069233019,0.049441566748843,6.79001169041152e-105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0400869858996995,0.00183787592443037,0.036484749087816,0.043689222711583,1.21399658964695e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.0713305956912792,0.0032744497207164,-0.0777485171438834,-0.0649126742386751,2.17545935543076e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.0654125367474295,0.00305374126321843,0.0594272038715214,0.0713978696233377,5.09912215089901e-101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.110934909577856,0.00518113453109578,-0.121089933258804,-0.100779885896908,6.43146697544973e-101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.0812980913962072,0.00380196380217037,-0.0887499404484611,-0.0738462423439533,1.13505752719166e-100
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0618714030158946,0.00289563589866178,-0.0675468493772717,-0.0561959566545175,1.57153629562959e-100
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,29581,0.0623846948107593,0.00292056174865714,0.0566603937833913,0.0681089958381273,1.79188930433318e-100
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0494884348312545,0.00232659479411169,-0.0540485606277134,-0.0449283090347956,1.17034066228155e-99
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.15996565527541,0.00751978477198672,-0.174704433428504,-0.145226877122316,1.57973729064024e-99
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0814761598757252,0.00384630698828451,-0.0890149215727628,-0.0739373981786875,7.4075330774005e-99
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,23787,0.0624471411676983,0.00294770834175858,0.0566696328178515,0.0682246495175451,1.07424517727897e-98
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0489290672335056,0.00231414968142594,-0.0534648006091004,-0.0443933338579107,1.68879418866258e-98
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.0844391160286326,0.00399583556805654,-0.0922709537420235,-0.0766072783152418,2.14245818634578e-98
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,29820,-0.0716549160701959,0.00340776001824553,-0.0783341257059571,-0.0649757064344346,1.89803015584662e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0697638485840989,0.00331636731533183,0.0632637686460485,0.0762639285221493,2.15770621524498e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,24966,-0.0277630082741884,0.00132100308377366,-0.0303521743183848,-0.025173842229992,3.21923983001174e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,29434,-0.10709501794413,0.00514000567008905,-0.117169429057505,-0.0970206068307559,1.01336425178713e-95
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0593398262937789,0.00285102167489044,-0.0649278287765642,-0.0537518238109937,1.57487772132138e-95
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.128258532667607,0.00621519744843296,-0.140440319666536,-0.116076745668679,6.17571660673253e-94
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.0827578864606038,0.00402872601568537,-0.0906541894513471,-0.0748615834698605,4.24012231473313e-93
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0436218875793214,0.00212654110882519,-0.0477899081526187,-0.039453867006024,7.27614654492297e-93
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,29433,-0.0413902006512211,0.0020213559489987,-0.0453520583112586,-0.0374283429911836,1.54461832607358e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0479802564295737,0.00234683776379808,-0.052580058446618,-0.0433804544125295,2.90137372540348e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,29443,0.0373458545553098,0.00182665476138694,0.0337656112229914,0.0409260978876282,2.9195923254665e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.146250963272363,0.00716235231216656,-0.16028917380421,-0.132212752740517,4.91299962685963e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.105256678113164,0.00516743442382178,-0.115384849583855,-0.0951285066424735,1.7552059937809e-91
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0393612276154085,0.00193595831912654,-0.0431557059208965,-0.0355667493099205,2.82473955024612e-91
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.077064596644011,0.00380207155355153,-0.084516656888972,-0.06961253639905,1.00913079715941e-90
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.112421053043279,0.00556354469601983,-0.123325600647478,-0.101516505439081,3.61094833935518e-90
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.0703644291227947,0.00350636854265453,0.0634919467791918,0.0772369114663976,7.13356061398653e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.056302793389183,0.002813534714898,-0.061817321430383,-0.0507882653479829,1.69082793127507e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0514577934422438,0.00257273928217657,-0.0565003624353098,-0.0464152244491777,2.05165090470738e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0427954222565586,0.00215424576948992,-0.0470177439647589,-0.0385731005483584,3.02948554646169e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0331088713445011,0.00166992814361964,0.0298358121830066,0.0363819305059956,6.39385328658912e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0571957545878167,0.00288954609820411,-0.0628592649402967,-0.0515322442353366,1.22695505919843e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.0739599791392179,0.003738437209805,-0.0812873160704357,-0.0666326422080001,1.53995192205129e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0817639546479427,0.00413495802523722,0.0736594369184777,0.0898684723774076,2.40217022348741e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,24381,-0.0384781950731167,0.00195135220583748,-0.0423028453965582,-0.0346535447496753,6.96513516773537e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,24240,-0.085374759663167,0.0043534530378944,-0.09390752761744,-0.076841991708894,5.70566984861672e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.169854581600144,0.00866832131085707,-0.186844491369424,-0.152864671830864,5.88873814830159e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0375835482015805,0.00192414280187136,-0.0413548680932484,-0.0338122283099126,2.48154590619289e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0216681075562776,0.00111174462308772,0.0194890880950256,0.0238471270175295,4.44440600879379e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,29192,0.0374380748276067,0.00192158107730307,0.0336717759160927,0.0412043737391207,5.24275246091694e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,29594,-0.0701657900404939,0.00362950241504369,-0.0772796147739795,-0.0630519653070082,9.36330166997136e-83
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0735876967152485,0.00381680791093085,-0.081068640220673,-0.066106753209824,3.2990515727148e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.0792446253197255,0.00411618179723615,-0.0873123416423083,-0.0711769089971426,4.30772192645455e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0345625596599079,0.00180084107053935,-0.0380922081581651,-0.0310329111616508,1.33748208855152e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,29694,-0.0480566700908561,0.00250845149439843,-0.0529732350198771,-0.0431401051618352,2.57820317204593e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,24867,-0.0573275801656984,0.00300599648772882,-0.0632193332816469,-0.05143582704975,1.65242801062214e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.0768673421504981,0.00404648458810904,-0.0847984519431918,-0.0689362323578044,5.50608254941438e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0759417695234492,0.0039981768756825,-0.0837781961997869,-0.0681053428471116,5.79785859575523e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,24938,0.0488619946676778,0.00257160767149772,0.0438216436315423,0.0539023457038133,6.20355138934858e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.111706615974954,0.00588939690400077,-0.123249833906795,-0.100163398043112,9.52915912993864e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.0847556277073872,0.00447525029834094,-0.0935271182921354,-0.0759841371226389,1.97885585064329e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.0730758725669097,0.00389537704181193,-0.0807108115688611,-0.0654409335649583,5.7678198501232e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0337311891906914,0.00180154891841193,-0.0372622250707788,-0.0302001533106041,8.94929639317994e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,28477,-0.0508076916242074,0.00272491959026391,-0.0561485340211247,-0.0454668492272902,3.95574213188043e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0720928460803012,0.00387000779277803,-0.0796780613541462,-0.0645076308064563,6.32153957895281e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0455986367995346,0.00245140987755559,-0.0504034001595435,-0.0407938734395256,8.8032519126452e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0429959473734875,0.00231193588576282,0.0384645530373924,0.0475273417095826,9.18448033283703e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0707183195083748,0.00380321623032861,-0.0781726233198189,-0.0632640156969308,9.83690927795959e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0553205483085982,0.00297506952866174,-0.0611516845847752,-0.0494894120324212,9.94712737617696e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0596241479742789,0.00321196223932521,-0.0659195939633563,-0.0533287019852015,2.1511290325792e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0601431796994286,0.00324225533077482,-0.0664980001477473,-0.05378835925111,2.23445475454065e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0470329956064817,0.00253758477182655,-0.0520066617592617,-0.0420593294537016,2.95627349488056e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,24922,-0.0332737290489879,0.00179519430372696,-0.0367923098842927,-0.0297551482136831,3.51727343054946e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,29218,0.0426535364113062,0.00230666917447672,0.0381324648293318,0.0471746079932806,6.57656373297643e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.0449762802065355,0.00243548221606569,-0.0497498253500242,-0.0402027350630467,1.02196286452891e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,24922,-0.0439239321351544,0.00238572415452651,-0.0485999514780263,-0.0392479127922824,3.37560945804827e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0335374801471105,0.00182799878054544,0.0299546025372414,0.0371203577569795,9.19372412604131e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.15340561526907,0.0083663004755523,-0.169803564201152,-0.137007666336987,1.36341295391818e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0360550449358499,0.00196942187012957,-0.0399151118013038,-0.0321949780703959,1.86385553158059e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0273385195868004,0.00149555386654515,-0.0302698051652289,-0.0244072340083719,3.07464055934204e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0622702087154763,0.00340652966410113,-0.0689470068571145,-0.0555934105738381,3.10324676388974e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0464505615460512,0.00254360221978999,0.0414651011952628,0.0514360218968396,4.28779077966894e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0371287444232872,0.00203757846009441,-0.0411223982050723,-0.0331350906415022,8.8009098512782e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,24867,-0.0543494235517051,0.00298511506268933,-0.0602002490745762,-0.048498598028834,1.37216002020576e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0486698407967978,0.00268702735167389,-0.0539364144060786,-0.0434032671875169,6.30201463675581e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0379911498533818,0.00210099633876447,0.0338731970294035,0.0421091026773602,1.08221237369456e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,29527,0.0477287511312765,0.00264147563467689,0.0425514588873098,0.0529060433752432,1.3785656596889e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,29566,-0.0490139367230348,0.00272033321421328,-0.0543457898228928,-0.0436820836231767,3.45247785725201e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0399745931568289,0.00222356966097209,-0.0443327896923342,-0.0356163966213236,7.00146741528078e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0202032196270175,0.0011266745203158,0.0179949375671985,0.0224115016868364,1.59012384756331e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,24845,0.0232925066448231,0.00129859647350134,0.0207472575567605,0.0258377557328857,1.72501202351363e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0475552425312359,0.00265480373601402,0.0423518272086484,0.0527586578538234,2.24138915903629e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0416453634061903,0.00232534411791503,0.0370876889350768,0.0462030378773037,2.38820003483145e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0472317655217654,0.00263984474358627,-0.0524058612191945,-0.0420576698243363,3.27750526239773e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0821574217905556,0.00460131809269035,-0.0911760052522287,-0.0731388383288825,6.2519826864357e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.0989561980455745,0.00554704843882916,-0.10982841298568,-0.0880839831054693,9.62960865118296e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,29694,0.0451562651279587,0.00253489203289961,0.0401878767434754,0.0501246535124419,1.28713180814646e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,24845,-0.157672230183097,0.00884868233432974,-0.175015647558383,-0.140328812807811,1.39244983000368e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.073377011150375,0.00412446601859378,-0.0814609645468188,-0.0652930577539312,1.93288619948153e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0238339187173376,0.00134217897829398,0.0212032479198814,0.0264645895147938,3.50854856248722e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,29480,0.0630903771028632,0.00356244148329772,0.0561079917955997,0.0700727624101267,8.10222068161249e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0278570271138383,0.00159411008126769,-0.0309814828731229,-0.0247325713545536,4.90660442006339e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0588625055948,0.00337485308122595,-0.0654772176340028,-0.0522477935555971,8.75268226497389e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0453044440429556,0.00259776302278697,-0.0503960595676181,-0.0402128285182931,8.95400943669202e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0868827039830141,0.00498515779152143,0.0771117947116321,0.096653613254396,1.27044619972209e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,24707,-0.0300550246030529,0.00172510749881372,-0.0334362353007278,-0.026673813905378,1.42277129563144e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.044608720914093,0.00256512561549386,-0.0496363671204609,-0.039581074707725,2.11943731348989e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0311017578223593,0.00178876652069464,-0.0346077402029208,-0.0275957754417978,2.23717226783518e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,24905,0.0407049592596684,0.00234223080249972,0.0361141868867689,0.0452957316325678,2.98577475719277e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0300010960065048,0.00173275540237869,0.0266048954178426,0.0333972965951671,7.912973835718e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0645511473683182,0.00373789786423004,-0.071877427182209,-0.0572248675544273,1.73926682504714e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0581270577557465,0.00336588986800913,-0.0647242018970444,-0.0515299136144486,1.98752271592229e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.0966457969831895,0.0056016974558262,-0.107625123996609,-0.0856664699697701,2.29527625920534e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0613771727879556,0.00356267904088156,-0.0683600237080834,-0.0543943218678277,3.99011683992463e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,24381,-0.0611323820600495,0.00355723753386345,-0.0681045676264219,-0.0541601964936771,8.35596904900427e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0318535148229145,0.00185486566525013,-0.0354890515268048,-0.0282179781190243,1.03212961537565e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0322915919378591,0.00188322877192991,-0.0359827203308417,-0.0286004635448765,1.38145300418777e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.0843158921713366,0.0049288797270153,-0.0939764964362866,-0.0746552879063866,3.13252750378681e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0602887039706254,0.00353485901497751,-0.0672170276399813,-0.0533603803012695,6.56830157320241e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,29468,0.0444561614450267,0.00262174655857945,0.039317538190211,0.0495947846998424,3.4652718544082e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.11233821847696,0.00664532495008461,-0.125363055379126,-0.0993133815747939,9.4367751715825e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,29786,-0.0519297688747895,0.00307686224399619,-0.0579604188730221,-0.045899118876557,1.30244060199162e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0322600139421066,0.00191884585542768,-0.0360209518187448,-0.0284990760654683,4.42917099654402e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,29530,-0.0321907196259585,0.0019249816061049,-0.0359636835739242,-0.0284177556779929,1.7405993512566e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.0704474156029177,0.00422163890573338,0.0621730033476803,0.0787218278581551,3.1174305865482e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0270106547654965,0.00162052788610947,-0.030186889422271,-0.0238344201087219,4.30611933639764e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0361328162028645,0.00216896097229087,-0.0403839797085547,-0.0318816526971744,5.69007996136258e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,29478,-0.0718213034462952,0.00431382544782285,-0.080276401324028,-0.0633662055685624,5.89955065463615e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,29545,-0.0372930577342867,0.00224237058275154,-0.0416881040764797,-0.0328980113920937,7.93601938168888e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.0401411956822081,0.00243496982150427,0.0353686548320597,0.0449137365323565,8.72353249926197e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0704220484249325,0.00427231491648952,-0.0787957856612519,-0.062048311188613,9.01021705288286e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0402831384414929,0.00245274282660288,-0.0450905143816346,-0.0354757625013513,2.40112686990522e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.076110128060708,0.0046331343934826,-0.0851910714719339,-0.0670291846494821,2.59410022298009e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0341817089588894,0.00208775474376755,-0.0382737082566738,-0.030089709661105,5.57358146504274e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,29487,-0.035046189529664,0.00214558993941797,-0.0392515458109232,-0.0308408332484048,1.03429704948839e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,29725,0.0509996450448379,0.00313253731174333,0.044859871913821,0.0571394181758548,2.44941143308355e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0482327724109169,0.00297083956738329,0.0424099268588457,0.0540556179629882,5.10296999583619e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,28916,-0.058897349726367,0.00363940016704381,-0.0660305740537728,-0.0517641253989611,1.19927618985294e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0492337958084032,0.00304222042749873,-0.0551965478463007,-0.0432710437705057,1.33897704920088e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0302910960827372,0.00187210785764747,-0.0339604274837263,-0.0266217646817482,1.38898540387157e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0327678389257574,0.0020273341524076,-0.0367414138644763,-0.0287942639870385,1.64348196779594e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,24381,0.0249486035764051,0.00154496063526775,0.0219204807312804,0.0279767264215299,2.34332131268909e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,24240,-0.066086539486373,0.00409974139859803,-0.0741220326276251,-0.0580510463451208,3.72592117782894e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.0651593981205159,0.00405418832791379,-0.0731056072432269,-0.0572131889978048,7.03955532707372e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,29434,-0.0358001121927607,0.00222825242480144,-0.0401674869453715,-0.0314327374401499,7.73226072801893e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0414605618859167,0.00258985776521351,0.0363844406660982,0.0465366831057352,1.93412575612312e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,24938,0.0644100250819243,0.00402318479116792,0.0565245828912352,0.0722954672726134,2.11415983706121e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0296216068945704,0.00185851693149962,-0.0332643000803097,-0.0259789137088312,6.61668007872333e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0497193819715434,0.0031286897646672,-0.0558516139102911,-0.0435871500327957,1.24382484394101e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,24922,0.0297910157524132,0.00187459622419782,0.0261168071529855,0.033465224351841,1.36740166967292e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,24381,-0.0687759471809591,0.00433875522206171,-0.0772799074162001,-0.0602719869457182,2.62373376469878e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,28774,-0.055316035916332,0.00349908377177088,-0.062174240109003,-0.0484578317236611,4.66809045311328e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0620858297725598,0.00394033301979556,-0.0698088824913591,-0.0543627770537604,1.15313536435903e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,29163,-0.0663841526470431,0.00421616962451837,-0.0746478451110991,-0.0581204601829871,1.25812138845356e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0398824701141452,0.00253345243797453,-0.0448480368925753,-0.0349169033357151,1.43664850379005e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0604775361891452,0.00384369242012999,-0.0680111733326,-0.0529438990456905,1.63168671355326e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.0294712014364087,0.00187651429325243,-0.0331491694511834,-0.0257932334216339,2.61209289313949e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0325545285103521,0.0020745736171459,-0.036620692799958,-0.0284883642207461,2.86573778693671e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0696497403558042,0.00445294695178017,-0.0783775163812933,-0.060921964330315,6.34536594600533e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,29628,0.0293913844213063,0.0018883347916362,0.0256902482296994,0.0330925206129133,2.07807632098996e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0464239038433789,0.002994357883986,-0.0522928452959915,-0.0405549623907663,5.35800721300719e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0334575499844371,0.00216883289486006,-0.0377084624583628,-0.0292066375105114,1.76159003599443e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0583750945333989,0.00380221682292363,-0.0658274395063292,-0.0509227495604686,5.43787568576338e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.0784318544932099,0.00510808544975166,-0.0884437019747231,-0.0684200070116966,5.78399528355745e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0418435017191503,0.00272732452662335,-0.047189057791332,-0.0364979456469685,6.39313554302478e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0465567766568988,0.00304342202947236,-0.0525218838346646,-0.0405916694791329,1.39987103967249e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,24381,0.0539328301053215,0.00353425229218206,0.0470056956126447,0.0608599645979984,2.46535055580812e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0451928108605212,0.00296737929380102,-0.0510088742763712,-0.0393767474446712,3.54881699217911e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0374335963351293,0.00246317691533097,-0.042261423089178,-0.0326057695810806,5.82811497073938e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0379840341602846,0.00250103353786041,-0.042886059894491,-0.0330820084260782,6.75272551461728e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.0657692169647789,0.00433102074494747,-0.0742580176248759,-0.0572804163046819,6.93071677026196e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0488483802762407,0.0032171040843015,-0.0551539042814716,-0.0425428562710097,7.72347047530875e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.103535354806674,0.00682005659129577,-0.116902665725614,-0.0901680438877347,8.08230131827743e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0327717681292164,0.00216034067425946,-0.0370060358507649,-0.0285375004076678,8.9070613901447e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0240606429410492,0.00158566982219385,-0.0271685557925491,-0.0209527300895492,8.98611155497107e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,24867,-0.0545358182465989,0.00360420318170819,-0.061600056482747,-0.0474715800104509,1.71161764330298e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.0792162141057107,0.00524312659468371,-0.0894927422312907,-0.0689396859801306,2.21557639210826e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0420110288983055,0.00278833332800576,-0.0474761622211968,-0.0365458955754143,4.16318817990311e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0409733161273542,0.00272404756176087,-0.0463124493484055,-0.0356341829063029,6.59772573260315e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0289862298726131,0.00192972429722177,-0.0327684894951678,-0.0252039702500584,8.30047080977344e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0587544432350721,0.00391946576274673,-0.0664365961300556,-0.0510722903400885,1.30005353734265e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.115455578430412,0.00772910911192059,-0.130604632289777,-0.100306524571048,2.8655554299526e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0427686891645221,0.00286354776647354,-0.0483812427868103,-0.037156135542234,2.95062137022906e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.0304616945424839,0.0020406189168613,0.0264620814654357,0.034461307619532,3.3472427580824e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0689845442129894,0.00462169165741355,-0.0780430598615199,-0.0599260285644588,3.38894538119019e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.0686603861818344,0.00460654074729467,-0.0776892060465319,-0.0596315663171368,4.70421169737346e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0548597991761942,0.00368881337905145,-0.062089873399135,-0.0476297249532533,7.61117741352759e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.0733582706701117,0.00493845690323906,-0.0830376462004603,-0.0636788951397632,9.89432300960451e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0705289620199081,0.00474800160101106,-0.0798350451578898,-0.0612228788819264,1.07776116781002e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,29478,-0.0356994018926204,0.00240719895679221,-0.0404175118479332,-0.0309812919373077,1.40976705211713e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.0771943898116526,0.00521662145694084,-0.0874189678672567,-0.0669698117560486,2.26856737536507e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0512265661946133,0.00346467628158588,-0.0580173317065216,-0.044435800682705,2.76131303499045e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0382723674388075,0.00259211703925688,-0.043352916835751,-0.033191818041864,3.68563936745458e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,29434,-0.0891678238900215,0.00604348760283337,-0.101013059591575,-0.0773225881884681,4.32127084328223e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,29511,0.0370193068517254,0.00251726696433239,0.0320854636016339,0.0419531501018169,8.76484771279207e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0356611750993509,0.00243452911962308,-0.0404328521738122,-0.0308894980248897,2.07066942730893e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.106449358347932,0.00727402031080368,-0.120706438157107,-0.0921922785387567,2.70414580848363e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0334731368484542,0.00229357153452666,0.028977736640782,0.0379685370561265,4.49172559161695e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,29443,-0.0318461635294807,0.002190079331116,-0.0361387190184681,-0.0275536080404933,9.7415374123903e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,29478,-0.0672211290481106,0.00462602861897172,-0.0762881451412952,-0.058154112954926,1.12621090551308e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.029874289726363,0.00205623391623051,0.0258440712505512,0.0339045082021747,1.16473424212505e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,29065,0.0272103231198029,0.00187335406472214,0.0235385491529475,0.0308820970866582,1.23770983651165e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0370818507701098,0.0025523319982317,0.0320792800535757,0.042084421486644,1.250579003649e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.0684463397740195,0.00472092822727993,-0.0776993590994882,-0.0591933204485509,1.93739403296961e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0315668349561159,0.00217880168145378,-0.0358372862517653,-0.0272963836604665,2.2718788064549e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,29820,0.0268113529727451,0.00185421487635778,0.0231770918150839,0.0304456141304064,3.14841125043024e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0260423504672131,0.00180316524159397,-0.0295765543407373,-0.0225081465936889,4.04163883183415e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0274153988997755,0.00190017223839252,-0.0311397364870249,-0.0236910613125262,5.01009220568621e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,29218,0.0252037419792799,0.0017500782690712,0.0217735885719003,0.0286338953866594,7.33111439950696e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0391974013248505,0.00272543170389386,0.0338555551852186,0.0445392474644825,9.64507956595487e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,29639,-0.0564312858738935,0.00392629360484848,-0.0641268213393965,-0.0487357504083905,1.10321678732745e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0582546868166177,0.00405355041765124,-0.0661996456352142,-0.0503097279980213,1.20739750388708e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.120903342105728,0.00843606980196234,-0.137438038917574,-0.104368645293882,1.99007141320492e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.058969672395615,0.00411858657384107,-0.0670421020803435,-0.0508972427108865,2.42315519385152e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.0737818909708234,0.00515373632605234,-0.083883214169886,-0.0636805677717608,2.67232202307455e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0647768613377196,0.00452802718129844,-0.0736517946130646,-0.0559019280623747,2.8716393412617e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0840552747865083,0.00588199916248164,-0.0955839931449723,-0.0725265564280443,3.83686266786468e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,29478,-0.065234600381562,0.00456857179350337,-0.0741890010968286,-0.0562801996662954,4.21744037667486e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,29581,-0.0333632670596327,0.00233825010657876,-0.0379462372685271,-0.0287802968507384,4.89292594677066e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0299293919485716,0.00209716644910017,-0.0340398381888079,-0.0258189457083353,5.02320015985012e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0261765414024995,0.00183640622099554,-0.0297758975956507,-0.0225771852093482,5.99352454978295e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0559096157459217,0.00392270420748365,-0.0635981159925896,-0.0482211154992537,6.1170707039283e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.0939763656666335,0.00661818160436111,-0.106948001611181,-0.0810047297220857,1.30293525562865e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,29725,-0.0532956180092015,0.00377029603375237,-0.0606853982353562,-0.0459058377830469,3.21001030096096e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.0849259452975216,0.00601590762373156,-0.0967171242400355,-0.0731347663550078,4.20662152245632e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0190834583441073,0.00135284241834542,-0.0217350294840644,-0.0164318872041503,4.88054451932582e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.068465509715045,0.00485596593577807,-0.0779832029491701,-0.05894781648092,5.41960262525456e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,29443,0.0274644549914136,0.00194830607083545,0.0236457750925762,0.0312831348902511,5.5852560631059e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0373578574438241,0.00265101317197155,-0.0425538432608884,-0.0321618716267599,6.39398377594013e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0254373830471329,0.00180542091221352,0.0218987580591944,0.0289760080350714,6.55881606930041e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0334829898316744,0.00237994674304618,-0.0381476854480449,-0.0288182942153039,8.21943915795184e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0599330983514776,0.00426176509437518,-0.0682861579364529,-0.0515800387665023,9.52260473697463e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.104457864692184,0.00743482091715307,-0.119030113689804,-0.0898856156945645,1.14598485019819e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0262190075696606,0.00187529920063504,-0.0298945940029052,-0.0225434211364159,2.80837715865632e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.029023835777434,0.00208010226659661,-0.0331008362199634,-0.0249468353349047,4.15579777829213e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0370319701010202,0.0026536086461175,-0.0422330430474105,-0.0318308971546299,4.32730904535332e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0369336897433075,0.00264809217859161,-0.0421239504133471,-0.0317434290732679,4.51524820230978e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,24229,-0.0793519047973518,0.00569737686917292,-0.0905187634609307,-0.0681850461337729,6.34477821167375e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.0888967290335608,0.00639283323698555,-0.101426682178053,-0.0763667758890692,8.05187510389318e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0639000631386785,0.00460293665443881,-0.0729218189813786,-0.0548783072959785,1.11265953346163e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.053193236293949,0.00383473118404104,-0.0607093094146694,-0.0456771631732285,1.289725741434e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.027215337405454,0.00196418524497606,0.0233655343253009,0.0310651404856071,1.60174746187627e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0560791083554861,0.0040474240906641,-0.0640120595731878,-0.0481461571377845,1.61606187889491e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0344351080456802,0.00248699635369583,-0.0393096208989241,-0.0295605951924364,1.97139770954229e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0461866629975506,0.00334180991310744,-0.0527366104272412,-0.0396367155678601,2.59687148035875e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0262533623872783,0.00190221845393663,-0.0299817105569941,-0.0225250142175625,3.43073439255849e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0745679369469323,0.00542434157135626,-0.0851996464267905,-0.063936227467074,7.62995491429902e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.102645772976385,0.00748640128149824,-0.117319119488122,-0.0879724264646489,1.18880895272085e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,24938,0.037536490781875,0.00273878978757924,0.0321684627982197,0.0429045187655303,1.34342529040059e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0214141633062516,0.00156546054331628,-0.0244824659711515,-0.0183458606413517,1.82810290903278e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,24240,-0.0561877801100158,0.00411067735288328,-0.0642447077216671,-0.0481308524983646,2.24201513070934e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0483048576126754,0.00354380255200346,-0.0552507106146022,-0.0413590046107486,3.5201052128534e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0590334017036136,0.00434625986637129,-0.0675520710417014,-0.0505147323655259,6.84158073370364e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0647519349033918,0.00477233523787936,-0.0741057119696353,-0.0553981578371482,8.30437596776783e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0411190798308214,0.00303132583415378,-0.0470604784657628,-0.03517768119588,9.14086339848519e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,24938,-0.104007440508336,0.0076800605365383,-0.119060359159951,-0.0889545218567209,1.23162162313266e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0342655825501512,0.00253191047389877,-0.0392281270789928,-0.0293030380213096,1.31897631688016e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.0675095108486624,0.00500227456643185,-0.0773139689988688,-0.0577050526984559,2.2045057324398e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0387845039685589,0.00287645030587926,0.0331466613690355,0.0444223465680822,2.59343859017088e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.0470985556452137,0.00350299287084996,0.0402326896183477,0.0539644216720796,4.34129387655874e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0427170771128789,0.00317734638104699,-0.048944676019731,-0.0364894782060268,4.400138432016e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0184865053580738,0.00137661830621384,-0.0211846772382529,-0.0157883334778947,5.40956518063812e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,24919,-0.0513300919409545,0.0038249112705925,-0.0588269180313158,-0.0438332658505932,6.41187142637273e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0291218111037856,0.00217083883147095,-0.0333766552134687,-0.0248669669941026,6.87537674557551e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.0832225613610951,0.00621952913266169,-0.095412838461112,-0.0710322842610782,1.08172814434258e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.078590717612473,0.00587982509949431,-0.0901151748074818,-0.0670662604174641,1.2627633576176e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.0777581451583769,0.00581894861750346,-0.0891632844486837,-0.0663530058680701,1.38686224616606e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,24381,-0.0417253361699214,0.00312353244037059,-0.0478474597530477,-0.035603212586795,1.47038706163482e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.0825782770573179,0.00620367925713309,-0.0947374884012987,-0.070419065713337,2.60448362732281e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.066433411494315,0.00500388626362194,-0.076241028571014,-0.056625794417616,4.14149491891477e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0306613053654355,0.00231765290955582,0.0261187056627061,0.0352039050681649,7.68939150574995e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0582641088472865,0.00440904019900037,-0.0669058276373272,-0.0496223900572458,9.34751010188894e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,24938,-0.0673809808193693,0.00510032113261917,-0.0773776102393028,-0.0573843513994357,1.02943932997175e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0291849959467878,0.00221120275274834,0.0248510385514011,0.0335189533421746,1.22364800501304e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0332335351872224,0.00252022476040702,-0.0381731757176202,-0.0282938946568246,1.35822396849383e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0342079110901204,0.00259725173338388,-0.0392985244875528,-0.029117297692688,1.67489547027128e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0768125759744836,0.00583328118109277,-0.0882458070894255,-0.0653793448595418,1.7350236002131e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.0490810260945516,0.00373813216219569,-0.0564077651324551,-0.041754287056648,2.8784953830117e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0306069782356059,0.00233775629978845,-0.0351889805831913,-0.0260249758880205,4.66695326275113e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0470805320883143,0.00359704155536541,-0.0541307335368305,-0.0400303306397981,4.92293072228032e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00789890334689898,0.000604821409616541,0.00671345338405056,0.0090843533097474,7.1384111294502e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.052974853901617,0.00406269675330434,-0.0609377395380935,-0.0450119682651405,9.40305787027936e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,24229,-0.0408209969186843,0.00313303800151193,-0.0469617514016477,-0.0346802424357209,1.12633385441307e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0412048762590867,0.00316692959594531,-0.0474120582671395,-0.0349976942510339,1.3537730036811e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.0878712154859378,0.00676092646846754,-0.101122631364134,-0.0746197996077415,1.70217984567283e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,29435,-0.0297731852541561,0.00229418854054843,-0.034269794793631,-0.0252765757146812,2.08875187279842e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,24557,-0.0211290703370423,0.00162918537184085,-0.0243222736658504,-0.0179358670082343,2.44852155208889e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,29433,0.155755721588412,0.0120745738201899,0.132089556900839,0.179421886275984,5.74459952583349e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0243833395591083,0.00189135661498249,-0.028090398524474,-0.0206762805937426,6.32671982990374e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0242409622356466,0.00188309663242684,-0.0279318316352033,-0.02055009283609,8.0887359664678e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0345770584877974,0.00268804957345474,0.0293084813238261,0.0398456356517687,9.19932723833701e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.043450092083285,0.00339371061335422,-0.0501017648854592,-0.0367984192811107,1.98237103566152e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.043565652949335,0.00341527120470931,-0.0502595845105652,-0.0368717213881048,3.60726862457598e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0284117956218342,0.00222898949183336,-0.0327806150258275,-0.0240429762178408,4.08469632070091e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.0690851268665943,0.00542833263998703,-0.0797246588409688,-0.0584455948922197,5.51645338263699e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0248210199428693,0.00195122041049924,-0.0286454119474478,-0.0209966279382907,5.67427834909573e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0198155714130056,0.00155920080120623,-0.0228716049833699,-0.0167595378426414,6.92004917235694e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0531382732722488,0.00418244729063598,-0.0613358699618954,-0.0449406765826023,6.92906647369149e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0267364536322902,0.00210653422436508,-0.0308652607120458,-0.0226076465525347,8.56177241068543e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.0840260028431248,0.00662304730326607,-0.0970071755575263,-0.0710448301287233,8.72681177040487e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0554923614579356,0.00438893539219115,-0.0640946748266302,-0.0468900480892409,1.51669307644773e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0457039386274839,0.00361640519509329,-0.0527920928098667,-0.038615784445101,1.62282425755e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0784344380957219,0.00622649608535651,-0.0906383704230207,-0.0662305057684232,2.72584720461693e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,29694,-0.037180583909839,0.00295206128270154,-0.042966624023934,-0.031394543795744,2.79352960631737e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0221248869717387,0.00175830537139819,-0.0255711654996792,-0.0186786084437983,3.24703037801085e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0175313467146983,0.00139355213325988,-0.0202627088958877,-0.0147999845335089,3.35060520892946e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0475986334795978,0.00378370455727248,-0.0550146944118518,-0.0401825725473437,3.37584219123937e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.078497974468161,0.00624257380813149,-0.0907334191320988,-0.0662625298042233,3.60921119490939e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0696574692480422,0.00554058961213275,-0.0805170248878224,-0.0587979136082621,3.870297314114e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,28424,-0.0784291471609801,0.00623977502230323,-0.0906591062046944,-0.0661991881172657,3.89092373818379e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.0902977738850598,0.00721133760984172,-0.10443199560035,-0.07616355216977,7.01893576072724e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,24966,0.0198286524042553,0.0015837318699904,0.0167245379390741,0.0229327668694365,7.41967127141404e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0345690024601997,0.00276242237345261,-0.0399833503121668,-0.0291546546082325,7.71431572220069e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0351129760559926,0.0028089859277285,-0.0406185884743405,-0.0296073636376448,9.15446452208742e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0507303106095259,0.00406094762489204,-0.0586897679543143,-0.0427708532647375,1.05442741532864e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,29786,-0.0294242582283227,0.00235698807947186,-0.0340439548640875,-0.0248045615925578,1.12374736487915e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0424044617671826,0.00339731567864608,-0.049063200497329,-0.0357457230370363,1.1531192733232e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0542766195425359,0.00435598995646526,-0.0628143598572078,-0.045738879227864,1.51965998429455e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,28797,-0.0399003777832223,0.00320378959294945,-0.0461798053854032,-0.0336209501810414,1.63989644299733e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,29434,-0.0244914964188471,0.00197388866156456,-0.0283603181955136,-0.0206226746421806,2.90745585828374e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0429995306609107,0.0034679055792209,-0.0497966255961836,-0.0362024357256377,3.24453792576107e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0512980632917937,0.00413766621014149,-0.059407889063671,-0.0431882375199164,3.30308259613245e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0615701330102465,0.00496930438942754,-0.0713099696135245,-0.0518302964069685,3.78457761805058e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0206407284247046,0.00166614155883837,-0.0239063658800278,-0.0173750909693813,3.83532513013315e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,28931,-0.0371903204711608,0.00300394130445545,-0.0430780454278935,-0.0313025955144282,4.09056598227567e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,29725,-0.0337466692072822,0.00272691300943048,-0.0390914187057659,-0.0284019197087984,4.33360064202744e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0341143640540059,0.00275966915572366,-0.0395233155992243,-0.0287054125087875,5.35914430263728e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,24845,-0.0318956815358009,0.00258085551875028,-0.0369541583525515,-0.0268372047190504,5.5496803043663e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0457031165416902,0.00370387901951249,-0.0529627194199347,-0.0384435136634457,6.77573494787313e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.0749344491722438,0.00607431366945338,-0.0868401039643724,-0.0630287943801152,7.05857391328479e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0341582610596314,0.00277800210101687,-0.0396031451776244,-0.0287133769416383,1.15529100685569e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0163888663682876,0.00133323978097208,-0.0190020163389929,-0.0137757163975823,1.21569924508296e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0247348240643386,0.00201331530073202,-0.0286809220537734,-0.0207887260749039,1.36300448212871e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0622274484272142,0.0050686027340978,-0.0721619097860459,-0.0522929870683825,1.52621184215895e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.0648804306956728,0.00528743958003707,-0.0752438122725454,-0.0545170491188001,1.58213593403301e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0580890753459175,0.00473346946149821,-0.067366675490454,-0.048811475201381,1.62189644070189e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0431162369267898,0.00351603562711516,-0.0500076667559355,-0.0362248070976441,1.75076903693078e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,28931,-0.0394307045162917,0.00322763098337236,-0.0457568612437015,-0.0331045477888819,3.0784512448265e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.087067500438327,0.007130665199019,-0.101043604228404,-0.0730913966482498,3.3174953541107e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,29349,-0.0578998700579115,0.00474767281676856,-0.0672053087787779,-0.0485944313370451,3.97758833610139e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0337460333426395,0.0027751582751784,-0.0391853435619892,-0.0283067231232898,6.11511171845316e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0248206754090184,0.00204307166734608,-0.0288250958770167,-0.0208162549410201,7.27507127974113e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,29293,-0.0586548556774122,0.00483470320413712,-0.068130873957521,-0.0491788373973035,8.61171276497429e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0650685464040161,0.00537175651764888,-0.0755971891786079,-0.0545399036294243,1.08398693588407e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.0197859929115664,0.00163420758900822,0.0165829460371103,0.0229890397860225,1.1612747767719e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0503773205708132,0.00416953782211314,-0.0585496147021549,-0.0422050264394714,1.57442950850057e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0278268476606336,0.00230660974860716,-0.0323478027679037,-0.0233058925533636,1.9629462085249e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0405066980401864,0.00336520038592942,-0.047102490796608,-0.0339109052837647,2.73211440261391e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0225233814735027,0.00187131909686487,0.0188555960436476,0.0261911669033579,2.74793041856994e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,29694,-0.0196324489250646,0.00163247473160818,-0.0228320993990166,-0.0164327984511126,3.09278201805112e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.023395919532588,0.00194795268952297,0.0195779322611229,0.027213906804053,3.73308776058292e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.0691014401393557,0.00577004260383414,-0.0804107236428706,-0.0577921566358408,5.88896907021377e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0224061780993884,0.00187244910571182,-0.0260761783465835,-0.0187361778521932,6.37330675250104e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,29566,-0.0338485711663391,0.0028315800469413,-0.039398468058344,-0.0282986742743341,7.37197632591106e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0409462497762555,0.00342632498666953,-0.0476618467501277,-0.0342306528023832,7.99067968142676e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0361109970082939,0.00302679947661212,-0.0420435239824537,-0.0301784700341342,1.01292829520169e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,29478,0.0303032640105951,0.00254123909880072,0.0253224353769457,0.0352840926442445,1.04787547674932e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.068543253353706,0.00575247266899263,-0.0798180997849315,-0.0572684069224804,1.1699238254117e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0510288363688682,0.00428675469209209,-0.0594308755653687,-0.0426267971723677,1.34813939041392e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0290394509619951,0.0024407692948319,-0.0338233587798657,-0.0242555431441246,1.49074523990113e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.0702917900393116,0.00591508950487166,-0.0818853654688601,-0.0586982146097632,1.71162452928657e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,29434,-0.0768141321459254,0.00646522072276561,-0.089485964762546,-0.0641422995293048,1.7604296858394e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0363474393741766,0.00305883898571208,-0.0423427637861722,-0.0303521149621809,1.78087294808572e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.0642811292869249,0.00542335231013546,-0.0749108998147905,-0.0536513587590594,2.54937047324199e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0188924237895041,0.00159451669794451,-0.0220176765174753,-0.0157671710615329,2.5988332123607e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.078736085361507,0.00665548678797401,-0.0917808394659361,-0.065691331257078,3.32315092771128e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0665460958732957,0.00562762830221066,-0.0775762473456286,-0.0555159444009628,3.43115940985677e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0458859390194691,0.00388440627215137,-0.0534993753128858,-0.0382725027260524,3.95983240550006e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0242541114909539,0.0020600013486896,-0.0282917141343855,-0.0202165088475223,6.47686940015101e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,24966,-0.0159607790434691,0.00135906053124227,-0.0186245376847039,-0.0132970204022342,9.19422155552554e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0676765709459051,0.00576908789758758,-0.0789839832251768,-0.0563691586666335,1.07363071551207e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0342269669778646,0.00291863994602794,-0.0399475012720793,-0.0285064326836498,1.09010313373843e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.0505958268669038,0.00431540607894205,-0.0590540227816302,-0.0421376309521774,1.15658097678327e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.021463547592354,0.00183467129409024,-0.0250595033287709,-0.0178675918559371,1.51647472057854e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0297256992927288,0.00254271912835707,-0.0347094287843086,-0.0247419698011489,1.73173934480698e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0409036098098826,0.00349895429235574,-0.0477615602228999,-0.0340456593968654,1.73738243285555e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.038739932899119,0.00331480540412999,-0.0452369514912137,-0.0322429143070242,1.74998176005356e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0229944916647545,0.00196778943106881,-0.0268513589496494,-0.0191376243798596,1.83563690875749e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0862650875050683,0.0073880751996751,0.0717844601137051,0.100745714896431,2.04019130736872e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0290123699891633,0.00248697831326832,-0.0338868474831692,-0.0241378924951574,2.23717578904658e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.059157742376457,0.00507595395094172,-0.0691066121203028,-0.0492088726326112,2.55038696814478e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.0865373133274718,0.00743572085341996,-0.101111326200175,-0.0719633004547687,3.18422144292812e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0241291966564451,0.00207757945217332,-0.0282012523827049,-0.0200571409301854,4.08970402854008e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0200270505004577,0.00172574723795982,-0.0234095150868589,-0.0166445859140564,4.67966334928194e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0535354844283306,0.00461347639687318,-0.062577898166202,-0.0444930706904592,4.74792412001111e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.0670393650938913,0.00579222448063564,-0.0783921250759372,-0.0556866051118455,6.52840330371962e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0476086429317718,0.00411496194551289,-0.0556739683449771,-0.0395433175185665,6.85075117426882e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0361218018509315,0.00312493956289271,-0.0422466833942012,-0.0299969203076618,7.73877550957231e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,24951,-0.0217442551826714,0.0018809102291221,-0.0254308392317508,-0.0180576711335921,7.82996885504052e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0168891528949539,0.0014612667557105,0.0140250700537613,0.0197532357361465,7.87314124903864e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0593306258198288,0.00514326389964595,-0.0694114230631349,-0.0492498285765228,1.01451032369671e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0569249089147586,0.00493607620677928,-0.066599618280046,-0.0472501995494712,1.05484266648638e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.042463285340129,0.00368361878048758,-0.0496831781498847,-0.0352433925303734,1.11531019524112e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0341093708931298,0.00296410333800045,-0.0399190134356106,-0.0282997283506489,1.44701457724856e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.045309192271884,0.00393877244607389,-0.0530291862661888,-0.0375891982775791,1.47338770399829e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,29453,-0.0249363147306234,0.00216946586989608,-0.0291884678356198,-0.0206841616256271,1.6388181872692e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.0491654519613505,0.00428924308869194,0.0407585355075143,0.0575723684151868,2.36254028313525e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0186556359762603,0.00162983894217757,0.0154611516495922,0.0218501203029283,2.8423433178847e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0206193109145062,0.00180389482006419,0.0170836770671804,0.024154944761832,3.50338559971246e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0266347486023969,0.00233171863536986,0.0220645800770719,0.0312049171277218,3.72413426694593e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0659257176659473,0.00578668836073379,-0.0772676268529855,-0.0545838084789091,5.27632795745041e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0516504534038313,0.00454417477737541,-0.0605570359674871,-0.0427438708401755,7.11201439987134e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0184917618832879,0.00162804345555665,0.0153007967103969,0.021682727056179,7.78283684937033e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0404911611333306,0.00358201323079315,0.033470415200976,0.0475119070656852,1.44249596815465e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,29349,-0.0401647831044683,0.00355886857824896,-0.0471401655178362,-0.0331894006911003,1.77352901572933e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.011418344578665,0.00101198683781912,0.00943485037653954,0.0134018387807905,1.87564889984625e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0306827340903925,0.00272218721223971,-0.0360182210263823,-0.0253472471544026,2.10392549614271e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.0532044135420136,0.00472205574497045,-0.0624596428021557,-0.0439491842818715,2.24508456508605e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.029595946430765,0.00262883516324966,-0.0347484633507343,-0.0244434295107957,2.4853543461295e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.0229953480929089,0.00204345833835335,0.0189901697497363,0.0270005264360814,2.63205158989925e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,24381,0.0164276868427131,0.00146372219984264,0.0135587913310216,0.0192965823544047,3.69796045865078e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,29163,-0.0266933877147434,0.00237944064892144,-0.0313570913866294,-0.0220296840428574,3.80299795389094e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,29434,-0.0299447930683409,0.00267311838356135,-0.0351841051001212,-0.0247054810365607,4.55498857456565e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0390590695200392,0.00348622166190723,-0.0458920639773773,-0.032226075062701,4.58582015557308e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0235137783007964,0.00210053323283434,-0.0276308234371517,-0.0193967331644411,4.98556777020012e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,29443,-0.0340598784258646,0.00304655981585055,-0.0400311356649316,-0.0280886211867975,5.85848159424131e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0565374253496195,0.00505780440618705,-0.0664507219857461,-0.0466241287134929,5.97777459763214e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.0727607839292156,0.0065172687617741,-0.0855346307022929,-0.0599869371561384,6.96084802245355e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.048025996432211,0.00430296727063977,-0.0564598122826649,-0.039592180581757,7.40097699710973e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.030020699880265,0.00269194488520534,-0.0352969118552675,-0.0247444879052625,8.01915947593213e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0405880380158125,0.00364051644149492,-0.0477234502411426,-0.0334526257904825,8.27226331936221e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0734428510059564,0.00660106638431092,-0.0863809411192058,-0.060504760892707,1.07071059258828e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,29333,-0.0259167466236437,0.00233130500982231,-0.0304861044428954,-0.0213473888043919,1.18540363215154e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,29474,0.0164461492843327,0.00148055697632226,0.0135442576107411,0.0193480409579244,1.30622868952725e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0783259157217935,0.00705676820640317,-0.0921571814063437,-0.0644946500372433,1.43916060477945e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0461754160040514,0.0041684890663396,-0.054345654574077,-0.0380051774340258,1.84697778032186e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0431359621402866,0.00389811052950876,-0.0507762587781238,-0.0354956655024495,2.09486370346287e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.0504118301403139,0.00455797333673529,-0.059345457880315,-0.0414782024003127,2.22347650252861e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.0708580364820982,0.00640966221761076,-0.0834209744286153,-0.0582950985355811,2.35759539563485e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0210005210134389,0.00191254043572563,-0.0247491002674612,-0.0172519417594167,5.37868780086955e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0467230255649122,0.00425480442198797,-0.0550624422320086,-0.0383836088978157,5.48114914696022e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0217271919327508,0.00198057168099648,0.0178452714379977,0.0256091124275039,6.02412773185342e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0399678741230853,0.00364720568721072,-0.0471163972700184,-0.0328193509761523,6.84646528606247e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.090405726189966,0.00825222119621456,-0.106580079734547,-0.0742313726453855,7.28617742067364e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.02352898476205,0.00214971717820014,-0.0277424304313222,-0.0193155390927777,7.97008800395104e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0210523019433722,0.00192465963789716,-0.0248246348336507,-0.0172799690530938,8.55423267357117e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,29786,-0.0280078938247888,0.00256201786785558,-0.0330294488457857,-0.0229863388037919,9.15552861859432e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.0509952086439829,0.00466858614998027,-0.0601456374979442,-0.0418447797900215,1.03375145000554e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,24445,-0.0959398528394246,0.00878602210600131,-0.113160456167187,-0.0787192495116621,1.07662421591274e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.0216652771536097,0.00198974363462624,-0.0255651746774772,-0.0177653796297423,1.47902718971469e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0515401325460771,0.00473838763521576,-0.0608273723111,-0.0422528927810542,1.67631539453093e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0491426611756849,0.00452469071255304,-0.0580110549722889,-0.040274267379081,1.99212133173213e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0637032774162178,0.00586633871430521,-0.075201301296256,-0.0522052535361796,2.03373297529394e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0285915381980395,0.00263392712271207,-0.0337540353585552,-0.0234290410375239,2.13106094160295e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0341390696712401,0.0031506047136399,0.0279638844325059,0.0403142549099743,2.63275592264437e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0323384680286712,0.00298454365570564,0.0264887624634882,0.0381881735938543,2.63689267653923e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0418507250532325,0.00387181743713439,-0.0494394872300159,-0.0342619628764491,3.51717034230752e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,29443,0.0189793886169355,0.00175798110296682,0.0155337456551205,0.0224250315787505,4.03618955357005e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0565136900105807,0.00525270093181648,-0.066808983836941,-0.0462183961842204,6.16194138873201e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0668764668838061,0.00622773742321037,-0.0790828322332985,-0.0546701015343138,7.52927279534488e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0177129112474804,0.00165078705773838,0.0144773686143131,0.0209484538806476,8.24749314544356e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,24240,-0.0540316538564111,0.00503757696610118,-0.0639053047099694,-0.0441580030028528,8.8532706292322e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0232244620854078,0.00216742277739648,0.0189763134417107,0.0274726107291049,9.65809550472018e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.0486676834931481,0.00454457599886063,-0.0575750524509149,-0.0397603145353813,1.0343094279611e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.0823641041584819,0.00769758030839645,-0.097451361562939,-0.0672768467540249,1.1661130689286e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0558659181924983,0.00522408566905829,-0.0661051261038525,-0.045626710281144,1.21701428217848e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.0279713353866903,0.0026165111907329,-0.0330996973205268,-0.0228429734528539,1.26313835586372e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,24966,0.0222024932772134,0.0020767374430207,0.0181320878888928,0.026272898665534,1.280177259011e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0528860650428412,0.00495372888583839,-0.0625953736590844,-0.0431767564265979,1.51013931298261e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,29433,-0.0270278963373964,0.00253520390944501,-0.0319968959999086,-0.0220588966748841,1.73117304706028e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,29478,-0.0786058113670223,0.00737521065126136,-0.0930612242434946,-0.06415039849055,1.78594037904706e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.027333806583771,0.00256609597833038,-0.0323633547012986,-0.0223042584662435,1.91276543220344e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,29478,-0.0261542613268108,0.00245790319376119,-0.0309717515865828,-0.0213367710670389,2.14746356210161e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0306161875730421,0.00287885853081504,0.0249736248526446,0.0362587502934396,2.29197881919232e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0602543081069337,0.00566857410835038,-0.0713647133593004,-0.0491439028545669,2.48057250187979e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.060569358401198,0.00569996792778057,-0.0717412955396479,-0.0493974212627481,2.51097287403756e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0158709580236307,0.00149341199353937,-0.0187980455309679,-0.0129438705162935,2.54007626666056e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0271529935649762,0.00255785457501328,-0.0321663885320023,-0.0221395985979502,2.81558582820503e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0294354231350226,0.00277391410504175,-0.0348722947809045,-0.0239985514891408,2.99883399902396e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0570202029782126,0.00537857839582482,-0.0675622166340293,-0.046478189322396,3.28331762513643e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,28795,-0.0357587392786925,0.00338598053927125,-0.0423952611356642,-0.0291222174217209,5.05161766136826e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0613783916923361,0.00581342982266384,-0.0727727141447573,-0.049984069239915,5.19096720328949e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.033263704456968,0.00315290381806718,0.0270840129735564,0.0394433959403797,5.64192843000411e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.100548291981106,0.0095400762640589,-0.119246841458661,-0.0818497425035505,6.43986764755281e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0303147260700164,0.00287902866261041,-0.0359576222487328,-0.0246718298913,7.02367706701383e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0297451565469388,0.00282754494718539,-0.0352871446434222,-0.0242031684504555,7.95613662208911e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0299358983594549,0.00284705634027475,-0.0355161287863934,-0.0243556679325164,8.22157273865581e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0516768649885078,0.0049225327883156,-0.0613250292536064,-0.0420287007234093,9.98913861076675e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0327314748638916,0.00312250058929848,-0.0388515760189166,-0.0266113737088666,1.15538761725637e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.0814808955751678,0.0077785901457687,-0.0967269322608745,-0.0662348588894612,1.2727869961056e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.015891947471081,0.00151869114150495,-0.0188685821084307,-0.0129153128337313,1.42450538708827e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0219997493268668,0.00210483574889665,-0.0261252273947043,-0.0178742712590294,1.58940461313714e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0424009710752988,0.00406001106945924,-0.0503585927714389,-0.0344433493791587,1.77026798805552e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,29455,-0.036096717434198,0.00345938849364952,-0.0428771188817511,-0.0293163159866449,1.91251482481934e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0280384525732359,0.00268730423876845,-0.0333055688812221,-0.0227713362652497,1.92519097887532e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0528426004128211,0.0050871757333924,-0.0628134648502702,-0.042871735975372,3.19629017487682e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0433962956222783,0.00418387766068279,-0.0515966958372165,-0.03519589540734,3.67249672187023e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0150390111952614,0.00145109560379099,-0.0178831585786917,-0.012194863811831,4.073079972051e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0602304235684708,0.00581916465600079,-0.0716359862942323,-0.0488248608427092,4.68941702874008e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0571171888385131,0.00552331076755858,-0.0679428779429279,-0.0462914997340983,5.06822834643208e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.0189046030213447,0.00183431386208722,-0.0224998581910356,-0.0153093478516537,7.28709653126708e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0281988470291029,0.00273895234354809,0.0228305004357487,0.0335671936224572,8.13676903530486e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0213444555165926,0.00207321117856777,-0.0254079494265855,-0.0172809616065998,8.29007142690706e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.018436069866157,0.00179093632733082,0.0149258346645886,0.0219463050677254,8.40304474655315e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0283905427236926,0.00276384478995991,-0.033807678512014,-0.0229734069353712,1.03834688545206e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0389189022637588,0.00379600574578785,-0.046359073525503,-0.0314787310020146,1.27016019189665e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0570075707700623,0.00556554292457793,-0.0679160349022351,-0.0460991066378896,1.39874509093195e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.030736728674885,0.00300271351763829,-0.0366220471694561,-0.024851410180314,1.52824620346942e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0941075627831784,0.00920454526539919,-0.112148471503361,-0.076066654062996,1.70134578676573e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,29227,-0.0503783839438609,0.00493116880228726,-0.0600434747963439,-0.0407132930913779,1.842487711253e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0391473562286042,0.00383496806121212,-0.0466638936285799,-0.0316308188286285,2.00546715469216e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0335359576644168,0.00328833220835939,-0.0399810887928012,-0.0270908265360324,2.25048778125199e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,28916,0.0162866089968279,0.00159742420248755,0.0131556575599523,0.0194175604337035,2.28272591503781e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0244628365260351,0.00240187790351902,-0.0291705172169324,-0.0197551558351378,2.5933431741664e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,24381,-0.0214800645615489,0.00211195897836664,-0.0256195041591475,-0.0173406249639503,2.99662713899919e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.016129558413383,0.00158730135941034,-0.0192406690778273,-0.0130184477489388,3.22746004315968e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0149189919923686,0.00147000601740331,0.0120377801982581,0.0178002037864791,3.73279759330839e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,29454,-0.0181753076708602,0.00179583344709783,-0.021695141227172,-0.0146554741145485,4.89022801416157e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,24966,-0.0149173539636314,0.00147603129185514,-0.0178103752956674,-0.0120243326315953,5.75571648986593e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.0721860180125568,0.00714638911290959,-0.0861929406738596,-0.058179095351254,6.07954306178929e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0400337172204114,0.0039738075963425,-0.0478223801092427,-0.0322450543315801,7.85452174047566e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0315330277525679,0.00313304356638887,-0.0376737931426901,-0.0253922623624458,8.64982906011713e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.0677152157389493,0.00672881107405523,-0.0809036854440976,-0.0545267460338011,8.74568945026941e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.01977977638183,0.0019664562838894,-0.0236340306982532,-0.0159255220654067,9.20006840413424e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,29694,-0.0414371581104937,0.00412292844616293,-0.049518097864973,-0.0333562183560143,9.98366282988378e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,29581,-0.0323162655100109,0.00322643101872082,-0.0386400703067038,-0.0259924607133181,1.41223605341686e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,24805,-0.0712033668172245,0.00710809806072158,-0.0851352390162388,-0.0572714946182103,1.41989284795394e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0259228361956738,0.00258995381463685,-0.030999145672362,-0.0208465267189856,1.54254337397494e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0228186538089143,0.00228123960683856,-0.0272898834383179,-0.0183474241795107,1.6194608117072e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,28774,-0.0237583596688102,0.00237528578695629,-0.0284139198112446,-0.0191027995263759,1.62654881993459e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,29349,-0.0207883565214631,0.00208125521578034,-0.0248676167443926,-0.0167090962985337,1.8681942573086e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0356530755344052,0.00357081262255985,0.0286542827941879,0.0426518682746225,1.94022256108061e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,24951,-0.0157676779068071,0.00158008917298213,-0.018864652685852,-0.0126707031277621,2.08443191058406e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0211814230683653,0.0021247643301148,-0.0253459611553903,-0.0170168849813403,2.30762724313935e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0564445950630512,0.00567855757860762,-0.0675745679171221,-0.0453146222089803,3.08347004735205e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0287598735133725,0.00289518206142319,-0.0344344303537619,-0.023085316672983,3.22975400004999e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0398543594258109,0.00401275737176314,-0.0477193638744667,-0.0319893549771552,3.34147251623185e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,29349,-0.0692053216800457,0.00697368502072008,-0.0828737443206571,-0.0555368990394344,3.56886459961672e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0355087555630594,0.00358022881565238,-0.0425260040417381,-0.0284915070843807,3.84798142428504e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0224394975196848,0.00226282757314307,-0.0268746395630452,-0.0180043554763244,3.90360575058744e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0326664199998912,0.0032949007577186,-0.0391244254850197,-0.0262084145147627,3.92481449449626e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0332631626773653,0.00335643919828798,-0.0398417835060098,-0.0266845418487209,4.08480313983098e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0282873376211945,0.00285673969176926,-0.0338865474170622,-0.0226881278253267,4.43136658850244e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0596995656779383,0.00602952548045082,-0.0715174356196219,-0.0478816957362547,4.53850377731823e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.0424822295606879,0.00429661099190762,-0.0509035871048269,-0.034060872016549,5.20802471431186e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.0515371048669563,0.00522243331964206,-0.0617730741734548,-0.0413011355604579,6.30727473316642e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0397685856078914,0.00403276406238235,-0.0476728031701608,-0.031864368045622,6.63789104360204e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0202057790976535,0.00204970451018657,0.0161883582576878,0.0242231999376192,6.86838951989991e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0259399267764424,0.00263417425762032,-0.0311029083213782,-0.0207769452315066,7.62263529928253e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0501715990818771,0.0050973185691132,-0.060162343477339,-0.0401808546864152,8.1088395134841e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0270843983320274,0.0027524458073221,-0.0324791921143787,-0.021689604549676,8.34463376073479e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,29349,0.0301822262106507,0.00308007228384656,0.0241452845343115,0.03621916788699,1.22943860285743e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0355564505822297,0.00363834673021364,-0.0426876101734484,-0.0284252909910109,1.59685920968057e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,24867,0.0310232078206959,0.00317518270917554,0.0247998497107118,0.03724656593068,1.65407803477235e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,29434,-0.0542219333313058,0.00555108176788226,-0.0651020535963551,-0.0433418130662566,1.67443144508844e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0233926611264049,0.00239577469200697,-0.0280883795227385,-0.0186969427300712,1.73612438510049e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0437517844352544,0.00448086954414474,0.0349692801287307,0.052534288741778,1.7366325300689e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0522037844496361,0.00535113407999843,0.0417155616528391,0.062692007246433,1.88691492441365e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0433614354662973,0.0044446283621651,-0.0520729070561409,-0.0346499638764537,1.91279252346623e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0165553571056793,0.00170022532128523,-0.0198877987353984,-0.0132229154759603,2.2604800234546e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0165929230976937,0.00170421459814862,0.0132526624853224,0.019933183710065,2.27716709014233e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.0827483346177666,0.00851308034038449,-0.0994339720849202,-0.066062697150613,2.67220892541325e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,23389,-0.0162518022308461,0.00167241076252779,-0.0195297273254006,-0.0129738771362916,2.79592761254198e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0500145991649918,0.00515253476068374,-0.0601135672959319,-0.0399156310340516,3.04710526063638e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0335291625771234,0.0034629970689678,-0.0403166368323003,-0.0267416883219465,3.9372942033847e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0112857294618599,0.00116733648902363,-0.0135737089803462,-0.00899774994337362,4.51119705105511e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.0386074791602998,0.00399455688052869,0.0307781476744636,0.046436810646136,4.57516785353282e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0285209159716577,0.00295354228907147,-0.0343098588582378,-0.0227319730850777,4.97370102142462e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0187726510891303,0.00194549904992731,0.0149594729512728,0.0225858292269879,5.33645085872184e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.0721713723468786,0.00748254195326445,-0.086837154575277,-0.0575055901184803,5.62942706085557e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0303006602030233,0.00314503207401665,-0.036464923068096,-0.0241363973379507,6.16321842615236e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.0901413382154348,0.0093562349167901,-0.108479558652343,-0.0718031177785262,6.1696399671885e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0249912639375153,0.00259610434242399,0.0199028994263643,0.0300796284486664,6.66647253916684e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.045451827734435,0.00472565942623695,-0.0547141202098595,-0.0361895352590106,7.23167603017308e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0209781835936321,0.00218460914394447,-0.0252600175157633,-0.016696349671501,8.38072170118382e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0542918031727728,0.00565705347321071,-0.0653796279802658,-0.0432039783652798,8.96434664108907e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,24890,-0.0305572607604354,0.00318895080528258,-0.0368076043387893,-0.0243069171820816,1.03537203071661e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0287043490093798,0.0029991915620931,-0.0345827644710823,-0.0228259335476774,1.14257257417385e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0434399381724517,0.00454163234462322,-0.0523415375679132,-0.0345383387769902,1.21033539064714e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0195824907496015,0.00204749342015038,-0.0235955778530962,-0.0155694036461067,1.21670375945429e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0410874484495127,0.00430440613017817,-0.049524084464662,-0.0326508124343635,1.4758564291721e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0337040962387032,0.00353976358705275,-0.0406420328693265,-0.0267661596080798,1.83136510316223e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0226671942675915,0.00238099638816168,0.0180004413467946,0.0273339471883884,1.85874881242724e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.033521477267626,0.00352555780580516,-0.0404315705670042,-0.0266113839682479,2.08687411003817e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0256460482465244,0.00270001439759111,-0.030938076465803,-0.0203540200272458,2.28531637050133e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.0699295767007792,0.00736511563063783,-0.0843652033368293,-0.055493950064729,2.40057227809862e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0664136044677834,0.007008306462642,-0.0801498851345618,-0.0526773238010051,2.82115116131216e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.04969374366647,0.00524454436499938,-0.0599730506218687,-0.0394144367110712,2.85174726480767e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0205402734446419,0.00216934959337467,-0.0247921986476563,-0.0162883482416276,3.04387857886453e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0226414414926643,0.00239154559542741,-0.0273288708597021,-0.0179540121256266,3.12561314253577e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.045818003261166,0.00484439773226864,-0.0553130228164125,-0.0363229837059194,3.36814971355395e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0370089515647651,0.00392192447683473,-0.0446959235393611,-0.029321979590169,4.13116937761003e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0287590477820092,0.00305032604199581,-0.034737686824321,-0.0227804087396974,4.46459308048104e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,29349,0.0188452344149581,0.00199886311469541,0.0149274627101551,0.0227630061197611,4.47808727879438e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.0186363404356174,0.00198054734024959,-0.0225182132225066,-0.0147544676487282,5.3940420630972e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0253670997870985,0.00269920656754682,-0.0306575446594903,-0.0200766549147068,5.96001253052276e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.025386177856759,0.00270149820665529,-0.0306811143418034,-0.0200912413717146,6.07897234391901e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0430542209408661,0.00459664282100098,-0.052063640870028,-0.0340448010117041,8.13073050108545e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,24922,-0.0295631902773766,0.0031578405829903,-0.0357525578200376,-0.0233738227347156,8.47751598355896e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,28870,-0.0318471421054821,0.00340405610641727,-0.0385190920740599,-0.0251751921369042,8.89149803267415e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,29434,0.0277249564849833,0.0029660539846628,0.0219114906750442,0.0335384222949224,9.59590956379553e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0367998303005733,0.00394227495658088,-0.0445266892154718,-0.0290729713856748,1.08368137535216e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,24240,0.0412830273798631,0.00442472187388545,0.0326105725070477,0.0499554822526786,1.14574202393614e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0161075698129844,0.00172712207420489,-0.0194927290784259,-0.0127224105475428,1.1852189530257e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0325926591777688,0.00349558609491126,-0.0394440079237948,-0.0257413104317427,1.19658060077685e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,24229,-0.0592862464302981,0.00635809927525264,-0.0717481210097933,-0.0468243718508029,1.20725517259087e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.0707426262431399,0.00759385323201645,-0.0856265785778921,-0.0558586739083877,1.29318465592851e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.0621345364785127,0.00667437627846496,-0.075216313984304,-0.0490527589727213,1.37391138009624e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,29478,-0.0361092913621588,0.00388536715764197,-0.0437246109911371,-0.0284939717331806,1.59021075211632e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.0634312107060984,0.00683782196923064,-0.0768333417657905,-0.0500290796464063,1.86655884659717e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0241576498934678,0.00260527692262845,-0.0292639926618196,-0.019051307125116,1.9372284617808e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0597329927476235,0.00644205503984246,-0.0723594206257148,-0.0471065648695323,1.94242441277302e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0332884165754422,0.0035983249807047,-0.0403411335376234,-0.026235699613261,2.3958135670357e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,29335,-0.0289329025339034,0.00312916783895146,-0.0350660714982482,-0.0227997335695585,2.47908588467847e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0227866521706502,0.00246516530829303,-0.0276183761749045,-0.0179549281663959,2.54461974666329e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.0602922768077532,0.00652675001104531,-0.073084706829402,-0.0474998467861044,2.68541834004785e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0223843991457164,0.00242758999236161,0.0176263227606877,0.0271424755307452,3.13838825585783e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.0214920157834373,0.00233194372475143,-0.0260626254839502,-0.0169214060829245,3.27394775090394e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0206010280466355,0.00223562463458397,0.0162192037628509,0.02498285233042,3.35506362849361e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0515686461365528,0.00560602123618516,-0.0625564477594757,-0.0405808445136299,3.89547758788682e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0383231162934742,0.00417529209158506,-0.046506688792981,-0.0301395437939675,4.65348937084539e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0518768183635079,0.0056534579946888,-0.0629575960330979,-0.0407960406939178,4.75308362839356e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0500613237764234,0.00545522502033633,-0.0607535648162826,-0.0393690827365642,4.78752229131474e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0293360730822922,0.00320516155656049,-0.0356181897331508,-0.0230539564314337,5.90278479651049e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,29566,-0.0354445003679068,0.00387688438976041,-0.0430431937718372,-0.0278458069639764,6.48111756474871e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.035978855423459,0.00393570318782569,-0.0436928336715973,-0.0282648771753206,6.53122029231795e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0200696950786328,0.00219568665050389,-0.0243732409136205,-0.0157661492436452,6.60038424840571e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,29169,-0.0319097501611147,0.00349225673752068,-0.0387545733666552,-0.0250649269555742,6.80723956406516e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0486730794209746,0.00533388754821264,-0.0591274990154714,-0.0382186598264778,7.69630506879608e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0344348446244577,0.00377408340973498,-0.0418320481075382,-0.0270376411413771,7.7725573877645e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0346988445420979,0.00380727154473768,-0.0421610967697838,-0.0272365923144121,8.45424972042161e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0234804859715655,0.00257824922081169,-0.0285338544443564,-0.0184271174987746,8.98798346032072e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0202243841561928,0.0022220078395372,-0.0245795195216858,-0.0158692487906999,9.42028149369567e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.058844101835258,0.00647146973599168,-0.0715281825178017,-0.0461600211527143,1.02351348243309e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0377531540331775,0.004158692923089,-0.0459041921624319,-0.029602115903923,1.17220193003269e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0255551826110938,0.0028163865693574,-0.0310753002870343,-0.0200350649351533,1.22094830295036e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0436372735318625,0.00482493365880377,-0.0530941435031178,-0.0341804035606071,1.61648635166746e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,29478,-0.074943421984814,0.00828922642403204,-0.0911903057759168,-0.0586965381937113,1.644143447083e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0207413721431636,0.00229548556466565,0.0162422204364189,0.0252405238499083,1.72711234878512e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0425932261347663,0.00471521509560059,-0.0518350477221435,-0.0333514045473892,1.78964751136832e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.019344527554134,0.00214415874647277,-0.0235470786972207,-0.0151419764110474,1.97779587715118e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.047208148610217,0.00523502156416747,-0.0574687908759852,-0.0369475063444487,2.05850786926824e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0447418990930222,0.00497718788055522,-0.0544971873389104,-0.0349866108471339,2.65828869881495e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,24922,-0.019207514686125,0.0021369207787466,-0.0233958794124683,-0.0150191499597816,2.68215797447633e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.049068899748213,0.0054637753398011,-0.0597778994142231,-0.0383599000822028,2.87487971274093e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0162710883066016,0.00181213950956046,0.0127192948678631,0.0198228817453401,2.89329323221868e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0356416764095103,0.00397013093522085,-0.0434231330425432,-0.0278602197764774,2.96638002367837e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0469034757272692,0.00522917886115487,-0.0571526662951327,-0.0366542851594056,3.18225424012842e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0407768480859715,0.00455079511517249,-0.0496964065117096,-0.0318572896602334,3.4225781473076e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.016113446806412,0.00180213627346128,-0.0196456339023961,-0.0125812597104279,4.06470500722757e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0573823316607607,0.00642994907901137,-0.069985031855623,-0.0447796314658985,4.74339737670068e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.030953013992015,0.0034821465423128,-0.0377780212149481,-0.024128006769082,6.50646822617882e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0638458508107868,0.00718264371557112,-0.0779238324933062,-0.0497678691282674,6.51384566490155e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,29362,-0.0255429701214342,0.00287454006845614,-0.0311770686556082,-0.0199088715872601,6.69270377491711e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,29694,-0.0218751608337297,0.00246566645807,-0.0267078670915469,-0.0170424545759125,7.58492951297257e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0626210800245277,0.00706106250003753,-0.0764607625246013,-0.0487813975244542,7.82430192524849e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.0180254137704862,0.00203287366737388,-0.022009846158539,-0.0140409813824334,8.01106620552474e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0471526556499712,0.00532519537894343,-0.0575900385927003,-0.036715272707242,8.94428415329065e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,29135,-0.0207213569553271,0.00234074951199151,-0.0253092259988304,-0.0161334879118237,9.03696889560933e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0313629102071377,0.00354447058580346,-0.0383100725553125,-0.0244157478589629,9.36781768413851e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,24381,-0.0422214546330707,0.0047858735877535,-0.0516017668650676,-0.0328411424010739,1.197096022563e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.038039301956846,0.00432157563783748,-0.0465095902070074,-0.0295690137066845,1.41362707079488e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0412919842284149,0.00469224886839611,-0.0504887920104713,-0.0320951764463585,1.45499144253637e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0238963772589434,0.00271771909510365,-0.0292231066853465,-0.0185696478325402,1.55433122813671e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,29030,-0.0254678267906908,0.00289788772056653,-0.0311476867230012,-0.0197879668583804,1.59887844506966e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,28931,-0.0313711393655133,0.00357541255707335,-0.0383789479773771,-0.0243633307536495,1.81506236427622e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0162153010443949,0.00185137019866377,-0.0198439866337759,-0.0125866154550139,2.08100649698721e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0445119488778323,0.00508294866417511,-0.0544745282596155,-0.0345493694960491,2.12852761346956e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,29594,-0.0338317085615715,0.00386944806697338,-0.0414158267728394,-0.0262475903503037,2.38166227420938e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,24951,-0.0423719915178682,0.00486787281758422,-0.0519130222403333,-0.0328309607954031,3.38594164674477e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0180111520742527,0.00206919684649529,0.0139555262551219,0.0220667778933834,3.39186632942044e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0352759860172416,0.00405394008987261,-0.0432217085933919,-0.0273302634410913,3.47511654639805e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.055366302180466,0.00636475749248123,-0.0678412268657292,-0.0428913774952028,3.52602707727966e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,29478,-0.0320566431906905,0.00368670661712048,-0.0392825881602466,-0.0248306982211344,3.63866072488043e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0499746187052594,0.00574768716049379,-0.0612400855398273,-0.0387091518706916,3.65426902077915e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0271054029630958,0.00311908842595703,0.02099198964822,0.0332188162779716,3.80161944035305e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0213087390277618,0.00246010268958377,-0.026130540299346,-0.0164869377561776,4.92503747113317e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0574221671909141,0.00664118076902067,-0.0704388814981947,-0.0444054528836336,5.58115087896883e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,24845,-0.0130689111730018,0.00151314609314536,-0.0160346775155667,-0.0101031448304369,6.11645140738344e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0135292294856697,0.00156809829843173,-0.0166027021505959,-0.0104557568207435,6.56439161636848e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,24793,-0.0369955149617126,0.00428958574138274,-0.0454031030148228,-0.0285879269086025,6.81650572011081e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0426190796618251,0.00494216330508674,-0.0523057197397952,-0.0329324395838551,6.88155382562299e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0305004086909016,0.00354364347036533,-0.0374459498928177,-0.0235548674889856,7.86153004158431e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0385921161055028,0.00449540805190042,-0.0474031158872276,-0.029781116323778,9.62473597115161e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0252930593457551,0.00294702878473103,-0.0310692357638279,-0.0195168829276823,9.81384109143716e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0243859467791128,0.00284699509403047,-0.0299660571634125,-0.0188058363948131,1.13751550436524e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0363613299728448,0.00425034302287341,-0.0446920022976767,-0.0280306576480129,1.24868279104983e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0311320999403956,0.00364180813238606,-0.0382700438798723,-0.023994156000919,1.31851380340017e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0192646005010457,0.00225414985013936,0.0148464667947726,0.0236827342073189,1.34285474603725e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0329381767396512,0.003858124606924,-0.0405001009692223,-0.0253762525100802,1.45273270342151e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0165986107225962,0.00194510514236918,-0.0204110168016397,-0.0127862046435526,1.48604416855587e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.0567019364152081,0.00664592257547702,-0.0697279446631431,-0.0436759281672731,1.5234612971145e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,23907,-0.0414051604390081,0.00485757654600475,-0.0509260104691774,-0.0318843104088388,1.63355041260122e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0356883611798695,0.00418896721641494,-0.0438987369240428,-0.0274779854356962,1.69271310723726e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0254029708205207,0.00298260600178091,-0.0312488785840113,-0.0195570630570301,1.73061465059127e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,29478,-0.0246878217036342,0.00290393680820944,-0.0303795378477248,-0.0189961055595437,1.95860761277041e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0445559343388603,0.0052463002575658,-0.0548386828436893,-0.0342731858340313,2.10975062370564e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0272300143436537,0.00320850767047779,-0.0335186893777902,-0.0209413393095173,2.22423272484222e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),24484,0.103629144634321,0.0122216127414971,0.0796747836609863,0.127583505607655,2.39427701991883e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0173602955639048,0.00204880434389583,-0.0213759520779406,-0.013344639049869,2.49330344697035e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0303095169263626,0.00357764479447568,-0.0373217007235349,-0.0232973331291902,2.52696273603407e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0280032064782123,0.00330814103450338,0.0215192500505857,0.0344871629058389,2.68136396486434e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0188308171512879,0.00222756039285785,-0.0231968355212893,-0.0144647987812866,2.95455717750947e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.052080422995731,0.00616075802708625,-0.06415550872882,-0.0400053372626419,2.98220094291358e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.0625545638618699,0.00740632167183537,-0.0770709543386672,-0.0480381733850726,3.17466651649716e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,29820,0.0174801833577468,0.00207033138892209,0.0134223338354596,0.0215380328800341,3.22623988545424e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0364135200860585,0.00431607318031705,-0.04487302351948,-0.0279540166526371,3.43872764586545e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.0241192536323253,0.0028594647459909,0.0185147027301832,0.0297238045344675,3.49492183022576e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0166382406619997,0.00197325101045938,0.0127706686814994,0.0205058126425001,3.55378138994707e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0375205074873735,0.00445048109019015,-0.0462434504241462,-0.0287975645506008,3.59223438974446e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0366543074700552,0.00434853890098995,-0.0451774437159956,-0.0281311712241149,3.66893837223989e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0300732739846962,0.00357374078406901,-0.0370778059214715,-0.023068742047921,4.10063445220039e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,24966,-0.0238740135821933,0.00283968782649221,-0.029439801722118,-0.0183082254422686,4.41795818627743e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0256472818796045,0.00305089057714626,-0.0316270274108112,-0.0196675363483979,4.454158900449e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0415168357908317,0.00494072128625643,-0.0512006495118943,-0.0318330220697691,4.58236324444954e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0386541287601908,0.00461242397819425,-0.0476944797574516,-0.0296137777629301,5.50295154740214e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0443208503056473,0.00528967508674571,-0.0546886134756689,-0.0339530871356257,5.62865161182585e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0181674047830705,0.00217109721625687,-0.022422755326934,-0.0139120542392071,6.17315227296019e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0232136878256731,0.00277523418051226,-0.0286531468194772,-0.0177742288318691,6.2939487694915e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0392515320158554,0.00469217625441478,-0.0484481974745083,-0.0300548665572024,6.31465030514256e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0269479430088705,0.00322593433924055,-0.0332707743137819,-0.020625111703959,6.96772623018019e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,29478,0.017663538693384,0.00211872316382916,0.0135108412922788,0.0218162360944891,7.95564256190366e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0378494475426863,0.00454112025378638,-0.0467500432401076,-0.028948851845265,8.17059554959686e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,28774,-0.0405779459713113,0.00487519020195304,-0.0501333187671393,-0.0310225731754834,8.92502465568057e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0195974134894261,0.00235492987047979,-0.0242130760355665,-0.0149817509432857,9.02567307411267e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.028759198122929,0.00346127446051223,-0.035543296065533,-0.021975100180325,1.01502541043314e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.023120696870715,0.00278801996186203,0.0176561777454654,0.0285852159959646,1.15218268330589e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0309958593166971,0.00374039008344262,-0.0383270238802447,-0.0236646947531496,1.22302212081726e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,24938,-0.0159168474899365,0.0019217521077888,-0.0196834816212026,-0.0121502133586705,1.26643211726249e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0191457979809878,0.00231366283145268,-0.023680577130635,-0.0146110188313405,1.33643571085283e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,24688,-0.0530188922304382,0.00640883183734043,-0.0655802026316255,-0.040457581829251,1.37402003499249e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.0136958939255798,0.00165585578935322,0.0104504165784475,0.0169413712727121,1.38137965828687e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,24922,-0.0168175891686449,0.00203439969533905,-0.0208050125715094,-0.0128301657657803,1.44619779583127e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0377509314002442,0.00456999954078881,-0.0467081305001903,-0.0287937323002982,1.51099048869181e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0223790779036065,0.00270944638072792,-0.0276895928098332,-0.0170685629973798,1.52148407532188e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.0135472006285074,0.00164319973485681,-0.0167678721088267,-0.010326529148188,1.74319124230168e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0694654036533617,0.00843481204027562,-0.0859976352523019,-0.0529331720544215,1.87940408490511e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0249951099845995,0.00303573801100192,-0.0309451564861633,-0.0190450634830357,1.89247407675667e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0351796498700214,0.0042732935961249,-0.0435553053184262,-0.0268039944216166,1.92603470229302e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0324336575214859,0.00394745722327601,-0.0401706736791069,-0.024696641363865,2.18480576644694e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0379958791012641,0.00462498437799084,-0.0470608484821262,-0.0289309097204021,2.20071308185712e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.04053177380314,0.00494246657686327,-0.050219008293792,-0.0308445393124879,2.48520058740376e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,28654,-0.03940947775411,0.00481130278620941,-0.0488396312150805,-0.0299793242931396,2.69698521645198e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0189134874612684,0.00231589674234805,-0.0234526450762705,-0.0143743298462662,3.29202667105938e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0356104858242293,0.00436499766617207,-0.0441658812499266,-0.0270550903985321,3.55964498954983e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0254736931117238,0.00313604030943058,-0.0316203321182078,-0.0193270541052399,4.73336652733247e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0568589916938918,0.00702239402085942,-0.0706228839747763,-0.0430950994130074,5.90520908871537e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,29443,0.0132747627160119,0.00164038249933063,0.0100596130173238,0.0164899124146999,6.06948499402545e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0498587399788003,0.00616645416040573,-0.0619449901331955,-0.037772489824405,6.47221263089154e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0306540693838627,0.00379473757227238,-0.0380917550255166,-0.0232163837422089,6.82756895329162e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0299850666233303,0.00371169733293254,-0.0372599933958781,-0.0227101398507825,6.85715690511595e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,29694,-0.0124087797913915,0.00153771077449226,-0.0154226929093963,-0.00939486667338668,7.31424871185871e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0133512485892619,0.0016552592565502,0.0101069404464235,0.0165955567321003,7.54039247460764e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0514571919499266,0.00638294816330877,-0.0639677703500118,-0.0389466135498414,7.86246945670934e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,24966,-0.011399333982452,0.00141428077119543,-0.0141713242939951,-0.00862734367090899,7.95805302705603e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0177456661992093,0.00220385155029405,-0.0220652152377856,-0.0134261171606329,8.50675479736013e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.0563496275709698,0.00699981381874451,-0.0700692626557091,-0.0426299924862306,8.63678097324954e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0413784447127719,0.00514399656386904,-0.0514606779779552,-0.0312962114475886,9.07872710026148e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0346146312739435,0.00431107505099151,-0.0430643383738868,-0.0261649241740001,1.01795935733014e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0145893424260773,0.00181927493144086,-0.0181551212917014,-0.0110235635604532,1.10217128508814e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0313456338207407,0.00390971655294389,-0.0390086782645107,-0.0236825893769707,1.1197900715437e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0292797623690635,0.00365322989561211,-0.0364400929644632,-0.0221194317736637,1.1536570417325e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.023531028942475,0.00293845164294893,-0.0292903941626549,-0.0177716637222951,1.2090349838195e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,24801,-0.0175895652004126,0.00219637686569007,-0.0218944638571652,-0.0132846665436601,1.21234652924248e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.0126134470279658,0.00157681348375981,0.00952289259979654,0.015704001456135,1.29622947303974e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0354953676981516,0.00444298316495631,-0.044203614701466,-0.0267871206948373,1.40866488525599e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.0218258582817691,0.00273552456288396,-0.0271874864250217,-0.0164642301385166,1.54269356024288e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0120952216487046,0.00151734838130309,-0.0150692244760587,-0.00912121882135055,1.62601353499087e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0421479333128514,0.00529906794338223,-0.0525341064818806,-0.0317617601438222,1.88677787893682e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0194795973973578,0.00245432062505201,-0.0242900658224598,-0.0146691289722559,2.16300475175543e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,28931,-0.0380590237768644,0.00480387543981646,-0.0474746196389046,-0.0286434279148241,2.40965450885004e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0184897933227159,0.00233667802844926,-0.0230696822584764,-0.0139099043869553,2.61958016739303e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0164231956400737,0.00208089758328684,-0.0205017549033159,-0.0123446363768315,3.09007632961389e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0626274335247876,0.0079438420576227,-0.0781973639577281,-0.0470575030918471,3.28706666325144e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0227713616211062,0.00288844859859528,-0.0284327208743529,-0.0171100023678594,3.2894592798887e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0205492751340675,0.00260670993500814,-0.0256584266066835,-0.0154401236614515,3.32083601156832e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0314974160912593,0.00399651700134858,-0.0393305894139025,-0.0236642427686161,3.35349477652623e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,29757,0.0247491995078617,0.00314327199925299,0.0185883863893258,0.0309100126263975,3.55943203088252e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.017801723771425,0.0022613670712574,-0.0222340032310895,-0.0133694443117605,3.63164791168792e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0356252888848506,0.00452752533742697,-0.0444992385462075,-0.0267513392234938,3.73166051216535e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0191917238514771,0.00243999344941977,0.0144093366906144,0.0239741110123399,3.80086067906289e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,29163,-0.0429278657044225,0.00545832871909727,-0.0536261899938532,-0.0322295414149919,3.8285038398746e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,29218,0.0226122276805766,0.00287667770807683,0.016973939372746,0.0282505159884071,3.95598004362447e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,29760,-0.0109942439485786,0.00139940434350038,-0.0137370764618393,-0.00825141143531782,4.08680758873909e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.040778016000784,0.00519288893885504,-0.0509560783209398,-0.0305999536806281,4.23663925815234e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.0392078903385239,0.00499385355337119,-0.0489958433031314,-0.0294199373739164,4.25899527092951e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0308724427780237,0.00393770624923669,-0.0385903470265276,-0.0231545385295197,4.65045167134967e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,28774,-0.0360730342854838,0.00460523179559911,-0.045099288604858,-0.0270467799661095,4.92493285364162e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0514276422802813,0.00657175343925962,-0.0643082790212302,-0.0385470055393324,5.22668335147728e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0197411432294288,0.00252426771436291,-0.0246887079495801,-0.0147935785092775,5.43520158584616e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0374636432082171,0.00479103873623326,-0.0468540791312343,-0.0280732072851999,5.47890130611101e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.0278919646502528,0.00357406474716053,-0.0348971315546875,-0.0208867977458182,6.19798124550881e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0137047261804437,0.00175654280472609,0.0102619022831805,0.0171475500777068,6.2890737800756e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0344383209029205,0.00441436213012569,-0.0430904706779669,-0.0257861711278742,6.36145998447014e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.0100199512069415,0.00128469995228057,0.00750193930047154,0.0125379631134114,6.4606148827924e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,24240,-0.0155723092125911,0.00199746051606772,-0.0194873318240838,-0.0116572866010984,6.64335041051421e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0176823525353234,0.00226890775157101,-0.0221294117284026,-0.0132352933422442,6.74151734497879e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0228048132857724,0.00292962368066802,-0.0285468756998817,-0.0170627508716631,7.29269841732914e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0304968398456067,0.00391922459381695,-0.0381785200494879,-0.0228151596417254,7.41180813178974e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0305295192923999,0.00392615685440618,0.0228342518577638,0.038224786727036,7.73099373487462e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.0164580852767634,0.00211636948151373,0.0123100010929964,0.0206061694605303,7.74567274578917e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0176209685499771,0.00226932854994354,-0.0220688525078664,-0.0131730845920877,8.50278223969046e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0300180125531459,0.00387169616220708,-0.0376065370310718,-0.02242948807522,9.25458138307593e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0262070772689834,0.00338401259438772,-0.0328397419539833,-0.0195744125839835,9.98002241018434e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0145280441889508,0.00187658618074859,-0.0182061531032181,-0.0108499352746836,1.01164503373124e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,29117,0.035437644775497,0.00458464699813924,0.0264517366591441,0.0444235528918499,1.11323144719693e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0253940833144424,0.00328829971959969,-0.0318391507648578,-0.018949015864027,1.18318571146729e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.056562079458314,0.00733541251552463,-0.0709394879887423,-0.0421846709278857,1.29683188313702e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0253258962167299,0.00328455611657661,-0.0317636262052201,-0.0188881662282398,1.29907573739893e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0139437964547853,0.00180863978662583,0.0103988624729987,0.0174887304365719,1.30236519611273e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,24805,-0.0355198656476646,0.00461258144374152,-0.044560525277398,-0.0264792060179312,1.40423338774939e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,28628,-0.0588269035806098,0.00764764154000626,-0.073816280999022,-0.0438375261621975,1.49308639509058e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.0416131431507177,0.00542011989019752,-0.0522365781355049,-0.0309897081659306,1.68329794800681e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,29498,-0.0486446936456807,0.00633760913932623,-0.0610664075587601,-0.0362229797326013,1.69779285252521e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0402184342815268,0.0052433246411708,0.029941517984832,0.0504953505782215,1.76753307370793e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.014368801655488,0.00187426512350653,0.0106952420134152,0.0180423612975608,1.82357853114342e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,29349,-0.0385483354819076,0.00503252298333511,-0.0484120805292445,-0.0286845904345708,1.91885859125512e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,29443,-0.0219757735764098,0.00287009977398986,-0.0276011691334299,-0.0163503780193897,1.96460732056477e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0351026223396806,0.00458640832977345,-0.0440919826660365,-0.0261132620133246,2.0130129595885e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0212790491925587,0.00278567879665,-0.0267389796339927,-0.0158191187511247,2.27246951725757e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0507645173470229,0.00665094807094911,-0.0638003755660831,-0.0377286591279626,2.38404513466351e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0406696555437857,0.00533558404852203,-0.0511274002788889,-0.0302119108086825,2.56657373928347e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,29594,0.024789369554085,0.00325520220280201,0.018409173236593,0.0311695658715769,2.70899842208816e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0198308221401166,0.00260669195485315,-0.0249399383716288,-0.0147217059086045,2.87599989431188e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0454789422066288,0.00598072518236461,-0.0572011635640635,-0.0337567208491942,2.95117883711012e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,29443,-0.0201553445573464,0.00265103808848451,-0.025351379210776,-0.0149593099039168,2.98385566118862e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0436090841398127,0.00573686742239754,-0.0548533442877119,-0.0323648239919135,3.01341585397155e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0258056450479751,0.00340128930454572,-0.0324721720848848,-0.0191391180110655,3.38879886506666e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,29786,-0.0290954678792743,0.00383632852540634,-0.0366146717890708,-0.0215762639694779,3.44297164441662e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0441274738872509,0.00582992915289009,-0.0555541350269155,-0.0327008127475863,3.86672340034521e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,24867,-0.0283629485329024,0.00375111861637548,-0.0357151410209983,-0.0210107560448064,4.13174906886855e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0394302041900225,0.0052162085994324,-0.04965397304491,-0.029206435335135,4.19688327148298e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.0404750917944923,0.00536181640866122,-0.0509842519554683,-0.0299659316335163,4.52003431696555e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0309561006600053,0.00410104000899215,0.0229180622423807,0.0389941390776299,4.53416490992447e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,28774,-0.0423059365641334,0.00560566751492694,-0.0532930448933902,-0.0313188282348766,4.58593140311586e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0195778457985351,0.00259474008023286,-0.0246635363557915,-0.0144921552412787,4.64470626577348e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0187010962312841,0.00248098285979908,-0.0235638226364903,-0.0138383698260779,4.92048075930622e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0240178372334053,0.00319206777419927,0.0177613843959747,0.0302742900708359,5.45481960029765e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0171939876157121,0.00228713970699775,-0.0216767814414276,-0.0127111937899965,5.7335606100883e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0184059715600479,0.00245073964966878,-0.0232094212733987,-0.0136025218466971,6.10048271567939e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0273153093921584,0.0036379717479334,-0.0344457340181079,-0.020184884766209,6.15848794274996e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0196287136166211,0.00262055985996823,-0.0247650109421588,-0.0144924162910833,7.07150087987824e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0341089437483926,0.00455511679621923,-0.0430369726689823,-0.0251809148278029,7.22275896469263e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0530641222502046,0.00709178113564663,-0.0669640132760719,-0.0391642312243372,7.49587452592002e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.0626058891824017,0.00836973050219069,-0.0790105609666954,-0.0462012173981079,7.6356104071382e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,28931,-0.0580237536906417,0.00775823024775945,-0.0732298849762502,-0.0428176224050332,7.70185838725322e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0195695753803194,0.0026171731632506,-0.0246992347802906,-0.0144399159803482,7.79149801538672e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0569685306120548,0.00764315801737941,-0.0719491203261184,-0.0419879408979911,9.33723591321498e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,24805,-0.0289125361436335,0.00387930939788135,-0.036515982563481,-0.0213090897237861,9.42171385291776e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0489600893193999,0.00657340163640753,-0.0618439565267587,-0.0360762221120411,9.72276786695299e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0511683864530184,0.00687823744821035,-0.0646497318515107,-0.0376870410545261,1.0408395164382e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.021850280338415,0.00294163242726656,-0.0276158798958575,-0.0160846807809726,1.13961683559409e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,28890,-0.0280824986089974,0.00378582723812702,-0.0355027199957264,-0.0206622772222684,1.22358420251249e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0231182189642415,0.00311775442484639,-0.0292290176369404,-0.0170074202915426,1.24847740949069e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.030833347552586,0.00416600553433245,-0.0389987183998776,-0.0226679767052944,1.38574986442669e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0229141785107759,0.00309688475925284,-0.0289840726389114,-0.0168442843826403,1.41565154410794e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0246368783634943,0.00333492572707598,-0.0311733327885633,-0.0181004239384254,1.54419625424628e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0223875781139847,0.00303193321194155,-0.0283301672093902,-0.0164449890185793,1.58645406825029e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0283801714535331,0.00384420486279384,-0.035914812984609,-0.0208455299224572,1.60205857730759e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0335532179836823,0.00454601912959941,-0.0424634154776972,-0.0246430204896675,1.6244591429622e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0287604303614251,0.00390052954769919,-0.0364054682749155,-0.0211153924479347,1.70723065161188e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0352390078769533,0.00478127350767075,0.0258677118019186,0.044610303951988,1.74827789380657e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.065697868075386,0.00894185018843554,-0.0832238944447197,-0.0481718417060523,2.0876050554906e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.0156612818710347,0.00213405098756337,0.0114785419354105,0.0198440218066589,2.211359548916e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.0154372965548714,0.00210810611342839,-0.019569184537191,-0.0113054085725518,2.4897297493306e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0142703313133286,0.00195328907251986,0.0104418847311897,0.0180987778954675,2.84101476655389e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.066697178658076,0.00913759211367509,-0.0846068592008792,-0.0487874981152728,2.96925725997541e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0398864370199427,0.00546577790853023,0.0291735123192234,0.0505993617206619,3.00604363861913e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0318872415050498,0.00437217101712634,-0.0404566966986174,-0.0233177863114821,3.10424325625804e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0320702000707469,0.00439904184272667,-0.0406923220824911,-0.0234480780590026,3.1855524069092e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0427191322086982,0.00586240546217853,-0.0542094469145682,-0.0312288175028283,3.26684175593356e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.0139614406825077,0.00191730914707387,-0.0177193666107725,-0.0102035147542429,3.39188237832367e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.018450714672779,0.00253485191515349,-0.0234190244264799,-0.0134824049190782,3.46774154282547e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,24888,-0.0220856544596413,0.00303637793472139,-0.0280369552116953,-0.0161343537075874,3.60158911107636e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0237065168447726,0.00326281962039198,-0.0301016433007409,-0.0173113903888043,3.82527686254469e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0174492489473934,0.00240633119035785,-0.0221656580804948,-0.012732839814292,4.24610981027067e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0311701046964192,0.00430605219525273,0.0227302423937239,0.0396099669991146,4.64210963001977e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.020896144656157,0.00288759484652689,-0.0265558305553497,-0.0152364587569643,4.71444449041524e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0327798705803104,0.00453097229328808,-0.0416605762751551,-0.0238991648854658,4.78246602063355e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0127980468561448,0.00177015021805173,0.00932855242876345,0.0162675412835262,4.97183342948181e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.011957863904634,0.00165714599404726,-0.0152058700529666,-0.00870985775630137,5.48581574638038e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0166501508407738,0.0023076282413392,-0.0211731021937986,-0.0121271994877489,5.54129961775272e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0347724582092679,0.00482655455146969,-0.0442325051301485,-0.0253124112883873,5.96930697684693e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0441044497752112,0.00612283180646556,-0.0561052001158837,-0.0321036994345388,6.01980640196367e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.0138687815808703,0.00192588421316837,-0.0176435146386803,-0.0100940485230603,6.1401616023962e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.013926455734241,0.00193683502335086,-0.0177226523800087,-0.0101302590884733,6.64738122754003e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,24845,-0.0302682342971678,0.00421623661672242,-0.0385320580659438,-0.0220044105283919,7.22139837670861e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0261790938910552,0.00365159664238729,-0.0333362233101342,-0.0190219644719761,7.75901602990755e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,24816,-0.041405031110391,0.00578297626822652,-0.052739664596115,-0.030070397624667,8.30374055484137e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.032997290686287,0.00461297541077074,-0.0420387224913977,-0.0239558588811763,8.72343326575566e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0375654098238251,0.00525866722200496,-0.0478723975789548,-0.0272584220686953,9.35404535706187e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0351788878871807,0.00492791528609581,-0.0448376018479285,-0.0255201739264329,9.64032738654994e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.0158773044666918,0.00222542030703417,-0.0202391282684787,-0.0115154806649048,9.93771832505676e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0506204690578794,0.00710684862018377,-0.0645498923534396,-0.0366910457623192,1.08205740559293e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0231261635082826,0.00324904713618018,-0.0294942958951958,-0.0167580311213695,1.12610662593344e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.0171370248573122,0.00240892465831818,-0.0218585171876159,-0.0124155325270086,1.15372072139971e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0309346575754103,0.00434925282482575,-0.0394591931120688,-0.0224101220387519,1.164699443024e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.0145927797920064,0.00205225042546943,-0.0186151906259265,-0.0105703689580863,1.18707592646045e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.02931470054566,0.00412426311234667,-0.0373982562458594,-0.0212311448454605,1.20538487957019e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0444062554434162,0.00625084050115551,-0.056657902825681,-0.0321546080611514,1.23971453770446e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0389627271332812,0.00548454651215898,-0.0497124382971128,-0.0282130159694496,1.24471226406637e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.0304745770921938,0.00429034729406785,0.0220654963958208,0.0388836577885668,1.25431196350933e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,24732,-0.022600700453152,0.00318258558924768,-0.0288385682080775,-0.0163628326982265,1.26873348528628e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.0350344184430874,0.00493479857111699,-0.0447066236424767,-0.0253622132436981,1.28061434037457e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,24922,-0.0267207150291087,0.00376607488783728,-0.0341022218092698,-0.0193392082489477,1.32706652162467e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,29349,-0.0264397727404642,0.00372708649190709,-0.0337448622646021,-0.0191346832163263,1.33288827066109e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,29434,0.0206515541972625,0.00291408002777306,0.0149399573428274,0.0263631510516977,1.40319190300074e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.043512661592877,0.00614392024750166,0.0314705779077738,0.0555547452779803,1.45122093010586e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0101734569008255,0.0014375681729653,0.00735582328181347,0.0129910905198375,1.51482422837522e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0134235658502944,0.00189732477616979,-0.0171423224115872,-0.00970480928900159,1.53529456377922e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0279444331640084,0.00395345071389738,-0.0356931965632473,-0.0201956697647696,1.61020966211474e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.0229540750243893,0.00324751364056015,-0.0293192017598872,-0.0165889482888914,1.61102027155177e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,29478,-0.011720769023344,0.00166093982494504,-0.0149762110802363,-0.0084653269664517,1.74259057991684e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0184307418304395,0.00261371914143662,-0.0235536313476552,-0.0133078523132237,1.80944572459209e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0222652667181347,0.00316059370633415,-0.0284600303825496,-0.0160705030537197,1.89970057717347e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.0323102668219415,0.00458698422233182,-0.0413007558977119,-0.0233197777461712,1.91131644759679e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0207128232220326,0.00294356891358388,-0.026482218292657,-0.0149434281514082,2.01320846216588e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0216287510521517,0.00307976415516975,0.015592413308019,0.0276650887962844,2.22075437948264e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.034340847810783,0.00489110984575454,-0.0439274231084618,-0.0247542725131041,2.248806442152e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0285004460348026,0.00406086494643629,-0.0364597413298177,-0.0205411507397874,2.29501228620875e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,29536,0.0241210330147621,0.00344355125704844,0.0173716725509472,0.030870393478577,2.52821271124467e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,29079,-0.0181447656286289,0.00259093777291519,-0.0232230036635427,-0.0130665275937152,2.55682125517167e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,29725,-0.0526660617551213,0.00752211591967839,-0.0674094089576909,-0.0379227145525516,2.58622588436328e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.0194951682139971,0.00278464355401792,-0.0249530695798722,-0.0140372668481219,2.60704806698709e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0285338576810224,0.00407777173069231,-0.0365262902731793,-0.0205414250888654,2.66407301190709e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0236714882608535,0.0033896300839047,-0.0303151632253067,-0.0170278132964003,2.95514778408938e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0362475850760787,0.0052000371541618,-0.0464396578982359,-0.0260555122539216,3.22130011022823e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0400628040422632,0.00574903957790516,-0.0513309216149573,-0.0287946864695691,3.27031517141083e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0391408587939725,0.00561794369590795,-0.050152028437952,-0.0281296891499929,3.31583257697677e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.022804304385998,0.0032738370678445,-0.0292210250389732,-0.0163875837330228,3.35130212077794e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0233800514748802,0.00336679076841602,-0.0299789613809756,-0.0167811415687848,3.88131218254572e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.0472638449347733,0.00682281898832558,-0.0606365701518914,-0.0338911197176552,4.39324478510849e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,29694,0.0141507498242917,0.00204767647761738,0.0101373039281616,0.0181641957204218,4.92220942558392e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,24805,-0.0164106528802379,0.00237954193258932,-0.021074555068113,-0.0117467506923628,5.45565605066206e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0159738801447437,0.00231720969514549,-0.0205156111472288,-0.0114321491422585,5.54988487129155e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0260210340752019,0.00378559670750278,-0.0334408036219074,-0.0186012645284965,6.37928608107642e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0212996758988269,0.00310148490735963,-0.0273785863172518,-0.015220765480402,6.68848095919297e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,29566,-0.0328578082076906,0.00478916369460617,-0.0422445690491187,-0.0234710473662625,6.97932307837454e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,29491,-0.0495041634476905,0.00722042386911627,-0.0636561942311584,-0.0353521326642226,7.21449700970629e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.0221690696866465,0.00323658187312441,-0.0285127701579704,-0.0158253692153227,7.58648902353755e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0156995000123341,0.00229249510801186,-0.0201927904240373,-0.0112062096006308,7.62318199750127e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0123168244956025,0.00180773859234332,0.00877365685460956,0.0158599921365954,9.75609918438455e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0338592859972494,0.00497008355088841,-0.0436006497569907,-0.0241179222375081,9.77157929864716e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0316151519836073,0.00464098585500131,-0.0407114842594098,-0.0225188197078047,9.83376194970973e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.015097500972446,0.00221800558565024,-0.0194447919203204,-0.0107502100245715,1.02076336377248e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.036084139707929,0.0053045482970942,-0.0464810543702336,-0.0256872250456244,1.04837357580406e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.00817312976553846,0.00120298966738095,0.0058152700174718,0.0105309895136051,1.11133490626644e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.0227562170150475,0.00334928102421518,-0.0293208078225093,-0.0161916262075858,1.11258168346506e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0253006338758325,0.00372807024537208,-0.0326076515567617,-0.0179936161949032,1.17084326043064e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0195595799539096,0.00288321834928903,-0.0252106879185161,-0.0139084719893031,1.19619496496971e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0197677392411327,0.00291522957023713,0.0140538892834679,0.0254815891987975,1.22215991103775e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0119141721033963,0.00175916304074824,-0.0153621316632628,-0.0084662125435297,1.28822495232463e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0222635669018127,0.00329021525391664,-0.0287123887994893,-0.0158147450041361,1.3477419000115e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0257239144256089,0.00380338779808598,-0.0331785545098574,-0.0182692743413603,1.37761874249564e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0348842516489649,0.00515843146370704,-0.0449947773178307,-0.0247737259800991,1.38145878563881e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0322918458156783,0.0047751320851982,-0.0416511047026668,-0.0229325869286898,1.38627107993067e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0241971116448324,0.00358476451888131,-0.0312232501018397,-0.017170973187825,1.50572822624664e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0367358523695765,0.00544536703463307,-0.0474087717574573,-0.0260629329816957,1.54511614927353e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,29443,0.0209984711206311,0.00311372354985144,0.0148955729629223,0.0271013692783399,1.57099885784777e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,29218,0.0155201851562901,0.00230301871496286,0.0110062684749629,0.0200341018376173,1.62374297478352e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,24528,-0.0129324519379785,0.00192012319410918,-0.0166958933984325,-0.00916901047752455,1.67302371599012e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0296887664119441,0.0044089174209736,-0.0383302445570524,-0.0210472882668359,1.6833240026143e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0123571722440878,0.00183552244778364,-0.0159547962417437,-0.00875954824643183,1.70134052185998e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,24951,-0.0335079059717782,0.00497908048681769,-0.0432669037259408,-0.0237489082176155,1.73652093377773e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0543686759529221,0.00809096630458946,-0.0702269699099175,-0.0385103819959268,1.8606500726056e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,28452,-0.0276100648457696,0.004109941082541,-0.0356655493675499,-0.0195545803239892,1.87870718329539e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.0119623179849775,0.00178070486006403,0.00847213645925203,0.015452499510703,1.8852915505217e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0298889272149277,0.00445289221638732,-0.0386165959590469,-0.0211612584708086,1.9509365061897e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,24845,-0.0128298875165404,0.00191270834542727,-0.0165787958735779,-0.00908097915950297,2.01953125452003e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0304300362112695,0.0045390054678658,-0.0393264869282864,-0.0215335854942525,2.06967474913707e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,24326,-0.05207378289361,0.00777484044681113,-0.0673124701693598,-0.0368350956178602,2.16299691976062e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,28534,-0.0348921329695981,0.00521750277024362,-0.0451184383992756,-0.0246658275399206,2.31180446300074e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0297622123988049,0.00445495611306201,-0.0384939263804065,-0.0210304984172034,2.4214001983643e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0246497414749934,0.00368976325087146,-0.0318816774467015,-0.0174178055032853,2.42322964002509e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0235082491888928,0.00352246326343958,-0.0304122771852344,-0.0166042211925512,2.53768551841481e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.047539487718807,0.00712486321104708,-0.0615042196124593,-0.0335747558251547,2.5621875926531e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0228922730289804,0.00343304464611405,-0.0296210405353639,-0.0161635055225969,2.63516473743342e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0434906203411681,0.00654085318931082,-0.0563106925922173,-0.0306705480901189,3.00099299328883e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0392726147944932,0.00590845099517013,-0.0508531787450267,-0.0276920508439598,3.04633429958246e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0262956458102183,0.00395846524454371,-0.034054237689524,-0.0185370539309126,3.13946117828559e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.024029371396346,0.00361855453056564,-0.0311217382762547,-0.0169370045164374,3.17839613302689e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,24229,-0.0191331462900411,0.00288134817621397,-0.0247805887154204,-0.0134857038646617,3.19574933468246e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0216101422761475,0.00325516783342753,-0.0279902712296654,-0.0152300133226295,3.21921819947107e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0243630502398203,0.00367033896136144,-0.0315569146040888,-0.0171691858755519,3.23831214428333e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0410856431418688,0.00618974473359507,-0.0532175428197151,-0.0289537434640225,3.25356212718302e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0143085135063587,0.00215664712652009,0.0100814851383794,0.0185355418743381,3.30999881185012e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0281894639393611,0.00424943251335409,-0.0365183516655351,-0.019860576213187,3.34097631833464e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0178526288108899,0.00269120145045579,-0.0231273836537832,-0.0125778739679965,3.34307584767931e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.0354698021817403,0.00535275526328464,-0.0459612024977782,-0.0249784018657024,3.49906619180803e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.00879371580966361,0.00132768049722755,-0.0113959695842296,-0.00619146203509762,3.57166909064751e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.02698479276204,0.00407491364640373,-0.0349716235089913,-0.0189979620150887,3.60177969280365e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,24822,-0.0440129498864461,0.00664698918770731,-0.0570410486943524,-0.0309848510785397,3.62868981226111e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0178375412361869,0.00270144871021867,0.0125427017641583,0.0231323807082155,4.09897404516261e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,24966,0.0103854719947673,0.00157498596067374,0.00729849951184681,0.0134724444776879,4.36658287108964e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0196404817328503,0.00298133461832474,-0.0254838975847668,-0.0137970658809339,4.55498796047623e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0270233895287067,0.00410276846911551,0.0189819633292403,0.0350648157281731,4.5889785256463e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,29218,-0.0590550247551889,0.00898165298701926,-0.0766590646097466,-0.0414509849006311,4.94489920040536e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0393140983411736,0.00598014455479819,-0.0510351816685781,-0.0275930150137692,4.97554157379784e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,29218,-0.0303709688652746,0.00462366737582611,-0.0394333569218938,-0.0213085808086554,5.16472871729893e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0305194982657353,0.00465189821830976,0.0214017777578482,0.0396372187736225,5.46262857001958e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,23693,-0.0105205445481641,0.00160381351874614,-0.0136640190449066,-0.00737707005142167,5.5026555954759e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.0188848065422064,0.00289051237469795,-0.0245502107966144,-0.0132194022877984,6.55467784458117e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.018200382907564,0.00278878000506809,0.0127343740976306,0.0236663917174975,6.85262436897921e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0296931122636888,0.00455354230375077,-0.0386180551790403,-0.0207681693483373,7.12601822423815e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0153175701236342,0.00234927317944917,0.0107129946919139,0.0199221455553546,7.16268454526789e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,24966,-0.0323661842224237,0.00497049362545274,-0.0421083517283111,-0.0226240167165363,7.57358888540599e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0261015945226732,0.00401403047780968,-0.0339690942591802,-0.0182340947861663,8.02413997717908e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0167152224108564,0.00257655111288228,0.0116651822296071,0.0217652625921057,8.87231374179571e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,28750,0.0529996199296752,0.00817045534935526,0.0369855274449389,0.0690137124144115,8.91382389503167e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0209314925834635,0.00323474776880053,-0.0272715982103125,-0.0145913869566144,9.927686215495e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0132866180679274,0.00205804048083703,-0.017320377410368,-0.00925285872548682,1.09518031693645e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0113840540224474,0.00176524985673358,0.00792416430324955,0.0148439437416452,1.14336849655304e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0168244583277106,0.00260899600965245,-0.0219380905066294,-0.0117108261487918,1.14651598299041e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.024406058129797,0.00378843495414823,-0.0318313906399276,-0.0169807256196665,1.1952166610447e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0366832637795966,0.00570246945206414,-0.0478601039056423,-0.0255064236535509,1.27136077747159e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,29786,-0.0205659091954403,0.00319778487693885,-0.0268335675542405,-0.0142982508366402,1.28435550635813e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,24177,-0.019209722101657,0.00298734134112446,-0.0250649111302609,-0.013354533073053,1.29669263408238e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0130412075085015,0.00202883778748594,-0.017017729571974,-0.00906468544502909,1.31356062573104e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0284292837026536,0.00442335766160102,-0.0370990647193916,-0.0197595026859156,1.32048537048623e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0371640663033826,0.00578661042065551,-0.0485058227278674,-0.0258223098788978,1.36212389548127e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0295116754731091,0.00459731110496033,-0.0385224052388314,-0.0205009457073869,1.38955511306579e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0151216861655413,0.00235998664675498,-0.0197472599931811,-0.0104961123379015,1.50137395844085e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.0217121716361493,0.00338858290274501,-0.0283537941255295,-0.0150705491467691,1.50671358114548e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0468256959822083,0.00731755028536759,-0.0611680945415288,-0.0324832974228879,1.59086352598263e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0313586773025075,0.00490255420611278,-0.0409676835464886,-0.0217496710585265,1.61974399585833e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0367711601464989,0.00575148948835366,-0.0480440795436721,-0.0254982407493257,1.65195481670458e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0149716853215853,0.00234742809571327,-0.0195726443891833,-0.0103707262539873,1.82192837187152e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0333561448582251,0.00523367930147715,-0.0436141562891204,-0.0230981334273299,1.87662634752541e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0194296487391266,0.00305064358008741,-0.0254089101560979,-0.0134503873221553,1.93039857895809e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0120035976461212,0.00188550617634848,-0.0156991897517642,-0.0083080055404782,1.96534633560112e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,29536,-0.013000091962835,0.00204358151457944,-0.0170055117314107,-0.00899467219425929,2.02815833615569e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0200788602866073,0.0031568039599141,-0.0262661960480389,-0.0138915245251757,2.04596684462194e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.022596655898666,0.00355314421561824,-0.0295608185612777,-0.0156324932360542,2.05286543981415e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0188358847408238,0.00296290921445918,-0.0246431868011638,-0.0130285826804838,2.09096281756532e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,29434,-0.0147147305037604,0.00231770591243343,-0.0192574340921299,-0.0101720269153909,2.20115096075471e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,29786,-0.0150431180324964,0.00237196626279757,-0.0196921719075796,-0.0103940641574131,2.2998619095284e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0464698526927774,0.00732898743747586,-0.0608346680702301,-0.0321050373153247,2.32863827762907e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,29786,-0.0214081518172982,0.00338001514729766,-0.0280329815060016,-0.0147833221285947,2.42696119165557e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.035020009922769,0.00552988365539291,-0.0458585818873391,-0.0241814379581989,2.44880633375624e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0390428914182413,0.00617223221279709,-0.0511404665553236,-0.026945316281159,2.5670622045678e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0183644877305326,0.00290591251692997,-0.0240600762637154,-0.0126688991973499,2.65893278481333e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.00977568453151451,0.00154708659993157,-0.0128079742673804,-0.00674339479564864,2.67398029537727e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0363461308217526,0.00575404796505755,-0.0476240648332654,-0.0250681968102398,2.7117114229771e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0347153250981561,0.00550358538766614,-0.0455023524579817,-0.0239282977383305,2.87145396649709e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0194609494800356,0.00308872790866227,-0.0255148561810137,-0.0134070427790576,3.00713885255451e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0152601753936827,0.00242564487332198,-0.0200144393453938,-0.0105059114419716,3.19519480938566e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.0120477074303326,0.00191506755028579,-0.0158012398288927,-0.00829417503177242,3.2083079895744e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,29531,0.012040620909846,0.00191594714787939,0.0082853645000024,0.0157958773196896,3.33668066741769e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.0114144714757318,0.00182449760505374,-0.0149904867816372,-0.00783845616982652,3.99826686432631e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.0155994915328448,0.00249705174216352,-0.0204937129474853,-0.0107052701182043,4.24962402985122e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0230651968520646,0.00369849932965595,-0.0303142555381903,-0.015816138165939,4.54077077554442e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,24195,-0.0191813868884138,0.00307615119396189,-0.0252106432285791,-0.0131521305482485,4.57743545274683e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0271566295395363,0.00435801668848005,0.0186149168301154,0.0356983422489572,4.68484076704766e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.0129393212954005,0.00207782144848721,-0.0170118513344354,-0.00886679125636553,4.82037172045842e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.0398868568317327,0.00641457419818773,-0.0524594222601807,-0.0273142914032848,5.09821242736296e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,29544,-0.0126070289601123,0.00202952868870233,-0.0165849051899689,-0.00862915273025577,5.30787691289281e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,29331,-0.0121388293705696,0.00195435095038521,-0.0159693572333246,-0.00830830150781457,5.32932725202816e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.0203799472840081,0.00328525996721555,-0.0268190568197505,-0.0139408377482656,5.61322566047191e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0440938953500594,0.00712538473521068,-0.0580596494310724,-0.0301281412690465,6.17922261951722e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0388284265548847,0.00629673811082095,-0.0511700332520937,-0.0264868198576756,7.07501278626147e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,29433,-0.0162672977884635,0.00263894655394854,-0.0214396330342026,-0.0110949625427244,7.17078602367946e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0161733286340196,0.00262373563129232,-0.0213158504713525,-0.0110308067966866,7.17642813938765e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0247576692016242,0.00401987558196247,-0.0326366253422706,-0.0168787130609778,7.4414827249951e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.014092976708007,0.00228981388278543,-0.0185810119182665,-0.00960494149774759,7.62421496163685e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.010489876661581,0.00170462346523143,-0.0138309386534346,-0.00714881466972741,7.66331864985953e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,29014,-0.0231187444201551,0.00375715595698674,-0.0304827700958491,-0.0157547187444611,7.69005729604857e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0218355826966287,0.00354988932286906,-0.0287933657694521,-0.0148777996238053,7.81442164293511e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.018526127227912,0.00301433981707285,-0.0244342332693748,-0.0126180211864492,8.04854340920027e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0356131229920242,0.00579929880046592,-0.0469797486409374,-0.0242464973431109,8.33159465334721e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0215229294998329,0.00350593756782532,-0.0283945671327705,-0.0146512918668953,8.43064586093212e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.0118263599216723,0.00192948418610952,0.00804457091689762,0.015608148926447,8.96289256622596e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,29434,-0.0201706089087437,0.00329350960339472,-0.0266258877313973,-0.01371533008609,9.22061552740418e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0109269977007959,0.00178484712891627,-0.0144252980734718,-0.00742869732812006,9.35282545721211e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0234435879540269,0.00383095271095482,-0.0309522552674984,-0.0159349206405555,9.52984219738088e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0121838996500908,0.00199507617080449,-0.0160942489448676,-0.00827355035531404,1.02803199059322e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0282835033179191,0.00463237549465876,-0.0373629592874502,-0.0192040473483879,1.03685660124336e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0212424340316412,0.00348788263869487,-0.0280786840034832,-0.0144061840597993,1.1437423561761e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0266502199425407,0.0043802847031072,-0.0352355779606308,-0.0180648619244505,1.18881754632502e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0284102987703038,0.00467280549386776,-0.0375689975382846,-0.019251600002323,1.22041192312222e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,24845,-0.0566830862080993,0.00932748813416806,-0.0749649629510687,-0.0384012094651299,1.24239220233056e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0119819384429369,0.00197193513897191,-0.0158469313153218,-0.00811694557055194,1.2458125292631e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.0179329284331073,0.00295550139440584,-0.0237257111661428,-0.0121401457000719,1.31384378630321e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0294760420436151,0.00486263877842143,-0.0390068140493211,-0.0199452700379091,1.3628778177404e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0248401931059438,0.00409975225721748,0.0168046786817975,0.03287570753009,1.38984514547715e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0186350466037633,0.00308603501609002,0.0125864179722268,0.0246836752352997,1.57399797285713e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,24195,-0.0193802961638212,0.00321126687215058,-0.0256743792332363,-0.013086213094406,1.61182193197164e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,28931,-0.0336598356216565,0.00558535483433304,-0.0446071310969493,-0.0227125401463638,1.69630757443442e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0372827384246751,0.00618737092305309,-0.0494099854338591,-0.025155491415491,1.70828453799706e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.0107868324127424,0.001793421504946,0.00727172626304822,0.0143019385624365,1.82766525350723e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,28353,0.012924661238568,0.00215115336185369,0.00870840064933478,0.0171409218278012,1.89825674822384e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,29311,-0.01428828673596,0.00237920220002361,-0.0189515230480063,-0.00962505042391374,1.92993771235667e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0140515861081314,0.00234058155025658,-0.0186391259466343,-0.0094640462696285,1.95842188018547e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0232123998917185,0.0038693258604904,-0.0307962785782797,-0.0156285212051574,2.00751949024596e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00648428715996848,0.00108120651054484,0.00436512239930059,0.00860345192063637,2.02970857620621e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,24111,-0.024188490168113,0.00403527532976514,-0.0320976298144527,-0.0162793505217733,2.07320177502421e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0218025827680055,0.00363767246880748,-0.0289324208068681,-0.0146727447291428,2.0813605066049e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0116680059483006,0.00194727540980817,-0.0154846657515246,-0.00785134614507655,2.10167442548948e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.0600146506217018,0.0100200804016971,-0.0796540082090281,-0.0403752930343754,2.13467640791752e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,29349,-0.0120913060458276,0.00202226544664685,-0.0160549463212554,-0.00812766577039976,2.26980207624458e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0159514037402081,0.00266790497010605,-0.0211804974816159,-0.0107223099988002,2.27071808135808e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,29296,-0.0125725322596241,0.00210354463539194,-0.0166954797449923,-0.00844958477425587,2.30148000116918e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0262202706432483,0.00438787877476985,-0.0348205130417972,-0.0176200282446994,2.32353722848711e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0365156598174403,0.00612117627911826,-0.0485131653245121,-0.0245181543103685,2.46731759114834e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0288801441855905,0.00484513588722524,-0.038376610524552,-0.019383677846629,2.54631602470574e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0461964825142393,0.00775519206891118,-0.0613966589693053,-0.0309963060591734,2.60076654389873e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.024771035365724,0.00416104380700972,0.0166153895039849,0.032926681227463,2.66118627547437e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.0210194254269145,0.00353507729134486,-0.0279481769179504,-0.0140906739358786,2.7791474396957e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.0287639680790639,0.00484245591047677,-0.0382551816635984,-0.0192727544945295,2.88896178979637e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0250670468045471,0.00422282917378616,-0.033343791985168,-0.0167903016239262,2.95263341019556e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0397342742729559,0.00669709557938764,-0.0528605816085557,-0.0266079669373561,3.00735350970356e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0114089221333645,0.00192431168640631,0.0076372712280081,0.0151805730387208,3.09147700397852e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,24966,0.0128054954946615,0.00217170407305724,0.00854895551146934,0.0170620354778537,3.7602717846418e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0130350381416563,0.00221228826987434,-0.01737112315061,-0.00869895313270264,3.86344106688807e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.0513005976522942,0.00871955370000051,-0.0683909229042952,-0.0342102724002932,4.06269197286585e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,24240,-0.0209323746963791,0.00356391287116208,-0.0279176439238568,-0.0139471054689014,4.3245606843692e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0196809826880704,0.0033594354139486,-0.0262654760994096,-0.0130964892767311,4.73344194166809e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0166867319035455,0.00284916972075963,-0.0222711045562344,-0.0111023592508567,4.77207750933874e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,24606,0.0124162481557511,0.00212233606274122,0.0082564694727783,0.0165760268387239,4.96977958793681e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0160150275895426,0.00273771013448447,-0.0213809394531321,-0.010649115725953,4.98347616750377e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0268800438642328,0.00459758762425907,-0.0358913156077806,-0.017868772120685,5.08259605428685e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.04113722068254,0.00703711222659516,-0.0549299606466665,-0.0273444807184135,5.09608896824448e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,24938,0.0198905527310648,0.00340983603637203,0.0132072740997756,0.0265738313623539,5.50172571266057e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,24951,-0.0274809187658443,0.00471556817673062,-0.0367234323922363,-0.0182384051394523,5.68875653773223e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0265332944293574,0.00455747968189095,-0.0354659546058636,-0.0176006342528511,5.89122286702795e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0115044894041275,0.00197672018348283,-0.0153788609637539,-0.00763011784450119,5.94572303878609e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0235645847381371,0.00404968211542714,-0.0315019616843743,-0.0156272077918999,5.98552685143194e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0153142461609944,0.00263743537612599,-0.0204836194982014,-0.0101448728237875,6.445341515058e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0342482643361272,0.00590368100538873,-0.0458194791066891,-0.0226770495655653,6.66540994777471e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0357618212029187,0.00616812995099787,-0.0478513559068745,-0.0236722864989629,6.78780852843784e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.0141985274660581,0.00245445400232739,-0.0190092573106198,-0.00938779762149647,7.34933001664989e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0264781499381481,0.00458722087648665,-0.035469102856062,-0.0174871970202343,7.91944954087077e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0180453318831358,0.00312772790139344,-0.024175678569867,-0.0119149851964047,8.03108322985019e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0348149518344198,0.00603487326579574,-0.0466433034353795,-0.0229866002334602,8.07327341960255e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0312754346354715,0.00542225996038211,-0.0419030641578204,-0.0206478051131225,8.10487933677133e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0307289391242495,0.00534009387455068,-0.0411955231183688,-0.0202623551301302,8.78246981345136e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,29478,0.018172937085745,0.00316074198570992,0.0119778827937536,0.0243679913777365,9.03485389737603e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0162454985160955,0.00282547555243658,-0.0217834305988712,-0.0107075664333198,9.05079560803666e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0238406896672466,0.00414829971070963,-0.0319713571002374,-0.0157100222342557,9.184861409511e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,24240,-0.0203071587054316,0.00353705150279793,-0.0272397796509155,-0.0133745377599477,9.50929481774495e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.0170898724834703,0.00297771696910414,-0.0229261977429145,-0.0112535472240262,9.60487376926706e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.0110142702467921,0.00192215599094118,0.00724684450454742,0.0147816959890368,1.01314597118463e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0259971483505292,0.00453934530677374,-0.0348942651518057,-0.0171000315492527,1.03174455447074e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0200739550845157,0.0035068391512748,-0.0269473598210143,-0.0132005503480171,1.05130422666571e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0120437607495375,0.0021058109177788,0.0079163713506911,0.016171150148384,1.08192686433663e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,29396,-0.0101188724955242,0.00176967735879447,-0.0135874401187613,-0.006650304872287,1.08880584465473e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,29349,-0.0231309563763622,0.00404725493111644,-0.0310635760413505,-0.015198336711374,1.10622313431401e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.00907136654050093,0.00158878862415696,-0.0121853922438486,-0.0059573408371533,1.14313431930123e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,24761,-0.0110904032198236,0.00194240420548664,-0.0148975154625774,-0.00728329097706977,1.14519627076077e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,24381,-0.0302053333907389,0.00529565663921639,-0.040584820403603,-0.0198258463778747,1.18526040692981e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0233101542002568,0.00408773923489147,-0.0313221231006441,-0.0152981852998695,1.19248483942492e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0269470930985247,0.00473509281149272,-0.0362278750090505,-0.017666311187999,1.27797131915551e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0213799497084782,0.00376074625045719,-0.0287510123593743,-0.0140088870575821,1.32031227258649e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,24229,-0.0222895148326076,0.00392999569693145,-0.0299923063985932,-0.014586723266622,1.43049662445451e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.0400449803344617,0.00706352207935765,-0.0538894836100027,-0.0262004770589207,1.45004380907726e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.00953100687866906,0.00168141261527031,0.00623543815273925,0.0128265756045989,1.45683800303671e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0131648092457275,0.00232317410777101,-0.0177182304969587,-0.00861138799449632,1.47183167600607e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0163829613943605,0.00289586685318299,-0.0220588604265992,-0.0107070623621219,1.55138174118814e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0216712905268705,0.00383303281780431,-0.029184034849767,-0.0141585462039741,1.5865874859186e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0117355789235958,0.00207600509209783,-0.0158045489041075,-0.00766660894308402,1.5915269142481e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.0152514568546036,0.00269890679922018,-0.0205413141810751,-0.00996159952813204,1.61290603903085e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0315400424675368,0.00558510820388721,0.0205932303879179,0.0424868545471557,1.64610275226835e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,24793,-0.0260841780889947,0.00462657616347816,-0.0351522673694119,-0.0170160888085775,1.74007712318771e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0228677618254629,0.00405622620934422,-0.0308179651957776,-0.0149175584551482,1.74216700127574e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0263377226750307,0.00467812774227643,-0.0355068530498925,-0.0171685923001689,1.81873666345648e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0232552620071187,0.0041344809876528,-0.0313588447429182,-0.0151516792713192,1.87830256175251e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.0168072857903089,0.00298879911662759,-0.022665332058899,-0.0109492395217188,1.88943076280599e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0125639385146417,0.00223443657624746,-0.0169434342040867,-0.00818444282519668,1.89506228205438e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.0130713585843135,0.00232513444570165,0.00851409507073822,0.0176286220978887,1.90725165566445e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0196650593075774,0.00350013679006575,-0.0265253274161062,-0.0128047911990485,1.94490457629327e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.00878737498474062,0.00156423921495444,-0.0118532838460513,-0.00572146612342991,1.95676542516665e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0290198928992087,0.00516837755228675,-0.0391499129016907,-0.0188898728967266,1.98781659040206e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0216366544864514,0.00386375159580083,-0.029209607614221,-0.0140637013586817,2.16360613611458e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,21656,-0.0403328551259037,0.00720514129954636,-0.0544549320730145,-0.0262107781787928,2.1973472488231e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,24938,-0.0320163507663702,0.00572249806657767,-0.0432324469768625,-0.020800254555878,2.23167474425986e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0226109780739238,0.00404213256317448,-0.0305335578977458,-0.0146883982501018,2.24464048112244e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0288905675813739,0.00516810991094539,-0.0390200630068269,-0.0187610721559209,2.28867240158032e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,29349,0.00577795274063084,0.00103492022264599,0.00374950910424469,0.00780639637701698,2.38502957900216e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.015024242277196,0.00269440442140647,-0.0203052749431527,-0.00974320961123932,2.48539461429873e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.0268732501754729,0.00481989884998467,0.0174262484295029,0.0363202519214428,2.49417571192379e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.0105657443872773,0.00190307916096625,0.00683570923178344,0.0142957795427711,2.84973102253286e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.0097449858627306,0.00175589818827906,0.00630342541370365,0.0131865463117575,2.88389307396666e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0408002861617826,0.00736685284124675,-0.0552393177306263,-0.026361254592939,3.08414303225136e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.0123987898172504,0.00223984989203159,-0.0167888956056323,-0.00800868402886848,3.13382032214743e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.0102838105779432,0.00185794772601458,0.00664223303495465,0.0139253881209318,3.14318366829396e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0394616786329716,0.00713168474708276,-0.0534397807372539,-0.0254835765286894,3.16973788802149e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.029856865579824,0.00540325048026971,-0.0404472365211526,-0.0192664946384953,3.30929513192081e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.00911324125438926,0.00164929902307538,0.00588061516916151,0.012345867339617,3.31787575077472e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.00885743301028486,0.00160586860034172,-0.0120049354669546,-0.0057099305536151,3.50349489646518e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,24776,-0.0354959293583252,0.00645432252260481,-0.0481464015026306,-0.0228454572140197,3.84503011237598e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.009149256370405,0.00166547073505234,-0.0124135790111076,-0.00588493372970241,3.97318984943975e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.041791932549772,0.00761501271380176,-0.0567173574688234,-0.0268665076307205,4.0961859998299e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.00809114650669787,0.00147566811185818,0.00519883700745583,0.0109834560059399,4.22228200637145e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,24195,-0.0157295594447193,0.0028708967342396,-0.0213565170438289,-0.0101026018456097,4.32072364090265e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,24805,-0.011534491496245,0.00210637655536196,-0.0156629895447545,-0.00740599344773559,4.39300464095777e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0174295677534872,0.00318497301656776,-0.02367211486596,-0.0111870206410144,4.47472104314274e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0235473019150436,0.00431455747100111,-0.0320038345582058,-0.0150907692718814,4.86349903181345e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.0160446287052452,0.00294042851906738,0.0102813888078731,0.0218078686026172,4.89309355263034e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,24805,-0.0288912329653158,0.00530003007937651,-0.0392792919208938,-0.0185031740097379,5.05236255556583e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0199677721995994,0.00366658170813647,-0.0271542723475469,-0.012781272051652,5.2047378173079e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.030545903821528,0.00561102552815786,-0.0415435138567174,-0.0195482937863386,5.25379485022874e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0223815913053294,0.00411210779521183,-0.0304413225839446,-0.0143218600267142,5.2855110359421e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0250225698622865,0.00461642320122701,-0.0340707593366914,-0.0159743803878815,6.00401045978472e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0247141743160633,0.00456580808212583,-0.03366315815703,-0.0157651904750967,6.25025453764098e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00919600860277356,0.00170114944292817,-0.0125302615109128,-0.00586175569463435,6.51264088018733e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,24903,0.0133045513580041,0.0024616792294176,0.00847966006834562,0.0181294426476626,6.55259980164937e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0331281924434617,0.00612985587284209,-0.0451427099542322,-0.0211136749326912,6.55304200338517e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0314883710340059,0.00583834152048276,-0.0429315204141521,-0.0200452216538597,6.97895118997042e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.0189589609713527,0.00351968300691922,-0.0258575396649143,-0.012060382277791,7.23770454551131e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0251893638132487,0.00467851249447935,-0.0343592483024282,-0.0160194793240692,7.35050140762473e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,24381,-0.0199231856280258,0.00370046883726815,-0.0271761045490713,-0.0126702667069802,7.3537136889363e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0378908723982759,0.00704387203560474,-0.0516968615880612,-0.0240848832084906,7.54798867783781e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0282446882573638,0.00525361649238467,-0.0385417765824378,-0.0179475999322899,7.66370469293686e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0171507685040473,0.00319036513236549,0.010897652844611,0.0234038841634837,7.69297095438265e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0231913514621069,0.00432044059675263,-0.031659415031742,-0.0147232878924717,8.02909293829056e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.0164861403347205,0.00307163366742899,0.0104657383465597,0.0225065423228813,8.06743518470441e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.0180453385660192,0.00336306031116433,0.0114537403561371,0.0246369367759013,8.12209602345879e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0241407885021451,0.00450432227537693,-0.0329692601618839,-0.0153123168424063,8.4103859530517e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0135451128528547,0.00252835974918193,-0.0185006979612513,-0.00858952774445808,8.52391072729071e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0155530471008228,0.00290486062576152,0.00985952027433025,0.0212465739273154,8.66019438499853e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,24845,0.0136718095893891,0.00255342954239842,0.00866708768628824,0.01867653149249,8.66540756176144e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.024359008261102,0.00455378639053948,-0.0332844295865594,-0.0154335869356446,8.91605002911274e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0152398877437619,0.00285660461640478,-0.0208388327919153,-0.00964094269560855,9.63959017754513e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,29434,-0.0340680266656062,0.00640882199326275,-0.0466293177724012,-0.0215067355588112,1.06961900612338e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,28722,-0.0223325092213517,0.00420449900127519,-0.030573327263851,-0.0140916911788523,1.09490665779279e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,24445,-0.0196509673650048,0.0037161834231773,-0.0269346868744324,-0.0123672478555773,1.24762561276479e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0267422342579845,0.00505786182208511,-0.0366556434292713,-0.0168288250866977,1.25231127914743e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.0114708336235025,0.00217249820906556,-0.015728930113271,-0.00721273713373401,1.30074126822293e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.032678030694496,0.00619058787043789,-0.0448115829205542,-0.0205444784684377,1.31250360834094e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0142496702769107,0.00269999152274475,0.00895768689233095,0.0195416536614904,1.31750562495925e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0197180958584261,0.00373787489575498,-0.0270443306541059,-0.0123918610627464,1.33539975142557e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0229839968030208,0.00436027581449513,-0.0315301373994313,-0.0144378562066104,1.36492799000047e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,24381,-0.0417567922806502,0.00792544986123835,-0.0572906740086774,-0.0262229105526231,1.38563160971535e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0249366297544763,0.00473400069737521,-0.0342152711213317,-0.0156579883876209,1.39436389823817e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.0075958009141733,0.00144459285216712,-0.0104272029044209,-0.00476439892392575,1.46564193491588e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0181088601594568,0.00344470042885283,0.0113572473189052,0.0248604730000083,1.47620349830788e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.0150405531021701,0.00286163016459502,-0.0206493482247763,-0.00943175797956388,1.48301372751401e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.00890959271841154,0.00169744805627257,-0.0122365909087058,-0.0055825945281173,1.54150456460675e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,29242,0.0177049570171816,0.00338678215740947,0.011066863988659,0.0243430500457042,1.72844746224871e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,29383,-0.0168508379253497,0.00322936550747321,-0.0231803943199972,-0.0105212815307022,1.82090232294013e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0245206440816846,0.00470160444677117,-0.033735788797356,-0.0153054993660131,1.84670680644974e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.020521306928622,0.00393513798678249,-0.0282341773827157,-0.0128084364745283,1.85429359207396e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0153302968981177,0.00293997763543236,0.0095679407326703,0.0210926530635652,1.85901437954047e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0296064884508489,0.00567900273403563,-0.0407373338095587,-0.018475643092139,1.86735585276595e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,29443,-0.0260279396883332,0.00499550203967756,-0.0358191236861012,-0.0162367556905652,1.89830575735648e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,-0.0179564781706311,0.00344728958045853,-0.0247131657483298,-0.0111997905929324,1.91505466655718e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0327930064890995,0.00629710760169804,-0.0451353373884277,-0.0204506755897714,1.92576050654594e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.0121267249985637,0.00232925461390243,-0.0166920640418124,-0.00756138595531491,1.94212855841161e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0532249954647751,0.0102304888950346,-0.0732767536990429,-0.0331732372305074,1.97850900469154e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0247734767794449,0.00476663255225086,0.0154308769770332,0.0341160765818566,2.03624778483174e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.0112131277308293,0.00215873205555073,-0.0154442425597088,-0.00698201290194991,2.06869875758627e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,29694,-0.0268047361639932,0.00516532060711214,-0.036928764553933,-0.0166807077740534,2.12398980716139e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.0355125561608017,0.00684765880963046,-0.0489339674276774,-0.0220911448939261,2.16189434738909e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0215850545492307,0.00416494832045264,-0.0297483532573179,-0.0134217558411435,2.20316288480169e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.0106150626566251,0.00204959348304384,-0.014632265883391,-0.00659785942985914,2.24405650282702e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0181693402836276,0.00351101731732583,-0.0250509342255862,-0.011287746341669,2.29501602612941e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0172480675153039,0.00333330874012061,-0.0237813526459403,-0.0107147823846675,2.30348295171506e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,28580,0.0235738036613737,0.00456040105734227,0.0146354175889828,0.0325121897337645,2.36630426173701e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0409925882175164,0.00793229123229982,-0.0565398790328241,-0.0254452974022088,2.38400666034545e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0209143887677279,0.00405484472805955,0.0129668931007311,0.0288618844347246,2.51403200271964e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0292691703750755,0.0056762704095945,-0.0403946603778807,-0.0181436803722703,2.53665716449617e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0188047242288286,0.00364967441599486,-0.0259580860841785,-0.0116513623734787,2.59076945607387e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0165884763063967,0.0032216594495185,-0.022902928827453,-0.0102740237853405,2.63813150028905e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00737250302648255,0.00143202058386854,-0.0101792633708649,-0.0045657426821002,2.64522116472403e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0161344875346,0.00313864493960897,-0.0222862316162336,-0.00998274345296645,2.75632795915316e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.0129479590023915,0.00251871954697057,-0.0178846493144538,-0.00801126869032921,2.75798174247076e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0335911723307342,0.00654505437647105,-0.0464194789086175,-0.0207628657528509,2.88060631368312e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.0123319798224647,0.00240416146806476,-0.0170441362998716,-0.00761982334505774,2.9245928094797e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0113369479842273,0.0022134649941561,0.00699855659568139,0.0156753393727733,3.04920356715796e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,24805,-0.0359943399629872,0.00702848664972745,-0.049770173796453,-0.0222185061295214,3.05855957763414e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,24867,-0.0089121205337919,0.00174866314534511,-0.0123395002986683,-0.00548474076891548,3.48462478381916e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,29390,-0.00979077070103103,0.00192684708139455,-0.0135673909805643,-0.00601415042149772,3.77276171128178e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.00955392931014741,0.00188021593069161,-0.013239152534303,-0.00586870608599185,3.77580695798391e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0384206323267979,0.00757235529977473,-0.0532624487143564,-0.0235788159392395,3.92357074270972e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0189567220823872,0.00373873224805855,-0.026284637288582,-0.0116288068761925,4.00003207394532e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,29795,-0.0116938887428417,0.00230930723393522,-0.0162201309213547,-0.00716764656432863,4.13411837548517e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0279808758979039,0.00552671238364167,-0.0388132321698416,-0.0171485196259662,4.16075207011148e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.0138371878666239,0.00273341898362232,0.00847968665872413,0.0191946890745236,4.16926654547499e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0277157473942998,0.00547719650239151,-0.0384510525389872,-0.0169804422496124,4.21863904659903e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0313209054303233,0.00619572646532858,-0.0434645293023673,-0.0191772815582793,4.32419541865488e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0190318074296305,0.00376835424127591,-0.0264177817425313,-0.0116458331167297,4.44042420767433e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,29023,-0.0258447183807122,0.00512546351558058,-0.0358906268712502,-0.0157988098901743,4.6245724003194e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,29426,0.0226865197234042,0.00453051035073474,0.0138067194359641,0.0315663200108443,5.54608309394094e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0182573965306013,0.0036583331327577,-0.0254277294708064,-0.0110870635903962,6.05873091694653e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0301730471948284,0.00605006399074106,-0.0420311726166809,-0.0183149217729759,6.16643027374959e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.010651308820296,0.00213660563913909,-0.0148390558730087,-0.00646356176758343,6.22648828107801e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.017054618979825,0.00342505915610214,-0.0237677349257852,-0.0103415030338648,6.4221340043097e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0122728688865614,0.00246696671647407,-0.0171081236508506,-0.00743761412227222,6.57382502344852e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0360226032354768,0.00724103539411389,-0.05021503260794,-0.0218301738630136,6.57628571803337e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,29581,0.0218664724814921,0.00439890499317001,0.0132446186948789,0.0304883262681053,6.70186102527241e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0173967059682428,0.00350277729046469,-0.0242621494575536,-0.010531262478932,6.85458971053456e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,24421,-0.00753737625477996,0.00151811777108002,-0.0105128870860968,-0.00456186542346313,6.91825180117215e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,24805,-0.0151505275605091,0.00305158801787652,-0.0211316400755471,-0.00916941504547115,6.92277593152989e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0193959911171607,0.00390806089580486,-0.0270557904729382,-0.0117361917613831,6.97723979810392e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0240867512748414,0.00485379779554959,-0.0336001949541186,-0.0145733075955642,7.00057492498106e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.0139140151655239,0.00280596487476266,0.0084143240109891,0.0194137063200587,7.14331102011647e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,29566,-0.010111307620368,0.00203920818845526,-0.0141081556697403,-0.00611445957099568,7.14519293344395e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0179407318405681,0.00362085834199065,-0.0250376141908697,-0.0108438494902664,7.28707031156064e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.0206387147209992,0.00416559152149598,-0.0288032741031313,-0.012474155338867,7.28875266306252e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0110070936389332,0.0022231041346732,-0.0153643777428927,-0.00664980953497373,7.41558988399195e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0165431567979421,0.00334156968955833,0.0099936802064078,0.0230926333894764,7.44364467558525e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,24845,-0.0284053409689788,0.00573857737735119,-0.0396529526285871,-0.0171577293093704,7.47406379417764e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,24240,-0.0247724997762624,0.005007504755625,-0.0345872090972874,-0.0149577904552374,7.58415656853902e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.00683501141403821,0.00138206565844671,0.00412616272348266,0.00954386010459377,7.636237813181e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,24966,0.00763277130951085,0.00154854729555685,0.00459761861021944,0.0106679240088023,8.3186363412536e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0312409099095569,0.00633843865697922,-0.0436642496772362,-0.0188175701418777,8.32681218688316e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0310112490875253,0.00629989971134396,-0.0433590525217595,-0.0186634456532912,8.6007325026292e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0409690565531649,0.00832382374451094,-0.0572837510924063,-0.0246543620139234,8.61842395072758e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0141696625728948,0.00288087667011591,-0.019816180846322,-0.00852314429946758,8.77572036484765e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.0177948150750597,0.00362055385206928,-0.0248911006251155,-0.0106985295250039,8.93834008371287e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0275083250697341,0.00561250008990114,-0.0385088252459403,-0.0165078248935279,9.57388048293931e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0206521265281125,0.00421567332780957,-0.0289148462506192,-0.0123894068056057,9.69831778255439e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0164966863511574,0.00336924609418456,-0.0231004086957591,-0.00989296400655563,9.82097579593785e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.010683309317394,0.00218325427845828,0.00640413093161583,0.0149624877031723,9.97988569850921e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,29114,-0.0132824591915035,0.00271839219948064,-0.0186105079024855,-0.00795441048052143,1.03375549210966e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0168903390752857,0.00346570586015879,-0.0236831225611969,-0.0100975555893744,1.10279641495916e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0171366666308189,0.00351786981329307,-0.0240316914648733,-0.0102416417967645,1.11539315542213e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0118259227676957,0.00243330300777846,0.00705664887244996,0.0165951966629415,1.17971784803415e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.0152276274679329,0.0031352695453962,-0.0213727557769094,-0.00908249915895633,1.19858764867208e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.010628158212475,0.00219026874148312,-0.014921084945782,-0.00633523147916813,1.22572571566478e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,28879,-0.0141346465917354,0.00291701740639242,-0.0198520007082645,-0.00841729247520622,1.26895802835104e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.010828904829109,0.00224317893892928,0.00643227410880758,0.0152255355494104,1.38957122814198e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0102950533534332,0.00213459623527976,0.00611124473228485,0.0144788619745815,1.42250755881143e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0131865165588364,0.002734311187493,-0.0185457664863227,-0.00782726663135017,1.42532495816322e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.0206713148965308,0.00429827326093251,-0.0290959304879585,-0.0122466993051031,1.52439764365661e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0184594196441562,0.00384065721435496,-0.0259871077842919,-0.0109317315040205,1.54664876100123e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0101060436848985,0.0021036244101408,-0.0142291475287745,-0.00598293984102257,1.56219932674585e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0320109890735037,0.00666741748140715,-0.0450791273370617,-0.0189428508099456,1.58708680250087e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.022442696324822,0.00467556970746403,-0.0316068129514515,-0.0132785796981925,1.59596627403594e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.0127466511420214,0.00265588705667913,-0.0179521897731125,-0.00754111251093029,1.59928222314157e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.0290224064016448,0.00604999477333448,-0.0408803961573804,-0.0171644166459093,1.61913306085162e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0359254298651987,0.00749127587322418,-0.050608330576718,-0.0212425291536793,1.62948536645159e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.00960644364044011,0.00200831720206839,0.00567014192438605,0.0135427453564942,1.73238558825479e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0246855263300517,0.00516865626408429,-0.0348160926076569,-0.0145549600524465,1.79848791096625e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0174600257392555,0.00365798519809758,-0.0246296767275268,-0.0102903747509843,1.82277964463638e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0289684061192655,0.00607542876554641,-0.0408762464997365,-0.0170605657387946,1.86839564822704e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0103118090523707,0.00216495554288399,-0.0145551219164234,-0.0060684961883181,1.91588616453422e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.00935910463763286,0.00196779745039396,-0.013215987640405,-0.00550222163486069,1.98273166086279e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.032366927853625,0.00680641571857338,-0.0457075026620289,-0.0190263530452212,1.99208384221384e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,29623,-0.0191600612539192,0.00402947824752845,-0.0270578386190749,-0.0112622838887634,1.99405630222459e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,24951,0.0195543103075544,0.00411256805513135,0.0114936769194969,0.0276149436956118,1.99782674988295e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.0199208482202794,0.00419054617104156,-0.0281343187155208,-0.0117073777250379,2.00782905453543e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.00540205644269557,0.00113659057029752,-0.00762977396047872,-0.00317433892491243,2.0167587380044e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.0419682719138431,0.00885023354159733,-0.0593147296553738,-0.0246218141723123,2.12549301707518e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.021482527503025,0.00453129694557686,-0.0303638695163556,-0.0126011854896943,2.13926700375364e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0103075025254378,0.00217531352250966,0.00604388802131884,0.0145711170295567,2.1641775337571e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.00871608705618354,0.00184134305246536,-0.0123251194390157,-0.00510705467335144,2.21838530146651e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0150219457385184,0.00317674339550027,-0.0212483627936989,-0.00879552868333786,2.27174316975477e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0467185176327702,0.00988810764781823,0.0273378266430465,0.0660992086224939,2.31690508785985e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0140588106242406,0.00298199232823165,-0.0199035155875747,-0.00821410566090659,2.43539114580804e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00659522826041357,0.00139891075365357,0.00385336318325258,0.00933709333757455,2.43605489922007e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,24101,-0.0206244191329503,0.00437944600567638,-0.029208133304076,-0.0120407049618246,2.49871202243145e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0288330356389421,0.00612404291278908,-0.0408361597480087,-0.0168299115298755,2.51295437277393e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0365933395874154,0.00779679984551426,-0.0518750672846233,-0.0213116118902074,2.70160211230099e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.0157077754912736,0.0033549729425214,-0.0222835224586155,-0.00913202852393163,2.85471133638734e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,28916,-0.015964590768947,0.00341361475131072,-0.022655275681516,-0.00927390585637803,2.92787405008216e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0206272720827339,0.00441345206695126,-0.0292776381339584,-0.0119769060315094,2.97335637052183e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.0173590328968196,0.00371990306685898,-0.0246500429078632,-0.010068022885776,3.07923390906489e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.0153135022133356,0.00328221792346561,0.00888035508334299,0.0217466493433282,3.09079481235722e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0377661804763144,0.00809836193244091,-0.0536389698638986,-0.0218933910887302,3.12642543600115e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.00897565367657728,0.00192502873814601,-0.0127487100033435,-0.0052025973498111,3.13590611136653e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0196663934322665,0.00422453898647017,-0.027946489845748,-0.0113862970187849,3.25270687081128e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0279403121535829,0.00602364509912171,-0.0397466565478614,-0.0161339677593043,3.52563976289512e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,28774,0.0234398898277478,0.00505914618314393,0.0135239633087857,0.0333558163467099,3.61683927154733e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.0153583318230018,0.00331592119021285,-0.021857537355819,-0.00885912629018461,3.64264129578449e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.0278906504656823,0.00602533638751164,-0.0397003097852051,-0.0160809911461594,3.69487398661341e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0280963805471437,0.00608092379447814,-0.0400149911843209,-0.0161777699099666,3.84902517379052e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0172701990773157,0.00373811496409841,-0.0245969044069486,-0.00994349374768284,3.85660635863338e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0114241314739473,0.00247315031831488,-0.0162715060978445,-0.00657675685005014,3.8708662437943e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.024118622685149,0.00522360057001455,-0.0343568798023776,-0.0138803655679205,3.90883176436606e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0114695644236811,0.00249138944566899,-0.0163526877371923,-0.00658644111016986,4.16858955731048e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0211560137935294,0.0046111083707376,-0.0301937862001751,-0.0121182413868837,4.49239239993349e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.00823348991981098,0.00179484845814989,-0.0117513928977848,-0.00471558694183719,4.51221040531134e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0151745325235257,0.00330980906043249,-0.0216617582819734,-0.00868730676507806,4.56880425592704e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,24329,0.00960489495058298,0.00209575686303995,0.00549721149902469,0.0137125784021413,4.60586691123965e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.00860869586916084,0.00188000313076059,0.00492388973287009,0.0122935020054516,4.6926659495701e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,24951,-0.028585408382965,0.00625155706865424,-0.0408384602375273,-0.0163323565284026,4.84193629956608e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0211548509056959,0.0046340454459485,-0.0302375799797549,-0.0120721218316368,5.01704395374268e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.0187338339426263,0.00411677632832678,-0.0268027155461468,-0.0106649523391058,5.37522590378398e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.00917093288093831,0.00201615863051215,-0.0131226037967421,-0.0052192619651345,5.41894310399907e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.0180784205105363,0.00398017742201577,-0.0258795682576872,-0.0102772727633854,5.59157776654912e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.0173411303424677,0.00383011932553788,-0.024848164220522,-0.00983409646441348,5.99010319678604e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0125929353137899,0.00278490879822981,-0.0180513565583203,-0.00713451406925944,6.15925260586028e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.0151035723136733,0.00334447732313839,-0.0216587478670246,-0.00854839676032206,6.33236732962332e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0125229672501084,0.00277317120025814,0.00708755169760249,0.0179583828026144,6.33356904370944e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0147321333007172,0.00326292957681375,-0.0211274752712721,-0.00833679133016223,6.36071449945035e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0266710126199015,0.00591044827811506,-0.038255491245007,-0.015086533994796,6.43633139689237e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,29349,-0.0134411677039454,0.00298228270176201,-0.019286441799399,-0.00759589360849189,6.60025433351082e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.00891879020103605,0.00197944024625254,0.00503908731838107,0.012798493083691,6.64612769379423e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.012334085011927,0.00273839215369395,-0.0177013336331672,-0.0069668363906869,6.69482358112477e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00939358657749639,0.00208898180288571,0.00529918224384039,0.0134879909111524,6.92758927232175e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,29497,0.0101548651861276,0.00227019435120055,0.00570528425777453,0.0146044461144807,7.73721416743318e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.0182451183410331,0.00407897720967818,0.0102503230100639,0.0262399136720023,7.74285100055508e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.026787624617597,0.00599169011066173,-0.038531337234494,-0.0150439120007,7.82743862355914e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.0083365226168294,0.00186555678228667,-0.0119930139101113,-0.00468003132354753,7.90066228418954e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0116413482039155,0.00260945898247647,-0.0167558878095694,-0.00652680859826166,8.18611952582464e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0107396960283596,0.00240900463289828,0.00601804694787901,0.0154613451088403,8.30422621596765e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,28797,-0.0176519780145881,0.00396256879325397,-0.0254186128493659,-0.00988534317981033,8.43344803642638e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0358057512356487,0.00803768091367208,-0.051559605826446,-0.0200518966448514,8.4372040735392e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.0347858659328558,0.00782582106652522,0.0194472566424664,0.0501244752232452,8.82104549207445e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.00982336913796857,0.00221001236436884,-0.0141549933721315,-0.00549174490380564,8.82963200493263e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.00831799698310345,0.00187437314670628,0.00464422561555914,0.0119917683506478,9.12303136918273e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0185496615589057,0.00418153558375063,-0.0267454713030569,-0.0103538518147544,9.20115411349027e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,28774,-0.0220280579734345,0.00496896597196554,-0.031767231278487,-0.0122888846683821,9.32195114412086e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0205383864373002,0.00463317195572818,-0.0296194034705274,-0.011457369404073,9.33107176998086e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,29820,-0.0265697147281798,0.00599661674356057,-0.0383230835455586,-0.0148163459108011,9.42253466137879e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.00946954620775741,0.0021403778063033,0.00527440570740294,0.0136646867081119,9.72046828828416e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,28277,-0.00694547761628018,0.00157350745610927,-0.0100295522302543,-0.00386140300230602,1.01848873749444e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0175228102753816,0.0039706385551285,-0.0253052618434335,-0.00974035870732976,1.02267373117012e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,24867,-0.0230502258274015,0.00523033313910079,-0.0333016787800391,-0.012798772874764,1.05237079384144e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0129187094398409,0.00293843983695305,-0.0186780515202689,-0.00715936735941294,1.10416273738166e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,24867,-0.0206853244352247,0.00471537018060079,-0.0299274499892022,-0.0114431988812471,1.1551035464805e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.0882330094207508,0.0201457467765816,-0.127718673102851,-0.0487473457386509,1.19234150438135e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,29581,-0.0106996284831065,0.00244344963509424,-0.0154887897678912,-0.00591046719832177,1.19687618302054e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0170151300310365,0.00389325764214164,-0.0246459150096341,-0.00938434505243889,1.245301198662e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0248310426113422,0.00569719869443846,-0.0359975520524415,-0.0136645331702428,1.31419425931275e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0119565023564282,0.00274328221130888,-0.0173333354905936,-0.00657966922226277,1.31502920174872e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,29566,-0.016661082081492,0.00382468239208792,-0.0241574595699843,-0.00916470459299965,1.32785190132462e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,29443,-0.0136311584652802,0.00312994086449356,-0.0197658425596876,-0.00749647437087281,1.33464437992483e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,28774,-0.00905441953466146,0.00208562785479873,-0.013142250130067,-0.00496658893925595,1.42099857554727e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0290762804102291,0.00670152761230267,-0.0422112745303424,-0.0159412862901159,1.43856383597892e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0109666940302984,0.00252933713298162,-0.0159241948109424,-0.00600919324965443,1.45725867199315e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.0121802888756794,0.00281433990558321,-0.0176963950906224,-0.00666418266073627,1.51017601750199e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,29725,-0.00836640245448086,0.00193451468273577,-0.012158051232643,-0.00457475367631875,1.53162691460945e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,24111,-0.0116931286154702,0.00271182010836882,-0.0170082960278731,-0.00637796120306736,1.62491814409856e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,24845,0.0222042798083742,0.00516081360660016,0.0120890851394379,0.0323194744773105,1.69544909788219e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.0125688339831228,0.00292365031523862,-0.0182991886009905,-0.00683847936525508,1.72224132503159e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0112882497445164,0.0026283573833318,-0.0164398302158467,-0.00613666927318609,1.75540618758356e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0216339285077489,0.00503991724715795,-0.0315121663121785,-0.0117556907033193,1.77339407107196e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.0100707369280579,0.00235060038027502,0.0054635601827189,0.014677913673397,1.83872898407499e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.00847899089001185,0.00198044977761826,-0.0123606724541436,-0.00459730932588006,1.86364279862441e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.010276249555404,0.00240140539690419,-0.0149830041333362,-0.00556949497747177,1.8811426767834e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0199223591769052,0.00465554617500002,-0.0290472296799053,-0.0107974886739052,1.88204889021923e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0203704917142192,0.00476919173137056,-0.0297181075077055,-0.0110228759207329,1.95099655665447e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.008734551263255,0.00204819704867791,-0.0127490174786637,-0.0047200850478463,2.00982155351326e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0162888527683325,0.00382166841417196,-0.0237793228601095,-0.00879838267655542,2.03151888193785e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0179738268736057,0.00421872906326084,-0.0262425358375969,-0.0097051179096144,2.04629815542159e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,28916,-0.0129525685107164,0.0030482020255685,-0.0189270444808307,-0.00697809254060215,2.15160051811939e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.0135322507155904,0.00318582058883354,-0.0197764590697042,-0.00728804236147671,2.16703110714448e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.0239671011286222,0.0056531732795183,-0.0350473207564781,-0.0128868815007663,2.24759103093971e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.0108763964220169,0.00256587650535572,-0.0159055143725141,-0.00584727847151969,2.25339875783956e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.00819556327150231,0.00193518327133295,-0.0119885224833149,-0.00440260405968974,2.29211789917621e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.016395306141694,0.00388280199999442,-0.024005598061683,-0.0087850142217049,2.42300376225508e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.0246208697683921,0.00583227410827022,-0.0360521270206018,-0.0131896125161825,2.4355766956576e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.019923844131529,0.00472127473446946,-0.0291775426110891,-0.0106701456519688,2.45171052967387e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0150849091979073,0.00357970248685986,-0.0221011260721526,-0.00806869232366197,2.51637850640081e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.0197060605176842,0.0046908088083645,-0.0289000457820786,-0.0105120752532897,2.66538441108035e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0107127425191612,0.00255086733018375,-0.0157124424863213,-0.00571304255200104,2.68264525070907e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.0134013577898657,0.00319865152313878,0.00713200080451365,0.0196707147752177,2.80149982954958e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,29434,-0.0193530466770824,0.00462552553538587,-0.0284190767264387,-0.0102870166277261,2.87296007637896e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0103882834500282,0.00248498567099561,-0.0152588553651796,-0.00551771153487679,2.9199807918783e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0242383330111066,0.00579871936468711,-0.0356038229658933,-0.0128728430563198,2.92420663172986e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.02589311335971,0.00619634696518032,-0.0380379534114634,-0.0137482733079565,2.94092663432752e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.0200205990022948,0.00480563125408231,-0.0294396362602962,-0.0106015617442935,3.10974079253025e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,29518,-0.010770130854646,0.00258932440969427,-0.0158452066976468,-0.00569505501164524,3.19935281026358e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,24793,0.0317032479054067,0.00764095564795781,0.0167269748354094,0.046679520975404,3.34867640918396e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,29313,-0.00696711918553274,0.00168180170774657,-0.010263450532716,-0.00367078783834947,3.44275013731676e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0136089083478553,0.0033001463434512,-0.0200771951810197,-0.00714062151469095,3.73833208399196e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0223159726360761,0.00541468790140652,-0.0329287609228328,-0.0117031843493193,3.77834388353993e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.0202631780034543,0.00492901482390059,-0.0299240470582995,-0.0106023089486092,3.95013201291776e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,29618,0.0116082553997998,0.00282586020512511,0.00606956939775458,0.017146941401845,4.00404301162601e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0206376873902297,0.00502610166139544,-0.0304888466465648,-0.0107865281338947,4.03710586469162e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0254750333288778,0.00620457335862367,-0.0376359971117802,-0.0133140695459754,4.0415575183576e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,24101,-0.0123021160322041,0.00299871092124025,-0.018179589437835,-0.00642464262657323,4.10109449392595e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0278381641793585,0.00679250800969368,-0.0411514798783581,-0.0145248484803588,4.17444368508411e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.0246347413846302,0.00601140389269219,-0.0364170930143069,-0.0128523897549535,4.18104109859146e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.00692106829329582,0.00168951859821435,-0.0102325247457959,-0.0036096118407957,4.20608493331284e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.0141556598407957,0.00346342458086812,0.00736734766229417,0.0209439720192972,4.37803965637291e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0161401082456575,0.00395037143801389,-0.0238828362641647,-0.00839738022715029,4.40812596232574e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0193280886280586,0.00473359095684598,-0.0286059269034767,-0.0100502503526405,4.45419244739465e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,24845,0.0110324860115221,0.00270255596361858,0.00573547632282971,0.0163294957002146,4.47429550143071e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.0124625730565625,0.00306409404623684,-0.0184681973871867,-0.00645694872593827,4.7689218329022e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.0301401636188467,0.00741299566978289,-0.0446696351316212,-0.0156106921060723,4.80069932353268e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0163187761943924,0.00401857244541737,-0.0241951781874104,-0.00844237420137435,4.90216945871266e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.0202765842905274,0.005003648315065,-0.0300837349880548,-0.010469433593,5.0836729079782e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.0120293382395868,0.0029751189719716,-0.0178605714246511,-0.00619810505452245,5.28376806341391e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00817221735840963,0.00202447057224901,0.00420425503680157,0.0121401796800177,5.43707378485225e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,29443,-0.0179172016011336,0.00443879727956752,-0.026617244269086,-0.00921715893318129,5.43919063328213e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0328386899990433,0.0081385936909286,-0.0487903336332633,-0.0168870463648232,5.47551254868567e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,29218,-0.00911827839231394,0.00226219537364595,-0.01355218132466,-0.00468437545996787,5.57469440720528e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.00887089671930684,0.00220176182856424,-0.0131863499032927,-0.00455544353532093,5.61813724099986e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0134949445670673,0.00335679037732166,-0.0200742537066178,-0.00691563542751687,5.82949043007438e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,24229,-0.0089933775780216,0.00223867438728437,-0.013381179377099,-0.00460557577894423,5.90519493793737e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.00781764637994065,0.00194898217045255,0.00399764132585366,0.0116376514340276,6.05739624710046e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0205860222982083,0.00513794972570839,-0.0306564037605967,-0.0105156408358198,6.17655881209007e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0154211206721304,0.00384929059793148,-0.022965730244076,-0.00787651110018467,6.18492302292865e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.00866773766920717,0.00216651705335292,-0.0129141110937789,-0.00442136424463544,6.33240974304055e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,29725,0.0121582137291765,0.00304471083316734,0.00619058049616854,0.0181258469621845,6.53375365159051e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.00987310610857446,0.00247418773733713,-0.0147225140737552,-0.00502369814339369,6.61100686604732e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,24867,-0.0169981267434664,0.00426468263920584,-0.0253569047163098,-0.00863934877062293,6.74481454611921e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.00708124393699776,0.00178019279802626,0.0035920660528663,0.0105704218211292,6.97212653861461e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,24240,-0.00812893378949651,0.0020440994509713,-0.0121353687134003,-0.00412249886559276,7.00575690586919e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0158260657857253,0.00398433435142254,-0.0236353611145135,-0.00801677045693714,7.14508922361529e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0255038220391781,0.00645256950010644,-0.0381508582593867,-0.0128567858189694,7.75513782516389e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00699956806011904,0.00177252254310842,0.00352542387562653,0.0104737122446115,7.87243278646112e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.00499452351145163,0.00126734250897158,-0.00747851482903592,-0.00251053219386733,8.13832909721122e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00925792591430195,0.00235139900853612,0.00464918385757117,0.0138666679710327,8.2670031213907e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.00930360837012485,0.00236665498099134,-0.0139422521328679,-0.00466496460738183,8.47474628700382e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00814234781309842,0.00207305746669928,0.00407915517836784,0.012205540447829,8.60018990808023e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0114705839179732,0.00292253052564389,-0.0171987437482352,-0.00574242408771114,8.69746061940743e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.0254625815950277,0.00649111686551653,-0.0381851706514401,-0.0127399925386153,8.77678760928486e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.0154880119050921,0.00395257471493265,-0.0232350583463601,-0.00774096546382415,8.93218706386694e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,29725,-0.00665416742778587,0.00170015300082372,-0.00998646730940037,-0.00332186754617137,9.10332683763475e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0106182042141222,0.00271465709075894,-0.0159389321120097,-0.0052974763162347,9.199393283552e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.0116509897618356,0.00298431586999256,-0.017500248867021,-0.00580173065665021,9.48431080667115e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.0224833743669729,0.00576026340210213,-0.033773490635093,-0.0111932580988527,9.51502933456276e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,29566,-0.0166578400908208,0.00426917531799759,-0.0250254237140961,-0.00829025646754549,9.56570610652728e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,28774,-0.0279953871958666,0.00717824877744836,-0.0420647547996653,-0.0139260195920678,9.63991699423442e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0162909064907172,0.00418409696893219,-0.0244917365498242,-0.00809007643161007,9.90613272702744e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.0112386423226969,0.0028909485284183,-0.0169049014383967,-0.00557238320699698,0.000101540311028415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0137908098506097,0.00354923498903141,-0.0207473104291113,-0.00683430927210813,0.000102316577968646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0174692823651711,0.00450070823439489,-0.0262906705045851,-0.00864789422575712,0.000104060827583437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0119084115029852,0.00306803992459425,-0.01792176975519,-0.00589505325078052,0.000104067090348798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0129339475072328,0.00333854698457929,-0.0194774995970082,-0.00639039541745734,0.000107244468008557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0142195163898678,0.00367126020734127,-0.0214151863962567,-0.00702384638347896,0.000107692474266041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,29274,0.00756522222293415,0.00196141013138513,0.00372085836541931,0.011409586080449,0.000115017760252455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.00711271014530826,0.00184447284232381,-0.0107278769162629,-0.00349754337435359,0.00011539163188621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.0094463262928406,0.00244958164942445,-0.0142475063257125,-0.00464514625996868,0.000115406077462213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.0168480810086914,0.00437265751059997,-0.0254184897294673,-0.00827767228791544,0.00011695484291881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,29566,-0.00839649586247024,0.00218060591118534,-0.0126704834483935,-0.00412250827654696,0.000118109152642509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.00929672322064168,0.00241530483200648,-0.0140307206913744,-0.00456272574990898,0.000118808684394047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,24951,0.0059322887787534,0.00154240790441884,0.00290916928609247,0.00895540827141432,0.000120300424496597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,24229,0.00895976994216702,0.00233306099839448,0.00438697038531384,0.0135325694990202,0.000123171982593196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0100748965763011,0.00262366221330469,-0.0152172745143783,-0.00493251863822392,0.000123333203730971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0201345311973457,0.00524959281187554,-0.0304237331086218,-0.00984532928606964,0.000125656869753715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.0110917505735245,0.00289236674376597,0.00542271175574317,0.0167607893913058,0.000125958346583384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.025754185146731,0.00672377672428309,-0.0389327875263258,-0.0125755827671361,0.000128303900021926
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0127510763096544,0.0033302917613368,-0.0192784481618745,-0.00622370445743422,0.000129077640851522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,29395,-0.0104920787829183,0.0027492254962675,-0.0158805607556026,-0.00510359681023394,0.000135703441934129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.015227879600432,0.00399262001704227,-0.0230534148338348,-0.00740234436702912,0.000137063027711211
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0310375444648201,0.00813986942454358,-0.0469916885369255,-0.0150834003927147,0.000137612998547047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,29454,-0.00935317452791321,0.00245348723631834,-0.0141620095110972,-0.00454433954472928,0.000138017997706462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.00745864069047779,0.00196101458110531,-0.0113022292694442,-0.00361505211151139,0.000143037077926804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0176816630620435,0.00466165733022398,-0.0268185114292825,-0.00854481469480454,0.000149135701422816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.0176359582449396,0.00467456291203927,-0.0267981015525365,-0.00847381493734259,0.000161844219180196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0173085660819201,0.00460408834347301,-0.0263325792351272,-0.00828455292871304,0.000170664404271168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0110121156799872,0.00292936023127792,-0.0167536617332919,-0.00527056962668247,0.00017083354816239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0175878918150358,0.00467923768135628,-0.0267591976704941,-0.00841658595957752,0.000171123216679881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,24805,-0.00866547573894892,0.00231483463000233,-0.0132025516137535,-0.00412839986414436,0.000181918134001081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0158680529786411,0.0042410088448431,-0.0241804303145336,-0.00755567564274866,0.000183293146404955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00725201879778621,0.00194284207445119,-0.0110599892637106,-0.00344404833186188,0.000189806855692834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.00768367223274688,0.00206203663712396,0.00364208042398392,0.0117252640415098,0.000194708063984469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0197621727406086,0.00532314560568763,-0.0301955381277564,-0.00932880735346085,0.00020560136665106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0107393890779677,0.00289434016627656,-0.0164122958038698,-0.00506648235206565,0.000207257505941452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0187958225485008,0.00507691777022519,-0.0287465813781422,-0.0088450637188594,0.000214198277138839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.0115805406551723,0.00312807751066805,-0.0177115725760816,-0.00544950873426288,0.00021427587167306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00795222800906838,0.00214834988828561,-0.0121629937901082,-0.00374146222802859,0.000214748405513139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0148917391695857,0.00402352695500789,-0.0227778520014011,-0.00700562633777018,0.000215011387883514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,28650,-0.00770609248848589,0.00208242438523373,-0.011787644283544,-0.00362454069342777,0.000215544823803693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0158893746442797,0.00431947865679352,0.0074231964769644,0.024355552811595,0.000235081552239744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.0156864283789175,0.0042817739767909,-0.0240787053734276,-0.00729415138440733,0.000249291271169946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0142909783736644,0.00390503306359678,-0.021944843178314,-0.00663711356901466,0.000253020397190158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0127267389420048,0.0034779323013915,-0.0195434862527321,-0.00590999163127742,0.000253459448809584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0120864402970489,0.00330750314841366,-0.0185691464679397,-0.00560373412615814,0.000258469867584031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0118991658436386,0.00325648053286025,-0.0182818676880447,-0.00551646399923247,0.000258642939769558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0166741995165083,0.00457115479481162,-0.0256336629143391,-0.00771473611867752,0.000265158712857572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0131515228252138,0.0036077097959165,-0.0202226340252102,-0.0060804116252175,0.000267452675579536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.0114376908514849,0.00313871895589697,-0.017589580005043,-0.00528580169792681,0.000268923157370816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.00787045134034153,0.0021619566670378,0.00363301627294744,0.0121078864077356,0.000272752852454022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0111661223637653,0.00307190107988989,-0.0171870484803494,-0.00514519624718106,0.000278642693973219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0129076180695184,0.00355696171144501,-0.0198792630239506,-0.00593597311508615,0.000285187833525096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0115012307901811,0.00317222959990128,-0.0177188008059876,-0.00528366077437461,0.000288774548216094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00859693786292349,0.00237262971504068,0.00394658362144375,0.0132472921044032,0.000291261914233311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.029727250755293,0.00821424372014777,-0.0458271684467826,-0.0136273330638033,0.00029635946296345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.00903411375181939,0.00249979256013462,-0.0139337071696832,-0.00413452033395553,0.000302188990209103
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0117947455059425,0.00327508931948106,0.00537557043975961,0.0182139205721253,0.00031720417687031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.00740876857690126,0.00206065763671085,-0.0114476575448545,-0.00336987960894799,0.000324593127009164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0111303812606026,0.00309733152058775,-0.0172011510409546,-0.00505961148025065,0.000326761630715918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.0143410021900276,0.00399180228001538,-0.0221649346588578,-0.00651706972119748,0.000328021096062509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.00582648190630975,0.00162242622094131,0.00264652651326478,0.00900643729935472,0.000329668554004533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.00879264804394015,0.00245404261085578,0.00398272452666282,0.0136025715612175,0.000340439269105448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0143307376832728,0.00400251351229354,-0.0221756641673681,-0.00648581119917743,0.000343695785857957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.0106722511429857,0.00298118817574036,0.00482912231853463,0.0165153799674369,0.000344428315321065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.0273100383771284,0.007637164045885,-0.042278879907063,-0.0123411968471938,0.000349544122519183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.00630257620580332,0.00176402495928709,-0.00976006512600601,-0.00284508728560062,0.000353694579716841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0179694612626998,0.00502984303281904,-0.0278279536070251,-0.00811096891837448,0.000354163121005943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,29443,0.0119481715475661,0.00334450363919513,0.00539294441474366,0.0185033986803886,0.000354181286659975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.00613817188708488,0.00172907106568583,-0.0095271511758291,-0.00274919259834065,0.000385854985660976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,29218,0.0135831399425479,0.00383237842873953,0.00607167822221839,0.0210946016628773,0.000394255764246453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.0171265055184478,0.00483480527038538,-0.0266027238484031,-0.00765028718849244,0.000397328209886059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,24938,0.0125343982269243,0.0035407896394732,0.00559445053355681,0.0194743459202918,0.000400854685005567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.00893301625105095,0.00252736350739576,0.00397938377655525,0.0138866487255466,0.000409271718119138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,24229,-0.012381598933499,0.00351247981158433,-0.0192660593642043,-0.00549713850279375,0.000424215305948744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.0194745506287301,0.00552792948846784,-0.030309292426127,-0.00863980883133309,0.000427589873743868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,28931,-0.0121143038933289,0.00344432734692666,-0.0188651854933052,-0.00536342229335269,0.000436833661997196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0135460482642225,0.00385268925691262,-0.0210973192077712,-0.00599477732067375,0.000438774616043257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,24938,-0.0210774111339877,0.00599995582017326,-0.0328373245415273,-0.00931749772644814,0.000443982558852095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,29725,0.0109592179673482,0.00312751060523728,0.00482929718108314,0.0170891387536133,0.000458767699024796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0113222754539181,0.00323433188446532,-0.0176615659474701,-0.00498298496036607,0.000464931970943289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00709866322611088,0.00203067944254922,-0.0110787949335073,-0.00311853151871441,0.000473629134218212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00657865796015643,0.00188268164010984,-0.0102687139747717,-0.00288860194554114,0.000476128642583695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00658301706056224,0.00188806047359911,0.00288241853230798,0.0102836155888165,0.000489971130708697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.0170836686185336,0.00490594851342867,-0.0266993277048538,-0.00746800953221346,0.000498098380528158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0124838943683984,0.0035891349515588,-0.0195185988734536,-0.00544918986334313,0.000505448863626458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.00704819757533735,0.00203263353427052,-0.0110321593025076,-0.00306423584816714,0.000526172842773118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0156953647683166,0.00453111998840578,-0.0245763599455919,-0.00681436959104123,0.000533293284640022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,24111,0.008545918337722,0.00246883088746183,0.00370700979829681,0.0133848268771472,0.00053805628714987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0196383157398599,0.00567679965055875,-0.030764843054955,-0.00851178842476474,0.000542287023761938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00650807004601676,0.00188200560488597,0.00281933906044026,0.0101968010315933,0.000544862411643511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.00972563331637268,0.00281299046369292,-0.0152390946252108,-0.00421217200753455,0.000546202938857672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.0139727927662625,0.00404637416760281,0.006041899397761,0.021903686134764,0.00055500443810682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0120220878581538,0.00348422892993626,-0.0188511765608289,-0.00519299915547875,0.000560652818576026
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.00842366444340202,0.00245273496594114,-0.0132310249766467,-0.00361630391015738,0.000594712110272463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.00947380829889704,0.00275981900357941,0.00406456305188139,0.0148830535459127,0.000598464852172456
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00733416982423261,0.00213876068122215,0.0031421988890372,0.011526140759428,0.000606279149668187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,24706,0.0169005470360658,0.00493017694882782,0.0072374002163633,0.0265636938557684,0.000609082477972837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,29349,-0.0192347000297791,0.00562142937977816,-0.0302527016141443,-0.00821669844541388,0.000623216872986883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.00890454918635061,0.00260711140075566,-0.0140144875318317,-0.00379461084086953,0.00063773206294241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.00586093376048671,0.00171985074604868,0.00249002629823128,0.00923184122274213,0.000655728226923065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,24938,0.00730631034715462,0.00214625768721737,0.00309964528020858,0.0115129754141007,0.00066460370228793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0196666465359794,0.00578453414865015,-0.0310043334673337,-0.00832895960462511,0.000675101260733449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,0.00614384613388781,0.00180861384679487,0.00259896299416987,0.00968872927360575,0.000682374766729167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0133198491200215,0.00392287705064976,-0.0210086881392951,-0.00563101010074801,0.000686117239739417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0110281123844833,0.00325067861306598,-0.0173994424660927,-0.00465678230287402,0.000693368123375714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0179099562699299,0.00528206440279517,-0.0282628024994084,-0.00755711004045133,0.000698227247118516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,23779,-0.0108238245282512,0.00319592784710775,-0.0170878431085824,-0.00455980594792,0.000708391034221285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.017618208633474,0.00520366313267557,-0.0278173883735182,-0.00741902889342992,0.000710835257688134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0152131307124693,0.00449451557382041,-0.0240223812371573,-0.00640388018778132,0.000713373727409784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0093332033210461,0.00275874372224272,-0.0147403410166418,-0.00392606562545038,0.000717573917397765
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0198368919301312,0.00586617599119383,-0.0313345968728711,-0.0083391869873913,0.000721857778092951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,24374,-0.00749339444880076,0.00222459364595116,-0.011853597994865,-0.00313319090273649,0.000757138906133411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,24016,0.0080917347295002,0.00240353582136957,0.00338080451961584,0.0128026649393846,0.000762214115530904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.00814232347215341,0.0024253210553907,-0.0128959527407192,-0.00338869420358763,0.000788324192354381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.00629464312778412,0.00187869417047455,-0.00997688370191424,-0.002612402553654,0.000807737243670112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0199575263106715,0.00596057743833844,-0.0316402580898148,-0.00827479453152812,0.000814463580498915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00982484770934782,0.00293612701741994,0.00407003875520474,0.0155796566634909,0.00082054573047023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.00509163782994371,0.00152488643833818,-0.00808041524908654,-0.00210286041080087,0.000841958904303887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,24111,0.0165017039500286,0.00494211775665229,0.00681515314699011,0.0261882547530671,0.000842096765682476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,29132,0.0154824005754328,0.0046384420369152,0.00639105418307898,0.0245737469677866,0.000845365945206325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.00310963405859186,0.000931787483216596,0.00128333059148733,0.00493593752569639,0.000847290948357942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.0128943121339851,0.00386742083414622,-0.0204744569689117,-0.00531416729905853,0.00085708636188929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0163802638341963,0.00491392792678239,-0.0260115625706898,-0.00674896509770279,0.000858881006944671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0211104306242018,0.0063352208632295,-0.0335274635161316,-0.00869339773227196,0.000862602108543071
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0119007374664631,0.00357177700578035,-0.0189014203977926,-0.00490005453513362,0.000863660989114556
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.00486991031410868,0.00146717677662925,-0.00774557679630201,-0.00199424383191536,0.000903932405513677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0137678371111051,0.00414948889999151,-0.0219008353550884,-0.00563483886712172,0.000908073548996105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.0134643445009416,0.00406470102621323,-0.0214311585123195,-0.00549753048956367,0.000925776906211035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.00598521715682571,0.00180773621215993,-0.00952838013265918,-0.00244205418099224,0.000931354457540962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.00966762756984829,0.00292349815558871,-0.0153976839548022,-0.00393757118489442,0.000944581571898681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.0137333255921406,0.00415851763744565,-0.0218840201615341,-0.00558263102274716,0.000959568551932577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.0103785719217019,0.00314450472693839,-0.0165418011865011,-0.0042153426569026,0.000966374211962597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0198661673551691,0.00601960860304774,-0.0316646002171427,-0.00806773449319553,0.000967182625516755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,29640,-0.0156470972627215,0.00474802005042487,-0.0249532165615542,-0.00634097796388874,0.000983622797159684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.00825413949038059,0.00250555533498108,0.00334325103381768,0.0131650279469435,0.00098769854514216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0276923375190998,0.00840847810695751,-0.0441729546087365,-0.0112117204294631,0.00099132171026985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0134185497614328,0.00408190196588042,-0.0214190776145584,-0.00541802190830719,0.00101261880980081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0125253504337597,0.00381243202466267,-0.0199977172020986,-0.00505298366542092,0.00101984363727655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.00785883290401707,0.00239620534067573,-0.0125553953717415,-0.00316227043629265,0.00104063172333845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,28797,-0.0150560381967454,0.00459105373410252,-0.0240545035155864,-0.0060575728779045,0.00104140573838866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.0202887218244237,0.00619097870532206,0.00815440356199245,0.0324230400868549,0.00105011656469579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0208345785953887,0.00637481403839942,-0.0333292141106516,-0.00833994308012586,0.00108332203779363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0139640684411093,0.00427266756188685,0.00558964001981109,0.0223384968624076,0.0010834701679709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00912088310228338,0.0027968710913398,0.00363901576325737,0.0146027504413094,0.00111134986749274
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0137198355528855,0.0042075998498288,0.00547293984722107,0.02196673125855,0.00111281210892107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0107333402195424,0.00329459176909927,-0.017190740086977,-0.00427594035210785,0.00112407699146636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.00696178502538054,0.00213713187383141,-0.0111505634980901,-0.00277300655267097,0.00112538512851434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,28797,0.0181571805219601,0.00557474364088499,0.00723068298582556,0.0290836780580947,0.00112709613943427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,24922,-0.00591871113921217,0.00181758571097164,-0.00948117913271658,-0.00235624314570776,0.00113001878921511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00744503771519587,0.00228698053714648,-0.011927519568003,-0.00296255586238877,0.0011336280678292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.00739902391772188,0.00227434516095765,0.00294130740224487,0.0118567404331989,0.00114248329815576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.00736740014236868,0.00226944668578707,-0.0118155156465113,-0.00291928463822604,0.00117030505208676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,24445,0.00755654484201815,0.00232832421354811,0.00299302938346386,0.0121200603005724,0.00117407909826647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0122866962935613,0.00379742799869021,0.00484373741612852,0.0197296551709941,0.00121580465614219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,29820,0.00580671685108987,0.00179740672265755,0.00228379967468106,0.00932963402749867,0.00123661111167226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.0113747511932006,0.00352261708450363,-0.0182790806788277,-0.00447042170757349,0.00124358426606097
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,29545,-0.00514009939596833,0.00159393494805868,-0.00826421189416334,-0.00201598689777332,0.00126203857558532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.00558780581099918,0.00173665696989159,-0.0089916534719867,-0.00218395815001166,0.0012942223894059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.00977695997789727,0.00304837925731933,-0.0157517833222432,-0.00380213663355138,0.00134150144234538
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.0138090564737938,0.00430579920692728,0.00536969002821634,0.0222484229193713,0.00134263354935227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,29373,-0.0145862340480498,0.00455058556290059,-0.0235053817513349,-0.00566708634476463,0.00135041111784462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.0111436710408189,0.00347925322192076,0.00432433472585417,0.0179630073557835,0.00136231971730081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.021769626506023,0.00679988626434366,-0.0350974035841366,-0.00844184942790941,0.00136900678777369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00739810143254278,0.00231287929558982,0.00286485801318673,0.0119313448518988,0.00138216788694395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.00494502753056426,0.00154625887656398,0.00191436013249887,0.00797569492862966,0.00138528870763282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.00651616513649427,0.00203791673121923,-0.010510481929684,-0.00252184834330457,0.00138819863715909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0165114364237155,0.00516656927373508,-0.0266379122002363,-0.00638496064719475,0.00139583972590443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.00801837078344908,0.00250999962439268,0.00309877151963942,0.0129379700472587,0.00140213987304165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0138718881289033,0.0043469349916604,-0.0223918807125577,-0.00535189554524896,0.00141836535243477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00668575478535005,0.00209536800881671,0.0025788334880693,0.0107926760826308,0.00142096119299993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.00992323523092101,0.00311388315941376,-0.016026446223372,-0.00382002423847004,0.00144048297702085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.00933774339536023,0.00293092001807994,-0.0150823466307969,-0.00359314015992355,0.00144432918181015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,24805,-0.0133045548522262,0.00418262244079409,-0.0215024948361826,-0.00510661486826975,0.00146992899139796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00866710820713562,0.00272517567485344,-0.0140084525298484,-0.00332576388442288,0.0014726566348418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,28722,-0.0078429010425575,0.00247039561652564,-0.0126848764509478,-0.00300092563416724,0.00150121353592388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,29443,-0.0262272443178101,0.00826612326200413,-0.0424288459113381,-0.010025642724282,0.00151100892871853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.00769324145683863,0.00242606069405315,-0.0124483204171828,-0.00293816249649447,0.0015203064398747
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0237338565907455,0.00749026761538117,-0.0384147811168926,-0.0090529320645984,0.00153321724076114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.0101647891504834,0.00320936406854175,0.00387443557614155,0.0164551427248252,0.00154092044342257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0122731236916262,0.00388131757870334,0.00466574123736766,0.0198805061458848,0.00156793947674465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00609701850974469,0.00192821738604161,0.00231771243310314,0.00987632458638624,0.00156885210544227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0215143401195073,0.00680570907430632,-0.0348535299051477,-0.00817515033386687,0.00157304616947848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,28774,-0.0131940908634773,0.00419222612921561,-0.0214108540767399,-0.00497732765021474,0.00164967785349075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,28751,-0.018652296632344,0.00592863468401488,-0.0302724206130131,-0.0070321726516748,0.00165611303679891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.00684014166162742,0.00217531409788356,-0.0111037572934792,-0.00257652602977564,0.00166572851013994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00788269450751175,0.00251900537771837,0.00294544396718374,0.0128199450478397,0.00175437174794257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.00823636737718927,0.00263208122481771,-0.013395246577832,-0.00307748817654655,0.00175478698422059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.0203014158081072,0.00650124680187745,-0.033043859539787,-0.0075589720764274,0.00179412664266246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.0118615898137185,0.00379875642385313,0.00441602722296637,0.0193071524044706,0.00179500458665384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,28916,-0.0100053617931287,0.0032114159105802,-0.0162997369778659,-0.00371098660839152,0.00183775113965764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0128418915463919,0.00412316267638853,-0.0209232903921134,-0.00476049270067039,0.00184386714003917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.00434696669165209,0.00139653816847342,0.00160975188144418,0.00708418150186,0.00185578050287755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,29536,0.0175531822314718,0.00564804826654057,0.00648300762905225,0.0286233568338913,0.00188644420210162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.0081540457411216,0.00262448165207743,-0.0132980297791934,-0.00301006170304984,0.00189262668636876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00924300368530878,0.00297508794355866,0.0034118313159338,0.0150741760546838,0.00189342847948541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0148005482481697,0.00476467411130686,0.00546178699000824,0.0241393095063311,0.001896203698252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,24101,0.0104815809171858,0.00337646352716821,0.00386371240393608,0.0170994494304354,0.00190946034330968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.0132298480181883,0.00427022637309461,-0.0215994917094538,-0.00486020432692291,0.00194907332292235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.00875888810483396,0.00282785440981993,0.00321629346158691,0.014301482748081,0.0019547575596144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0150638449192007,0.00487114588886955,-0.024611290861385,-0.00551639897701637,0.00198692045542319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0140352519744638,0.00454344573230307,-0.0229404056097779,-0.00513009833914981,0.00200937810689022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0248738607350827,0.00805982327120344,-0.0406711143466414,-0.00907660712352395,0.00202986792936843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,28671,-0.00999495634629893,0.0032401281693483,-0.0163456075582216,-0.00364430513437626,0.0020392332739414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.00987961000470278,0.00320676709641318,-0.0161648735136726,-0.00359434649573295,0.00206596801716415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0129499966457566,0.00420356929382955,-0.0211889924616625,-0.00471100082985064,0.00206738111749212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.00892133079012554,0.00289641951470265,-0.0145983130389427,-0.00324434854130834,0.00207148363138228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.0180660230325031,0.00586806783886744,-0.0295674359966833,-0.00656461006832291,0.00208097512584821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.00777343428781625,0.0025258781703566,-0.0127241555017152,-0.00282271307391733,0.00208924406855301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.0122877562926032,0.00399737826650921,-0.0201226176949613,-0.00445289489024514,0.00211435423810665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.00542816108432735,0.00176878832005869,-0.00889498619164238,-0.00196133597701231,0.0021511002766281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,28443,-0.00750874131396596,0.00245102058437848,-0.0123127416593478,-0.00270474096858414,0.00218956946947575
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,28845,-0.00922850315255977,0.00301258097386651,-0.0151331618613381,-0.0033238444437814,0.00219096804411978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.00492343359411856,0.00160871677056963,-0.00807651846443503,-0.00177034872380209,0.0022118883362251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00777550105106176,0.00254302982417341,0.00279116259568189,0.0127598395064416,0.00223381266844341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0109835549198786,0.00359600087616967,0.00393539320258605,0.0180317166371711,0.00225772010191969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,24195,-0.00834600082328363,0.00273616923836248,-0.0137088925304741,-0.00298310911609318,0.00228898258272973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0103520982195565,0.00339405402097317,-0.0170044441006639,-0.00369975233844909,0.00229036073070443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.0116720489855399,0.00382951812704349,-0.0191779045145452,-0.00416619345653468,0.00230676644487737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.0050106187453856,0.00164406201590347,-0.00823298029655639,-0.00178825719421481,0.00230798973318615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.00473790697215297,0.00155465023655064,0.00169079250851372,0.00778502143579221,0.00230903052765021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.00583357300369194,0.00191864656719887,-0.00959412027540172,-0.00207302573198216,0.00236421218295193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.0169285528951564,0.00557222292681838,-0.0278501098317204,-0.00600699595859237,0.00238342891497725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00781449664166343,0.00257853163502477,0.00276057463701487,0.012868418646312,0.00244327657373876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,29497,-0.00678519888240029,0.00224127981718845,-0.0111781073240896,-0.00239229044071093,0.00246899139637046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,29786,-0.0159918151911726,0.00529756315181108,-0.0263750389687223,-0.00560859141362284,0.00254066902425496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.00561384079373345,0.00186264877372816,-0.00926463239024064,-0.00196304919722627,0.00258134654708342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.00686816224196288,0.00227907605474499,0.00240117317466271,0.0113351513092631,0.00258450233501295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,24281,-0.00883144243489787,0.00293096248558416,-0.0145761289066428,-0.00308675596315291,0.00258814000363571
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0120769502188846,0.0040157606577836,0.00420605932962876,0.0199478411081405,0.00263775005586083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0145639618674869,0.00484573292668055,-0.0240615984037808,-0.00506632533119304,0.00265388454316552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,24381,0.0106359910775343,0.00355336815269864,0.00367138949824494,0.0176005926568236,0.00276332901731341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00533004267808171,0.00178390837941582,0.00183358225442669,0.00882650310173672,0.00281235574942722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0349367553987502,0.0117241699832703,0.0119573822315404,0.0579161285659601,0.00288589177282307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,24445,0.00582991919700913,0.00196058228117876,0.00198717792589876,0.0096726604681195,0.0029464921297225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,24016,0.00633075127749906,0.00213252023939182,0.00215101160829109,0.010510490946707,0.00299385890767879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,24381,-0.00787028655812167,0.0026551615222833,-0.0130744031417969,-0.00266616997444639,0.00303817821689962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0171775497632853,0.00580332133247526,-0.0285520595749368,-0.00580303995163381,0.00307987038131342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0061310224025153,0.0020718522653488,-0.010191852842599,-0.00207019196243164,0.00308682665667979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,24636,-0.0200873793002262,0.00679164940341254,-0.0333990121309148,-0.00677574646953768,0.00310279799318401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.00623600214806158,0.00210994943737891,-0.0103715030453242,-0.00210050125079892,0.00312441013727089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.00819695706267976,0.00278604540685733,-0.0136576060601201,-0.00273630806523939,0.00326253106937522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.00773516862834386,0.00265102510715066,-0.0129311778383592,-0.00253915941832856,0.00352823804708053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00992830911491235,0.00340580165277594,-0.0166036803543532,-0.00325293787547151,0.00355873001201548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0153357770447622,0.00526121020976826,-0.025647749055908,-0.0050238050336164,0.0035615543163544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.00960101075939402,0.00329569307417969,-0.0160605691847862,-0.00314145233400183,0.00358020991288921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.0103777481177338,0.00356368578162033,0.00339292398575797,0.0173625722497097,0.00359347663829425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00637751849144941,0.00219015736534323,0.00208481005537667,0.0106702269275221,0.00359567559994615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0173262833736015,0.00596560920698364,-0.0290188774192895,-0.0056336893279136,0.0036827587215444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00589733561757969,0.00203373653756088,-0.00988345923119902,-0.00191121200396037,0.00373781958822691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0150709437894123,0.00520213371177632,-0.0252671258644939,-0.00487476171433074,0.00376949936634428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.0144397105719856,0.00498690538048121,-0.0242140451177287,-0.00466537602624241,0.00378805658197253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.0172927324585057,0.00597558726736493,-0.029004883502541,-0.00558058141447048,0.00380830630688834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0112910220799706,0.00390318269071693,-0.0189412601537758,-0.00364078400616543,0.00382189503119467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.0128658322827338,0.00444761273965832,-0.0215831532524641,-0.00414851131300349,0.00382222198076166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.00999697631464844,0.00345708389659597,0.00322109187732034,0.0167728607519765,0.00383405675879877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0110746464672786,0.00383010885384874,-0.0185816598208221,-0.00356763311373509,0.00383724393797024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.00947413548750842,0.00327766131418506,-0.0158983516633111,-0.0030499193117057,0.00384941247596168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,24229,0.0078893510381576,0.00273620211280153,0.00252639489706659,0.0132523071792486,0.00393851741272027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.00730750739356485,0.0025370427569081,-0.0122801111971047,-0.00233490359002497,0.00397606075239677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,24845,0.00600035270466872,0.00208679548148048,0.00191023356096698,0.0100904718483705,0.00403870606057024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.00705011026854808,0.00245247181355799,0.00224326551397442,0.0118569550231217,0.00404706803847987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.0118331107612234,0.00411821457205107,-0.0199048113224435,-0.00376141020000332,0.00406476639670864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.0115951953288817,0.00404070621545738,0.00367541114658527,0.0195149795111782,0.00411353778875301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0171263470739029,0.00599348915685824,-0.0288735858213451,-0.00537910832646077,0.00427303286843209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00547971839324701,0.0019233050335926,-0.00924939625908851,-0.00171004052740551,0.00438769939686775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,28931,0.00913422399059203,0.00322043079665839,0.00282217962914159,0.0154462683520425,0.00456660996825597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0131845071728529,0.00466188380697606,-0.0223217994345259,-0.00404721491117979,0.00468563367677975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.0112474835987452,0.00398520665309659,0.00343647855867586,0.0190584886388145,0.00477110530340817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.00826762087733528,0.00292943411532214,-0.0140093117433667,-0.00252593001130389,0.00477246450880114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0120563574878798,0.00429903616536967,-0.0204824683720044,-0.00363024660375527,0.005044533409739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.0203164265170647,0.00724655313071877,0.00611318238085592,0.0345196706532735,0.00505748519079443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0146262321530187,0.00521707640814741,-0.0248517019129876,-0.00440076239304977,0.00505857419252741
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,24111,0.00769643541535143,0.00274695632229038,0.00231240102366229,0.0130804698070406,0.00508581391336248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0195948145167992,0.00699878144382222,-0.0333124261466908,-0.00587720288690767,0.00511831999032115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.00764679652592916,0.00273466199245561,-0.0130067340311422,-0.00228685902071617,0.00517330421015696
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.00441394569289944,0.00157971763935861,-0.00751019226604231,-0.00131769911975657,0.00520718334867455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00389830477916201,0.00139681735431685,-0.00663606679362305,-0.00116054276470098,0.00526113057683902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.0121761832219369,0.00436980295419722,-0.0207409970121634,-0.00361136943171031,0.00533262563221361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,24016,0.00900099113184113,0.00323760639219284,0.00265528260314317,0.0153466996605391,0.00543781806723773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.01173957845076,0.00422642962106627,-0.0200233805080499,-0.00345577639347011,0.00547863336987174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0177887586176058,0.00642453749991934,-0.0303808521174477,-0.00519666511776385,0.00562850569021101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.018134559904177,0.00655325123888597,-0.0309789323323935,-0.00529018747596044,0.00565722715478142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0163359448261876,0.00590776667109422,-0.0279151675015323,-0.00475672215084291,0.00569295394179109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0109889336736191,0.00397697025045204,-0.0187837953645051,-0.00319407198273312,0.00572840348150376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00738455877348333,0.00267557517350232,0.00214043143341878,0.0126286861135479,0.00578463299913469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0213431492965255,0.00779110595528788,-0.0366137169688898,-0.00607258162416126,0.00615838548423674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,24229,-0.0118019818123645,0.00431119728750983,-0.0202519284958838,-0.00335203512884527,0.00619498500822577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.015714022887429,0.00575224617424226,-0.0269884253889438,-0.00443962038591411,0.00630263771954559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00637710453853521,0.00233686837437734,0.00179684252475562,0.0109573665523148,0.00635900446777984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00788753225120255,0.00289451812534476,0.00221427672552681,0.0135607877768783,0.00643496545049907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.0044880282768333,0.00164998318314972,-0.00772199531580675,-0.00125406123785985,0.00653113739796263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.0184948044844168,0.00681277193525359,-0.0318478374775138,-0.00514177149131972,0.00663694342558298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00511944585524156,0.00188603020165807,0.00142282665999173,0.00881606505049138,0.0066433846120078
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,29786,0.00773807288003624,0.00285219122759341,0.00214777807395316,0.0133283676861193,0.00667099250672256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.00912103095009025,0.0033634703656005,-0.0157134328666672,-0.00252862903351327,0.00669592251333281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.00500115939526994,0.00184862341938661,-0.00862446129726771,-0.00137785749327218,0.00682805636260428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,24101,0.0176849497631824,0.00654951093180016,0.00484790833685408,0.0305219911895107,0.0069347475233052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,29434,-0.0112808126780123,0.00418888471087007,-0.0194910267113176,-0.00307059864470695,0.00708449705886636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.00751433906034371,0.00279050448097911,-0.0129837278430628,-0.00204495027762465,0.00708899575104378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00521187403146579,0.00193675437324936,0.00141583545989703,0.00900791260303454,0.00712791617039766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00793491720265448,0.00295473819270439,0.00214363034495388,0.0137262040603551,0.00724731575039636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.00493656931541145,0.00184223328225307,-0.00854734654862746,-0.00132579208219544,0.00737368350588824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0173158202870417,0.00646661013346818,-0.0299903761486393,-0.00464126442544403,0.00741645754200638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.00734975080636721,0.00274613382004454,-0.0127321730936545,-0.00196732851907991,0.0074466558109557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.00922809926515783,0.00344843501272395,-0.0159870318900968,-0.00246916664021889,0.00745513996605124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.00610784202530463,0.00229053295914719,0.00161839742537614,0.0105972866252331,0.00766741052859578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,29392,0.0143431044095853,0.005379692179984,0.00379890773681668,0.0248873010823539,0.00767658260789401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0149914758329416,0.00562372842420314,-0.0260139835443798,-0.00396896812150345,0.00768657032336241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0228062912435368,0.00859774829133174,-0.039657877894547,-0.00595470459252656,0.00799288587871921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.00513836564067665,0.00194105618362153,-0.00894283576057485,-0.00133389552077845,0.00812121392432074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,24966,0.00268066466225241,0.00101333723074541,0.000694523689991407,0.00466680563451342,0.00816497331228466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.005296431489758,0.00200403560969697,-0.00922434128476406,-0.00136852169475195,0.00822558873416955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.00969208166354898,0.00367299712408488,-0.0168911560267553,-0.00249300730034262,0.00832682124165817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,24111,0.00829140833396979,0.00316150796367477,0.00209485272516725,0.0144879639427723,0.00873135137028115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,24966,0.00374867241758185,0.00143096378012734,0.000943983408532268,0.00655336142663142,0.00880646326714776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,28931,-0.00883651839358355,0.00337641564981324,-0.0154542930672175,-0.00221874371994959,0.00887187297101543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.00985680855279386,0.0037689896245915,-0.0172440282169932,-0.00246958888859451,0.00892190563759102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,28774,-0.0121299025159662,0.00464073154290645,-0.0212257363400628,-0.00303406869186952,0.00895904223569773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00771840458804476,0.00295788496515076,0.00192095005634927,0.0135158591197403,0.00907463860169229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.00831052997966922,0.00318707463154365,0.00206386370184366,0.0145571962574948,0.00912412400020085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0117948013172865,0.00452604313640824,-0.0206658458646467,-0.00292375676992639,0.00916577266102625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00823567990922196,0.00316249872683878,0.00203718240461795,0.014434177413826,0.00921539657289879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.0098752199479398,0.0037940666127803,0.00243884938689041,0.0173115905089892,0.00925192823170728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.0132887397983813,0.00511277910848071,-0.0233097868510035,-0.00326769274575914,0.00935091614384249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,24966,0.00344823901002762,0.00132777287839269,0.000845804168377955,0.00605067385167729,0.00940944517076213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.00744949447537605,0.00287304308640714,0.00181833002601806,0.013080658924734,0.00952280601674344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0064058725817669,0.00247093576431436,0.00156283848371075,0.0112489066798231,0.00953318345129659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,29381,-0.00721550137420661,0.00280006221561684,-0.0127036233168156,-0.0017273794315976,0.00997369606903802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0130073701120726,0.00505513160176788,-0.0229154280515377,-0.00309931217260756,0.0100848773588669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.00382885607177696,0.00149007073274026,-0.00674939470794786,-0.000908317435606056,0.0101870429118759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,24587,-0.00940386351884802,0.00366698625438783,-0.0165911565774482,-0.00221657046024786,0.0103393411651692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,29820,0.00554822317632425,0.00216904395480006,0.00129689702491613,0.00979954932773237,0.0105351797728702
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.00916637160458078,0.00358766795527187,-0.0161982007969137,-0.00213454241224791,0.0106248976710154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,28931,-0.00869205085321187,0.00342428988459378,-0.0154036590270157,-0.00198044267940805,0.0111428100009091
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.0104342422284335,0.00411544214194522,-0.0185005088266462,-0.00236797563022088,0.0112373694017431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,24229,0.0094307283038117,0.00373028843090872,0.0021193629792306,0.0167420936283928,0.0114728404468863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.0205739971303918,0.00813998638343114,-0.0365283704419168,-0.00461962381886673,0.0114922185789645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.00448793884626319,0.00177815417090326,-0.00797312102123358,-0.00100275667129281,0.0116112196982743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0059269918741788,0.00234977531428902,-0.0105325514901853,-0.00132143225817232,0.0116620516974322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00709492852535704,0.00282725240058545,0.00155351382020955,0.0126363432305045,0.0120974722541239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,28916,-0.013091678107183,0.00521891158370028,-0.0233207448112356,-0.00286261140313048,0.0121296751305332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00484729967382558,0.00193750870250848,0.00104978261690896,0.00864481673074221,0.01236102079552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00701247654916141,0.00280702775929816,0.00151070214093701,0.0125142509573858,0.0124884225552442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,24101,0.00813414570527118,0.00325796803243729,0.00174852836169408,0.0145197630488483,0.0125423724668709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0111663093569149,0.00447803144712096,-0.019943250993272,-0.00238936772055784,0.0126519134027756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.0089223226839271,0.00358886841155794,-0.0159565047705807,-0.00188814059727355,0.0129214799262188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00251515465312493,0.00101173092543954,0.000532162039263432,0.00449814726698642,0.0129256055157447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.00765038023198289,0.00307839457047002,-0.0136840335901041,-0.00161672687386165,0.0129549555379092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.00778679806434102,0.00313741486946602,-0.0139361312084944,-0.00163746492018762,0.0130745937502657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,29590,-0.00693645192268914,0.0028068052165232,-0.0124377901470746,-0.00143511369830368,0.0134679510370916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.00756464099325281,0.00306373633002333,-0.0135695642000985,-0.00155971778640707,0.0135524039165069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0143633190350582,0.00582382822375447,-0.025778022353617,-0.00294861571649947,0.0136584905641961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0119441305068067,0.00485204704998964,0.002434118288827,0.0214541427247864,0.013834893226085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.00849396131888644,0.00345274689849589,-0.0152613452399384,-0.00172657739783449,0.0138972478526681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00530961345370573,0.002158867592771,0.00107823297187458,0.00954099393553689,0.0139222223438093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,29478,-0.0057493790861761,0.00233882240591253,-0.0103334710017647,-0.00116528717058755,0.0139678234927138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0101606080597017,0.00413429960199722,-0.0182638352796163,-0.00205738083978719,0.0139923545899758
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.00892694310227551,0.00363890334291989,0.00179469255015253,0.0160591936543985,0.0141651796001531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00459294837895876,0.00187280534334157,0.000922249906009282,0.00826364685190824,0.0141946760543441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.00500884151132434,0.00204430571189073,-0.00901568070663018,-0.0010020023160185,0.0142856802607666
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.00642091416083964,0.00262105363267717,-0.0115581792808869,-0.00128364904079238,0.0143015408576957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.00976162540907731,0.00398573502396374,-0.0175736660560462,-0.00194958476210837,0.0143255887791004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.0132575120610753,0.00541548938693613,-0.0238718712594701,-0.00264315286268046,0.0143681926051499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.0109328818991805,0.0044662752656035,-0.0196867814197633,-0.00217898237859762,0.014377016761962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.00976506549720228,0.00399115903781276,0.00194239378308926,0.0175877372113153,0.0144251732179778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,24229,-0.00828191519395388,0.00340013598922529,-0.0149461817328354,-0.00161764865507232,0.0148677036755504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00527404683473022,0.00217148421044163,0.00101793778226462,0.00953015588719582,0.0151559820974803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,24016,0.00682406306543131,0.00281690672819344,0.00130292587817216,0.0123452002526904,0.0154198743056565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.00635629003037664,0.0026268440565485,-0.0115049043812117,-0.00120767567954157,0.0155385845168153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,24793,-0.0134610950375222,0.00556347075801312,-0.0243654977232279,-0.00255669235181645,0.0155468789185353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00983013534588362,0.00406544535474149,0.0018618624505903,0.0177984082411769,0.0156133003235366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00426777301634574,0.00177133319761117,-0.00773958608366363,-0.000795959949027861,0.0159878770644173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.00982754472989525,0.00408160177694064,-0.0178274842126989,-0.0018276052470916,0.0160578744013669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.00668034538110748,0.00277951417510808,-0.0121281931643193,-0.00123249759789564,0.0162485939204144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00631779688837063,0.00263321708608811,0.00115669139963794,0.0114789023771033,0.0164353748700477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.00664035707897955,0.00277295860743922,-0.0120753559495604,-0.00120535820839867,0.0166422896703213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.00647182005941863,0.00270538047529825,-0.0117743657910032,-0.00116927432783406,0.0167537907819514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.00801070783958385,0.00335286696871374,-0.0145823270982628,-0.00143908858090492,0.0168908282352576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00198086158726379,0.000830060223536474,0.000353943549132296,0.00360777962539527,0.0170202354165127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.0111023348480074,0.00466100876581636,-0.0202379120290074,-0.00196675766700731,0.017228484619418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.00715461274159355,0.00300988990396134,-0.0130539969533578,-0.00125522852982933,0.01746010052517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,28774,0.00532015002533455,0.00223830641292485,0.000933069456001848,0.00970723059466724,0.0174670259430202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,24445,0.00577209225394562,0.00242918543911837,0.00101088879327362,0.0105332957146176,0.0175023386213767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0388441726509298,0.0163718494982582,-0.0709329976675159,-0.00675534763434362,0.0176700112638198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.00628290920131965,0.00265403779824865,-0.011484823285887,-0.0010809951167523,0.0179247243539337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.00822506846452006,0.00347980317246237,-0.0150454826825463,-0.00140465424649381,0.0181018939939401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0191522488762508,0.00810321846275589,-0.0350345570632523,-0.00326994068924926,0.0181079266936452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,28797,0.00892247954231639,0.00377917737945769,0.00151529187857932,0.0163296672060535,0.0182344152869652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00606482708219849,0.00256986581133406,0.00102789009198372,0.0111017640724133,0.018283937807846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.00953606755632657,0.00404442461948878,-0.0174631398105246,-0.00160899530212856,0.0183886177484426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00438075876087041,0.00185879968628343,0.000737511375754893,0.00802400614598592,0.0184412148253625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,24845,-0.00617851502883198,0.0026243645348011,-0.0113222695170421,-0.00103476054062182,0.0185658730953555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,29478,-0.00459251757817276,0.0019572062509171,-0.00842864182997027,-0.000756393326375249,0.0189589920647103
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.00402823840863605,0.00171758732992722,-0.00739470957529339,-0.000661767241978702,0.0190203213651351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,29169,0.00514363449133964,0.00219375854205809,0.000843867748905777,0.00944340123377349,0.0190507232080192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,29478,0.00419901500007673,0.00179740992434501,0.000676091548360515,0.00772193845179294,0.0194902160884544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00591822447390651,0.00253608432181894,0.000947499203141378,0.0108889497446716,0.0196245143138171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0112729652989817,0.00483772551501801,-0.0207549073084169,-0.00179102328954637,0.0198026202848762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.00612242249170423,0.00262747252658434,-0.0112722686438095,-0.000972576339598931,0.0198059834071543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00822495265783877,0.00353092278826262,0.00130434399284405,0.0151455613228335,0.0198444557363122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0168847637614323,0.00725079856336574,-0.0310963289456292,-0.00267319857723549,0.0198841971498929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0084264465469788,0.00362544958587955,-0.0155323277353027,-0.00132056535865488,0.0201203934066682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.0115181941340778,0.004960061367504,-0.0212399144143856,-0.00179647385376993,0.0202310004572221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0106038068255707,0.00456870985306571,-0.0195584781375795,-0.00164913551356194,0.0202957550355505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.01196426355898,0.0051601785613011,-0.0220782135391302,-0.00185031357882987,0.0204249468325863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.00663948066411638,0.00287241960453289,0.00100953823923191,0.0122694230890008,0.0208158986224755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.00617812009932133,0.0026732282596587,-0.0114176474882524,-0.000938592710390282,0.0208352277114093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00694892894767336,0.00300959991828779,0.0010501131078293,0.0128477447875174,0.0209563330461893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00797712800187004,0.0034655037498633,0.00118474065213796,0.0147695153516021,0.0213511712095604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.00340773273091108,0.00148593466978911,-0.00632016468369774,-0.000495300778124425,0.0218362769871593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,24111,0.00731205442253116,0.0031983758422913,0.00104323777164022,0.0135808710734221,0.0222525219520397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,24538,-0.00513739444653195,0.00225013204221106,-0.00954765324926562,-0.000727135643798272,0.0224299060758669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00725182122491501,0.00318503798015492,0.00100914678381136,0.0134944956660187,0.0228045553890639
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,24229,0.00887686150867393,0.00390085286956917,0.00123118988431835,0.0165225331330295,0.022877417620596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,0.0067170176446641,0.00295347951686293,0.00092819779161276,0.0125058374977154,0.0229568446548705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.00556017875931623,0.0024457437176735,-0.0103538364459563,-0.000766521072676177,0.0230099641521927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,29400,0.0109874503386528,0.00483648995919167,0.00150793001863716,0.0204669706586685,0.0231068825717278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00752550208044377,0.00331297067350134,0.00103207956038115,0.0140189246005064,0.0231238340356583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00348627037868934,0.00153604106699803,0.000475629887373206,0.00649691087000547,0.0232362743035398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.00624398350053085,0.00275862273962675,0.000837082930862425,0.0116508840701993,0.0236172435723254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,29434,-0.00535446284280314,0.00236844486716902,-0.00999661478245441,-0.000712310903151863,0.0237819875098154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,29434,-0.00989362123386817,0.00439189775612225,-0.0185017408358678,-0.00128550163186857,0.0242855065000068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,24445,0.00642869413737365,0.00285381321968159,0.000835220226797732,0.0120221680479496,0.0242889167312336
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0194921293273903,0.00865298391139704,-0.0364519777937285,-0.00253228086105208,0.0242900204729143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.0134209457457462,0.00596407445926753,-0.0251105316859105,-0.00173135980558181,0.0244388833373895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0222607707629805,0.00991508728491589,-0.0416943418414157,-0.00282719968454541,0.0247666368454799
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00507856122036666,0.00226572883897649,-0.00951938974476059,-0.00063773269597274,0.0250032931706522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.00803383152227755,0.00358722269014985,-0.0150647879949713,-0.00100287504958385,0.0251277724500019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.017311152674528,0.00775131420096749,-0.0325037285084243,-0.00211857684063171,0.0255368414984357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00522314314993089,0.00234542803567058,0.000626104200016552,0.00982018209984523,0.0259584005983032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00435991380979701,0.00195840566503651,-0.00819838891326857,-0.000521438706325446,0.0260059457884712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.00981705555608089,0.00441508728819683,0.0011634844712151,0.0184706266409467,0.0261879795325176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,24111,0.00787431103876942,0.00354690826771196,0.000922370834053982,0.0148262512434849,0.026424693323585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00704789348245235,0.00317580629270289,0.000823313148754681,0.01327247381615,0.0264792655240311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,29434,-0.00472840069630478,0.00213119074283114,-0.0089055345522538,-0.000551266840355748,0.0265170499264911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00561417288189084,0.00253092158104946,0.000653566583033887,0.0105747791807478,0.0265482273254718
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,28931,0.00741431033089374,0.00334548116990528,0.000857167237879395,0.0139714534239081,0.0266844371250566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00385650821452555,0.00174327340310921,0.000439692344431501,0.0072733240846196,0.0269606916058451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.00672872674880332,0.00304732510137976,-0.0127014839475076,-0.000755969550098998,0.0272480416024615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.00738442870329126,0.00334680756174368,-0.0139441715243089,-0.000824685882273639,0.0273630112606351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.00508651861894573,0.00230812599720143,0.000562591664430917,0.00961044557346054,0.0275514745416105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,24938,-0.00654566073230509,0.00297249593228916,-0.0123717527595919,-0.000719568705018332,0.0276690943612995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.00316558663165472,0.00143779310324989,0.000347512149284947,0.0059836611140245,0.0276943825596221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,28916,0.00579233832373163,0.0026320587781882,0.000633503118482759,0.0109511735289805,0.0277660483577604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00528855288346532,0.00240647004274719,0.00057187159968083,0.0100052341672498,0.0279825923682679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.00562346961997973,0.00256475883448419,-0.0106503969355688,-0.000596542304390713,0.0283462708574284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0115692684518176,0.00528283052827407,-0.0219236162872348,-0.0012149206164004,0.0285340234154562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,28114,-0.00420512315526382,0.00192028556949122,-0.00796888287146662,-0.000441363439061019,0.0285438453560709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,24229,-0.00595993081037514,0.002730218968784,-0.0113111599891918,-0.000608701631558505,0.0290490808733347
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0104690994588344,0.00479874415944437,-0.0198746380113454,-0.00106356090632347,0.0291459608463322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00706659573359298,0.00324605607771749,-0.0134288656459193,-0.000704325821266701,0.0294915445731605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00844139517027416,0.0038946921890172,0.000807798479800457,0.0160749918607479,0.0302133976205645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.0119135884400642,0.00550063972290077,0.00113233458317872,0.0226948422969497,0.0303320773349955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,29541,0.00403173183458813,0.00186517061615156,0.000375997426931068,0.0076874662422452,0.0306578983197485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,24938,0.0131308173803495,0.00607875735735432,0.00121645295993505,0.025045181800764,0.0307732390114509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.00547600000818611,0.00253791432661302,-0.0104503120883476,-0.000501687928024592,0.0309626750456787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,29443,0.0035374484646775,0.0016421876679655,0.000318760635465124,0.00675613629388988,0.0312398495665154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00521314208853685,0.00242238669161014,0.000465264172980975,0.00996102000409272,0.0314018132956282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00417551967880762,0.00194289867169287,0.000367438282289582,0.00798360107532565,0.0316348797196135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.00481052685705563,0.00223903489564091,0.00042201846159945,0.0091990352525118,0.0316836140582356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.0160041947009058,0.00747205978767643,-0.0306494318847516,-0.00135895751705998,0.032211990775023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.00577169311846804,0.00269797534326927,-0.0110597247912758,-0.000483661445660266,0.0324239638969053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,29478,-0.0117844252244031,0.00551285200958649,-0.0225896151631927,-0.000979235285613618,0.0325551762276597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,29199,0.0185744987843762,0.00869791120404897,0.00152659282444021,0.0356224047443122,0.0327274635025131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,24805,0.0166861478514411,0.00781901458916026,0.00136087925668696,0.0320114164461952,0.0328486835656426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.0067931934792843,0.00318938476399476,-0.013044387616714,-0.00054199934185457,0.0331864928489452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,28916,-0.01689881480395,0.00796276621853208,-0.0325058365922729,-0.00129179301562714,0.0338269780161817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0109238026119822,0.00515427702310894,-0.0210261855772758,-0.00082141964668872,0.0340680335333495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00545957187713685,0.00258184412711817,0.000399157387985247,0.0105199863662885,0.0344726349626737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.0102269509277434,0.00484248855655822,0.000735673356889271,0.0197182284985975,0.0347035309353876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00508577083635356,0.00240834140727759,0.000365421678089474,0.00980611999461764,0.0347197399376606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00575334368072682,0.00272744485245749,-0.0110991355915435,-0.00040755176991014,0.0349180940199678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00638712864426536,0.00304022068215449,0.000428296107242545,0.0123459611812882,0.0356621061552157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,29434,0.0127600472498795,0.00607849145688875,0.00084620399437753,0.0246738905053814,0.0358066419262701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,28797,0.0124117297233604,0.00593745808693234,0.000774311872973025,0.0240491475737478,0.0365896158665792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.00609406035926924,0.00292020528019828,-0.0118176627084579,-0.000370458010080604,0.0369110839399467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0114809140603459,0.00550161005388662,-0.0222640697659637,-0.000697758354728168,0.036912459557312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.00999499848078219,0.00480255191755479,-0.0194080002391896,-0.00058199672237479,0.0374272409041218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0124512114361159,0.00598487555538618,0.00072085534755896,0.0241815675246728,0.0374932781538319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,24938,0.00673393575458598,0.0032415217243784,0.000380553174804324,0.0130873183343676,0.0377749129246147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0129361622214114,0.00625795152041313,0.000670577241401673,0.0252017472014211,0.0387301113087495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00589838409783616,0.00285444573387784,0.000303670459435583,0.0114930977362367,0.0388027404839529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.00741022437767267,0.00359035765383241,0.000373123376161143,0.0144473253791842,0.0390356913014937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.0102758556366012,0.00499178461899016,0.000491957783380469,0.0200597534898219,0.0395477582719906
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.00484781046955048,0.00235756359865125,0.000226985816194025,0.00946863512290693,0.0397661497434557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.0076100064806754,0.00370274406050504,0.000352628122085518,0.0148673848392653,0.0398671365602534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,24845,-0.00724117508108089,0.00352539083646555,-0.0141509411205534,-0.000331409041608407,0.0399855253862955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,29218,0.00490595114772834,0.00239213665147248,0.000217363310842275,0.0095945389846144,0.0402889250426895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.00811984062964209,0.00396115492932676,0.000355976968161632,0.0158837042911225,0.0403879163715794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.0117780830181119,0.00574839804101285,-0.0230449431784971,-0.000511222857726687,0.040479376592364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.0065274369754122,0.0031972667099934,-0.0127940797269993,-0.000260794223825132,0.0412049227477866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0143078678874942,0.00702541038652488,0.00053806352990538,0.0280776722450829,0.0417019299166716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.00671472192059298,0.0033056142582498,-0.0131937258667626,-0.000235717974423367,0.0422328492017726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,0.00899046928336786,0.00443731660274431,0.000293328741989025,0.0176876098247467,0.0427646941432294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0107774555439696,0.00532979640653879,0.000331054587153557,0.0212238565007856,0.0431755722003534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.00750399267857611,0.00371158035448624,-0.0147786901733691,-0.00022929518378307,0.0432099850125325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.00489131440307873,0.00242302949836699,-0.00964045221987802,-0.000142176586279441,0.0435299932849016
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00329314588079906,0.0016327623220917,9.29317294993326e-05,0.00649336003209879,0.043714938565012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,28872,0.00774496093247769,0.00384077881999462,0.000217034445288231,0.0152728874196672,0.0437561356668473
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,24111,0.00474883442256635,0.00235563044840693,0.000131798743688762,0.00936587010144393,0.0438162268692994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.00531296468918259,0.00264163536751996,-0.0104905700095217,-0.000135359368843469,0.0443110938472092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.00657685404228723,0.00327012211299347,0.000167414700820026,0.0129862933837544,0.0443159964800572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.00766939060671271,0.00381647094617962,-0.0151496736612248,-0.000189107552200658,0.0444897389898497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,29713,-0.00290724341050469,0.00144737808390405,-0.00574410445495662,-7.03823660527536e-05,0.0445856881229019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,29757,-0.00411061425125038,0.00204755454696562,-0.008123821163303,-9.740733919776e-05,0.0446977646797683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00709495344045733,0.00354384888230411,0.000149009631141273,0.0140408972497734,0.0452904805595104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0077176400798932,0.00385840284026888,0.000155170512966205,0.0152801096468202,0.0454881233154467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,24195,0.00474000498375255,0.00237113613152365,9.25781659661916e-05,0.0093874318015389,0.0456147865579298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.00913122372848563,0.0045749243192974,-0.0180980753943085,-0.000164372062662737,0.0459525865983887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00532397253718975,0.00267076428656123,-0.0105586705388498,-8.92745355297511e-05,0.0462259701965632
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00685947748160138,0.00345939177131731,7.90696098194547e-05,0.0136398853533833,0.0473946634115503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00684354993226716,0.00345368766278935,7.43221132000317e-05,0.0136127777513343,0.0475443751653423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.00428008867026413,0.002161319121839,4.39031914596898e-05,0.00851627414906858,0.0476775327254667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00757671308358235,0.00384669860800326,3.71838118959616e-05,0.0151162423552687,0.0488880540356167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.00898171860764108,0.00456057923848568,4.29833002091491e-05,0.017920453915073,0.0489157486546054
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.00426964003860796,0.00217076446716357,-0.00852433839424856,-1.49416829673607e-05,0.0492060538287164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,29293,-0.00750349664461602,0.00382644761230796,-0.0150033339647396,-3.65932449242212e-06,0.0498935829141101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.00888469947728328,0.0045314439351589,-0.0177663295901947,-3.06936437183443e-06,0.0499281755015017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,28797,-0.00991237987786167,0.00507630335839804,-0.0198619344603218,3.71747045984812e-05,0.0508675813265024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00455159511593604,0.00233929942749379,-3.34317619517903e-05,0.00913662199382388,0.0517013639373046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.0058676605800105,0.00301704798321269,-0.0117810746271074,4.57534670863687e-05,0.0518064551694864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.00700667421826257,0.00360544515649537,-0.0140733467249935,5.99982884683502e-05,0.0519840495186624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.0036535138674198,0.0018808569569047,-3.29657681134177e-05,0.00733999350295302,0.0520893515670391
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0058020440995089,0.00298959537576724,-0.0116616510360127,5.7562836994895e-05,0.0522988918669129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.007653709016165,0.0039446467572315,-7.7798628008747e-05,0.0153852166603387,0.0523557379507137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,0.00600438336828094,0.00310245006687559,-7.64187627952072e-05,0.0120851854993571,0.0529546785306251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.0089129781309292,0.00461228609628826,-0.0179530588796542,0.000127102617795789,0.0533144736854603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,24867,-0.0049471695708241,0.00256195534162537,-0.00996860204040983,7.42628987616314e-05,0.0534927796851852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.0129196793540919,0.00671533274406508,-0.0260817315324594,0.000242372824275656,0.0543776083591075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,24229,0.013610829931159,0.00708072003218052,-0.00026738133191481,0.0274890411942328,0.054587521673749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.00702502302448388,0.0036547233064962,-0.0141882807052164,0.000138234656248683,0.0545932344512709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.00844261597118078,0.00439898706518387,-0.0170646306189412,0.000179398676579606,0.0549682822647885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0107923239789507,0.00562336814789487,-0.0218141255488246,0.000229477590923288,0.0549696838394864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,29218,-0.00561871856884644,0.00292770790310143,-0.0113570260589252,0.000119588921232363,0.0549747440894956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.00900872498831634,0.00469427147733257,-0.0182094970838882,0.00019204710725549,0.0549847321168579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.0049527198667753,0.00258317259346941,-0.000110298416424741,0.0100157381499753,0.0552114488020875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00862318870515184,0.00451808810481272,-0.000232263980281101,0.0174786413905848,0.056326606261389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.00838866469321513,0.00440471813503433,-0.0170219122378824,0.00024458285145215,0.0568583956741399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.00451179246223571,0.00237131257261335,-0.000135980180086451,0.00915956510455787,0.0570969468243208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,24016,-0.00942303831325325,0.00495351195256488,-0.0191319217402804,0.000285845113773915,0.0571446279074081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00282684159894616,0.00148637872549634,-0.00574014390091899,8.64607030266738e-05,0.0572050669411801
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.00958026644481761,0.00504400592425055,-0.0194665180563487,0.000305985166713466,0.0575301931084385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0145590682036706,0.00767537120752104,-0.0296027957704118,0.000484659363070647,0.0578588580351295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.00375161331366164,0.00198098776984281,-0.00763434934255356,0.000131122715230271,0.05826221731047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,24101,0.0069516785136614,0.00368230277131823,-0.000265634918122331,0.0141689919454451,0.0590565230470978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,24195,-0.00781225985320419,0.00414306838679656,-0.0159326738913254,0.000308154184917061,0.0593579209610465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0141223328637805,0.00749193173829478,-0.000561853343277316,0.0288065190708382,0.059440721273736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,24111,0.00783042545795873,0.00415649082966045,-0.000316296568175755,0.0159771474840932,0.0595901291477227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.00620362240837279,0.00331299568262475,-0.00028984912957172,0.0126970939463173,0.0611475691837885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.00509305129632264,0.00272048189893676,-0.0104251958182387,0.000239093225593402,0.061201014024257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.00893832414012339,0.00478168993342501,-0.000433788129389634,0.0183104364096364,0.0615957270763328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,29349,-0.00533975847929519,0.00285825849794253,-0.0109419451352626,0.000262428176672167,0.0617461120712931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0102085238301786,0.00546843652456212,-0.0209266594183204,0.000509611757963159,0.0619405166394345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00729930051500147,0.00391012968239151,-0.0149631546924888,0.000364553662485889,0.0619440600891317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,29443,0.00250238667626057,0.00134195381041124,-0.000127842792145465,0.00513261614466661,0.0622286678684328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.0052270155344641,0.00280413389443179,-0.0107231179675504,0.00026908689862221,0.0623280287440174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,29820,0.00218740212734544,0.00117498746114699,-0.000115573296502664,0.00449037755119355,0.0626638702649763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.0101405042132841,0.00546922301667358,-0.000579172899396081,0.0208601813259643,0.0637366708541815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.00804267514427212,0.00433916329779322,-0.000462084919402595,0.0165474352079468,0.0638218011227993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.0044097410314448,0.0023800512208359,-0.00907464142428316,0.000255159361393554,0.0639221458900957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0186044513837563,0.0100802614995648,-0.00115286115539072,0.0383617639229034,0.0649575989765137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.00661302311426329,0.003590764603926,-0.0136509217379582,0.000424875509431659,0.065532915571066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00528329109598352,0.0028712682128823,-0.00034439460126579,0.0109109767932328,0.0657720971085125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00325285770783456,0.00176999175808097,-0.000216326138004145,0.00672204155367326,0.0661070155264244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00664783999971934,0.00362775204898708,-0.013758234015734,0.000462554016295336,0.0668897992957415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,24833,0.00592380916008496,0.00323802116456952,-0.000422712322471297,0.0122703306426412,0.0673436891649653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,-0.00462261956278779,0.00252806183762646,-0.00957762076453564,0.000332381638960072,0.0674833652575212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.00786277493092927,0.00430760937557709,-0.0163056893070604,0.000580139445201815,0.0679627348768975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00376362202629061,0.00206233374108966,-0.00027855210624513,0.00780579615882635,0.0680234373782572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00327719257486175,0.00179587221377966,-0.000242716964146389,0.0067971021138699,0.0680364979758676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00623057596562263,0.00341692664388911,-0.000466600256400027,0.0129277521876453,0.0682484834033798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.00916317612258154,0.00502591082959506,-0.000687609103424776,0.0190139613485879,0.0682874366492667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.00485311583554303,0.00267898655028885,-0.000397697803023127,0.0101039294741092,0.0700663131931233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00954548341053899,0.00528199398292106,-0.000807224795986296,0.0198981916170643,0.0707475894458581
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00486934258499494,0.00269718220464964,-0.0101558197061082,0.000417134536118358,0.0710328873553487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.00752560701779307,0.00420798494855196,-0.0157732575169549,0.000722043481368774,0.0737221975589974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.0115305371581875,0.00645758368700607,-0.00112632686834438,0.0241874011847194,0.0741797424031273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.00734584265650084,0.00411413962522821,-0.0154095563219481,0.000717871008946463,0.0741909977284574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.00495939574690542,0.00278904894376647,-0.0104259316766877,0.000507140182876863,0.0753869288401449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00668318012964862,0.00376032481469217,-0.000687056507148029,0.0140534167664453,0.0755314344458139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,24229,0.00324933823665636,0.00183270741358794,-0.000342768293975996,0.00684144476728872,0.0762459773862867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.0078108214925911,0.00441364963139553,-0.0164615747701263,0.000839931784944136,0.0767902510058947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00397316690043355,0.00224719010412087,-0.000431325703643369,0.00837765950451046,0.0770635328218894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,24111,-0.00810970214045304,0.00459989566878667,-0.0171254976512749,0.000906093370368842,0.0779100068254648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,29820,-0.00631159502579962,0.00358162529790786,-0.013331580609699,0.000708390558099787,0.0780431705764292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,28774,-0.00464346579450958,0.00264808386429217,-0.00983371016852222,0.000546778579503071,0.0795235853091596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00636005519136808,0.00362803942018451,-0.000750902072193562,0.0134710124549297,0.079609738920949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.0115971139504114,0.00661666543210938,-0.0245657781973458,0.00137155029652295,0.0796636642180454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,28797,0.0197504401171563,0.0113026838879688,-0.00240282030326256,0.0419037005375751,0.080576643234891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.005823705782779,0.00334511663956516,-0.00073272283076871,0.0123801343963267,0.0817017198502476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00515737592529511,0.00296973301074823,-0.000663300775771431,0.0109780526263616,0.0824623964524349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00199072688201716,0.00115336308456738,-0.000269864763734906,0.00425131852776922,0.0843563296195798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.00661350546207445,0.0038380867664897,-0.0141361555243943,0.000909144600245366,0.084878698630452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0141226810306628,0.00820109145541439,-0.030196820283275,0.00195145822194941,0.0850711601720056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.00828988751628962,0.00483240755180568,-0.0177614063178287,0.00118163128524952,0.0862703552453205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.00767023284910748,0.00447349058203905,-0.016438274389904,0.00109780869168907,0.0864319806389697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.00455359799163066,0.00266546882504882,-0.000670720905465023,0.00977791688872635,0.0875789143251498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0114538209847929,0.00671041159298173,-0.00169858573745132,0.024606227707037,0.0878561484685495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.010112041182541,0.00592819264733666,-0.0217312987713208,0.0015072164062389,0.0880667391074332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00479649022447865,0.00282244451869618,-0.00073550103216587,0.0103284814811232,0.0892548173944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0108980051411437,0.00641317727806336,-0.0234678326061479,0.00167182232386049,0.0892705069228123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.00667157003421352,0.00392708552518505,-0.00102551759514917,0.0143686576635762,0.0893583321815093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.00474254105864551,0.00279457784303929,-0.000734831513711488,0.0102199136310025,0.0896995818633243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00569767682961389,0.00335914388222431,-0.0122815988387735,0.000886245179545753,0.0898666886302077
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00812218600192951,0.00480882609829217,-0.00130311315072314,0.0175474851545822,0.0912292357423229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.0051530981730521,0.00305143490786163,-0.0008277142463567,0.0111339105924609,0.091281074738641
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,24938,0.0102204453459869,0.00605344098157994,-0.00164429897790978,0.0220851896698836,0.0913528244629678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,24101,-0.00509028148020494,0.00301706245555879,-0.0110037238931002,0.000823160932690294,0.0915846219142496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.00837684914042508,0.00496807668571938,-0.0181142794444351,0.00136058116358491,0.0917805931701678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.00914692613455483,0.00542478458288486,-0.0197795039170092,0.0014856516478995,0.0917821415104711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.00334734765164329,0.00198705308535999,-0.00724197169894886,0.000547276395662285,0.092080319430543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.00230584125997983,0.00136893753990162,-0.00498895883818701,0.00037727631822735,0.0921165533626699
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.00505261582378167,0.00300610473249191,-0.0109445810994658,0.00083934945190248,0.0928152901396721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00456941648566229,0.00272145432641169,-0.000764633994104617,0.00990346696542921,0.0931581601534575
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,24101,0.0104585248638121,0.00624118629257288,-0.00177420026963078,0.0226912499972549,0.0938046425497477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00379586411303782,0.00227197016681918,-0.00824892564000341,0.000657197413927765,0.0947865983860795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.0078618817579931,0.00471841248035888,-0.0013862067035103,0.0171099702194965,0.0956837519816352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.00710426953340523,0.00426461121131217,-0.0154629075075771,0.00125436844076661,0.0957527337893216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00518858814969931,0.00312385277011447,-0.0113113395791237,0.000934163279725045,0.0967349035203066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.0078893462345583,0.00475004177979153,-0.0014207356538331,0.0171994281229497,0.0967464005650087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,28931,-0.00538506423154627,0.00325315217207266,-0.0117612424888087,0.000991114025716147,0.0978669420119802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,24195,0.00671477190577168,0.00405985306529648,-0.00124254010220942,0.0146720839137528,0.0981517566656912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.00316496548149563,0.00191453090076187,-0.00058751508399763,0.00691744604698889,0.098317689534709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.00380513069339621,0.0023129203298576,-0.0083384545399171,0.000728193153124685,0.0999469039585021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,28847,-0.00998391756454473,0.0060894113687991,-0.021919163847391,0.00195132871830151,0.101108884642307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00366364276161363,0.00223654877756531,-0.000719992842414388,0.00804727836564164,0.101418348021406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.00956208150602764,0.00584499059041445,-0.02101826306324,0.00189410005118468,0.101862205541441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.00957567392243846,0.00585880235194647,-0.0210589265322535,0.00190757868737661,0.102186254736749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,29208,-0.00507839994106424,0.00310919033290069,-0.0111724129935496,0.00101561311142112,0.102405925637295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.0130318673147407,0.00797996496524782,-0.00260886401714505,0.0286725986466264,0.102464277077117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.00800098568864462,0.00490547087581797,-0.00161373722795861,0.0176157086052478,0.102896211391712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.00479918499294986,0.00294495985135689,-0.0105713063016094,0.000972936315709636,0.103193503646593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.00338334407987335,0.00207759263477826,-0.00745542564403873,0.000688737484292031,0.10343316736685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,29478,-0.00446040761933195,0.00274667146923679,-0.00984388369903606,0.000923068460372157,0.104401024872982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,24016,0.00617135598118638,0.00380210621342101,-0.0012807721971188,0.0136234841594916,0.104572315013251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00525995101662767,0.00324139921023719,-0.00109319143543722,0.0116130934686926,0.104657894673377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00695235375748112,0.00428739523494773,-0.00145094090301642,0.0153556484179787,0.104906421277783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.0057300313139162,0.0035420817180699,-0.0126725114813332,0.0012124488535008,0.105739960993182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.00813918110912288,0.00503225831741655,-0.0180024074112593,0.00172404519301356,0.10580241015137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,24240,-0.00198875552531448,0.00123372174768663,-0.00440685015078028,0.000429339100151324,0.106975659569107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.00632466365638264,0.00392724972121698,-0.0140220731099679,0.00137274579720263,0.10730922080317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00718458563927623,0.00447360429129379,-0.0015836787716596,0.0159528500502121,0.108286011059403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.00654069234971303,0.0040802608289672,-0.0145380035744887,0.00145661887506269,0.108943747421595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.00752765574726385,0.00470432494376688,-0.0167481326370469,0.00169282114251924,0.109576630302617
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.00329224445758132,0.00205776624682063,-0.000740977386187113,0.00732546630134975,0.109631201534738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,24647,-0.0047969749342538,0.00300212182508056,-0.0106811337114117,0.00108718384290409,0.110086626494243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.0104462532568222,0.00655026839566268,-0.023284779312321,0.0023922727986767,0.110773634220142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00584083818337555,0.00367023292421119,-0.00135281834807837,0.0130344947148295,0.111530945395281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,29439,0.00633040058984786,0.00402869073446776,-0.00156583324970894,0.0142266344294047,0.116116884786284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00690016264798669,0.00439253777628003,-0.0155095366894955,0.00170921139352216,0.116222826420977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.00574978597346762,0.00368524141514226,-0.0129728591471464,0.00147328720021121,0.118718992863244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,29349,-0.0201261161223543,0.0129112115160197,-0.0454320906937529,0.00517985844904428,0.119052318397881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,24016,0.00646257943469701,0.00415208967392265,-0.00167551632619138,0.0146006751955854,0.119610905058043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.00584078420261783,0.00375486774001244,-0.0132003249730422,0.00151875656780655,0.119834237758455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.00973804895007831,0.006262989525004,-0.00253741051892952,0.0220135084190861,0.1199930214549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.00670162478292363,0.00431252432739871,-0.0151541724646251,0.00175092289877784,0.120199606735027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.00374528163011945,0.002410864084063,-0.00098001197464402,0.00847057523488292,0.120314309322881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00610062436461962,0.00392933363090091,-0.00160086955194616,0.0138021182811854,0.120535455106271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.00707260582866916,0.00455611023878942,-0.0160025818966964,0.00185737023935811,0.120592943760044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.00241372819442165,0.00155744917215398,-0.00546632857184345,0.000638872183000148,0.121203230839912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,24111,-0.00541088018622705,0.00349359376320026,-0.0122583239620996,0.00143656358964546,0.121442788883691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.0047293205725799,0.00305408942883627,-0.010715335853099,0.00125669470793919,0.121510060294689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.00566373060855335,0.00367034825743281,-0.00153015197601497,0.0128576131931217,0.122816436758688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,24726,0.00365847392235823,0.00237435097813039,-0.000995253994777325,0.00831220183949379,0.123370692717212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.00430634045935313,0.00279622415346539,-0.00117425888143904,0.00978693980014531,0.12356000184797
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.00814319685811749,0.00528941334210355,-0.00222405329240548,0.0185104470086404,0.123688650469083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00333976585321211,0.00217486558962701,-0.000922970702456844,0.00760250240888105,0.124644829846518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00404382936854158,0.00263882842017942,-0.00112827433501007,0.00921593307209323,0.125428562266365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.00772303838994333,0.00507920888819763,-0.00223221103092403,0.0176782878108107,0.128393477359722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00347526279216878,0.00228685619028046,-0.00100697534078093,0.00795750092511848,0.128607425958145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.00297827573759759,0.00195994122823824,-0.000863209069749358,0.00681976054494454,0.128629084261046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.00513299650419329,0.00337824334231447,-0.0117543534551296,0.00148836044674306,0.128667633194948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,24793,0.00357798731334748,0.0023566038115622,-0.00104095615731443,0.0081969307840094,0.128956277415203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,28916,0.00336527917466251,0.00223874664830399,-0.00102266425601332,0.00775322260533834,0.132798954838267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00514505721345642,0.00342765615605429,-0.00157314885241,0.0118632632793228,0.133357703728407
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00300453613303453,0.0020118259249251,-0.000938642679818662,0.00694771494588772,0.135335751154979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.000830401966515318,0.000556595287441072,-0.000260524796869183,0.00192132872989982,0.135729997094499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00319511228391061,0.00214502732615458,-0.00739936584317359,0.00100914127535236,0.136357254742422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,24111,-0.0075255622322396,0.00505817481082815,-0.0174395848614628,0.00238846039698358,0.136816222364166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,24546,0.00348164069988272,0.00234325419096364,-0.00111113751440602,0.00807441891417146,0.137341083932999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00364591674835005,0.0024563438425569,-0.00116851718306148,0.00846035067976159,0.137745747887422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00358359462052032,0.00242004222408183,-0.00115968813868007,0.00832687737972071,0.138671252534866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.00326165996051598,0.00220360725745132,-0.00758073018512058,0.00105741026408861,0.138846982206887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.00511389708828537,0.00345979840301347,-0.0118951019581918,0.00166730778162104,0.139394108712157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,24229,-0.00413523669837797,0.00279871911961047,-0.00962072617281449,0.00135025277605855,0.139542298811188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00300419984515946,0.00203747550941629,-0.000989252153296457,0.00699765184361538,0.140367279909132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,29725,0.00318816631850664,0.00216605976389544,-0.00105731081872842,0.00743364345574171,0.141065588649362
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,24845,0.00226694763543358,0.00154405923559821,-0.00075940846633891,0.00529330373720607,0.142069629537337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,24101,0.00496528120990374,0.00338443787122484,-0.00166821701769694,0.0115987794375044,0.142364127451452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.00254745914459549,0.00174561671102454,-0.00596886789820359,0.000873949609012622,0.14448242923822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00238002874661827,0.00163169063646459,-0.00557814239408887,0.000818084900852331,0.144680312325523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00556652483930075,0.00382151884482278,-0.00192365209655189,0.0130567017751534,0.145230236995244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00646758521585075,0.00445639767304465,-0.00226695422331675,0.0152021246550183,0.146708410642378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,24016,0.00304983544990915,0.00211013409125871,-0.00108602736895792,0.00718569826877622,0.148378890155129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",29725,0.00721893773075112,0.00499956638990892,-0.00258021239347036,0.0170180878549726,0.148774059580506
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.00480986397726276,0.00334098017216852,-0.0113581851147131,0.00173845716018755,0.149977538014046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.00191920573395642,0.00133457828670301,-0.00453497917589432,0.000696567707981472,0.150429149858533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,24016,0.0068178566645579,0.0047427220165844,-0.00247787848794751,0.0161135918170633,0.150577409036616
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00346602905379738,0.00241855800238639,-0.00127434463087995,0.00820640273847471,0.151842993294907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00399754988301625,0.00279466156116,-0.00947508654288986,0.00147998677685736,0.152608441856622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0117953616274991,0.00827128900481377,-0.0280070880769341,0.00441636482193586,0.153861381843619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00335829226980048,0.00235937230699712,-0.00126607745191387,0.00798266199151483,0.154637907024082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,28916,-0.00473020150386857,0.00332424584972541,-0.0112457233693304,0.00178532036159323,0.154764419909538
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.00463262689853463,0.00327405741438672,-0.0110497794307326,0.00178452563366334,0.157094061469361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,24016,0.00904472448440481,0.00639846254564934,-0.0034962621050679,0.0215857110738775,0.157498877970683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.0032427066949985,0.00229460914136136,-0.00125472722206976,0.00774014061206677,0.157612078751297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00442319065866509,0.00313214866817375,-0.0105622020482856,0.00171582073095546,0.15790672150513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00342899409564988,0.00243093401219496,-0.00133563656825226,0.00819362475955201,0.15838520558157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00328427673056589,0.00233264629637146,-0.00128771001032218,0.00785626347145396,0.159155351815823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00654532070856075,0.00465454362793588,-0.0156682262193151,0.00257758480219357,0.159669077419684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,29413,-0.0122570442995399,0.00873700339039192,-0.0293815709447081,0.00486748234562823,0.160660558228841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,24445,0.0054642235840438,0.00389606299020725,-0.0021720598767624,0.01310050704485,0.160779061558036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.00549481128113879,0.00393218695163745,-0.0132018977063482,0.00221227514407062,0.162306186590884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.00450913205085283,0.00323576107574143,-0.010851223759306,0.00183295965760037,0.163470160240688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.00445993919339538,0.00320427016339759,-0.0107403087136546,0.00182043032686389,0.163971418691764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.00523061071792511,0.0037723581182781,-0.00216321119389998,0.0126244326297502,0.165587941136419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,24016,0.00321197766630006,0.00232342009053203,-0.00134192571114271,0.00776588104374284,0.166850983931558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,0.00378677737790996,0.00274707409420077,-0.00159748784672355,0.00917104260254348,0.168068604339232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.00541301721667994,0.00392815663549378,-0.0131122042222478,0.00228616978888788,0.168212278083099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.00414228444879508,0.00300953827744282,-0.00175641057499286,0.010040979472583,0.168715195528631
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.00486740753217066,0.0035531461384217,-0.0118315739634772,0.00209675889913587,0.170732735784634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,29443,0.00315123478856014,0.00230224144202243,-0.00136115843780381,0.0076636280149241,0.171082203357863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.0047739873251815,0.00349097778268553,-0.00206832912888214,0.0116163037792451,0.171472575733789
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.00271876868627178,0.00198894566319077,-0.00117956481358212,0.00661710218612568,0.171654576217517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.00486747508881934,0.00358217078270628,-0.0118885298229236,0.00215357964528496,0.174220751282857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.00565157999876469,0.0041783291655512,-0.00253794516571567,0.0138411051632451,0.176198288449362
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0031660693746963,0.0023415644624783,-0.00775553572115377,0.00142339697176116,0.176348434451219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0049565689454351,0.00368392388555322,-0.0121770597611194,0.0022639218702492,0.178489634310386
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,29565,0.00354596726350306,0.00263561523907688,-0.00161983860508763,0.00871177313209376,0.178505130197956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,28797,0.00837485176896633,0.00624031595116946,-0.00385616749532581,0.0206058710332585,0.179588513076824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,24867,0.00325967047654152,0.00242991549578233,-0.00150296389519184,0.00802230484827488,0.179778593894554
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.00712470559721314,0.00532278869176702,-0.0175573714330765,0.00330796023865023,0.180736725285269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,29536,0.00287739180095433,0.00215016330350398,-0.00133692827391346,0.00709171187582213,0.180834997814971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00469855428917502,0.00351253360097468,-0.00218601156873536,0.0115831201470854,0.181021957807911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,0.00238220265479567,0.00178305116992977,-0.00111257763826667,0.00587698294785801,0.181551151544807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.00640372461762503,0.00479527574849782,-0.0158024650846808,0.00299501584943069,0.181748156953478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00306985785696027,0.00229952067719039,-0.00143720267033289,0.00757691838425344,0.181889234370494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00272265269941786,0.00204659455141416,-0.0012886726213539,0.00673397802018962,0.183419000948365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.0044270077478457,0.00333421896693945,-0.010962076923047,0.00210806142735563,0.184271343182912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.00350509464552932,0.00266259949486035,-0.00171360036439696,0.0087237896554556,0.188043932332527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,24016,0.00399921096842608,0.00304106995645005,-0.00196128614621601,0.00995970808306817,0.188499924742707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.00654225488217056,0.00500302439727469,-0.016348182700829,0.00326367293648783,0.190998753780699
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,0.00469580243239896,0.00361619732439225,-0.00239194432340985,0.0117835491882078,0.194111421495761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,23801,0.00348135790012805,0.00268358234814446,-0.00177846350223509,0.00874117930249118,0.194547420333453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00356356599267813,0.00274954293133865,-0.00182553815274563,0.00895267013810188,0.194968056718517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00454958805894876,0.00351381315715455,-0.00233748572907417,0.0114366618469717,0.195411184824522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.00391511546370576,0.0030324210193776,-0.00985866066168585,0.00202842973427432,0.196686204680423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.00636004892936043,0.00500581318071719,-0.0161714427635661,0.00345134490484526,0.203905221192072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.0032395428295597,0.00255430139510431,-0.00176688790484474,0.00824597356396414,0.204713939197885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,24111,0.00372029964786817,0.0029353831494377,-0.00203305132502972,0.00947365062076606,0.205025150638977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00787586453584128,0.00621788805727531,-0.00431119605641833,0.0200629251281009,0.205293993548941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00314584669529258,0.0024866123125839,-0.00172791343737186,0.00801960682795702,0.205842851219423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,29694,-0.00564296627782882,0.00446273871269253,-0.0143899341547062,0.00310400159904855,0.206073958947633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,24101,0.00416922235500706,0.00329843111315418,-0.00229570262677514,0.0106341473367893,0.206241668169678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,29725,-0.00541886147773527,0.00429341190370712,-0.0138339488090012,0.00299622585353068,0.20691045164225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,24195,-0.00499312137242809,0.00396066833989356,-0.0127560313186195,0.00276978857376328,0.207437599654366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0084981471916139,0.00674897176008336,-0.0217261318413773,0.00472983745814949,0.207978755208681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.00762909351964159,0.00607922657810119,-0.00428619057343675,0.0195443776127199,0.209508749066061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00422305222565259,0.00336727201339573,-0.00237680092060303,0.0108229053719082,0.209800952038363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.00590727399656363,0.00471139815457767,-0.0151416143795359,0.00332706638640862,0.209917012150175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,24756,0.00501645777572378,0.0040232473492582,-0.00286910702882228,0.0129020225802698,0.212457759851751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.00554749267575929,0.00446004338472721,-0.00319419235830604,0.0142891777098246,0.213575775691205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,29694,-0.00228364878125581,0.00183610681535832,-0.0058824181393581,0.00131512057684649,0.213603229465461
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00590298206094917,0.00475201377070216,-0.00341096492962707,0.0152169290515254,0.214172496923347
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,24445,-0.00369792761779098,0.0029984646036735,-0.00957491824099104,0.00217906300540908,0.217485522059202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.00615771337816533,0.0050004010742688,-0.0159584994837322,0.00364307272740151,0.218168953405924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00659165654449282,0.00537966242508426,-0.017135794897658,0.00395248180867232,0.220477300097142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00722816473918385,0.00591305278693688,-0.00436141872321243,0.0188177482015801,0.221565222534373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,24195,-0.00503390859401027,0.00412950885366912,-0.0131277459472017,0.0030599287591812,0.222852655371369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.00724645453994556,0.00595721986015904,-0.0189226054658573,0.00442969638596615,0.223838541202736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,28774,0.00371656339922355,0.00305791521244495,-0.00227695041716855,0.00971007721561564,0.224226879740623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.00301382005991678,0.00248683747718255,-0.00186038139536103,0.00788802151519458,0.225557220566572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00243602572281204,0.00201049144329781,-0.00637658895167575,0.00150453750605168,0.22565569247639
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.00302855515523607,0.0024995713280992,-0.00792771495831049,0.00187060464783835,0.225665833447923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.00447894987305647,0.00369919009221032,-0.0117293624537887,0.00277146270767576,0.22598487604433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,28916,0.00188968490752254,0.00156321260346335,-0.00117421179526562,0.00495358161031071,0.226731510198583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,29820,-0.00335783521489393,0.00279511607281666,-0.00883626271761459,0.00212059228782674,0.229635756569324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00226844446519911,0.00188884071037014,-0.00597057225752459,0.00143368332712637,0.229772023476153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,0.00596249994419956,0.00497588292981874,-0.00379023059824517,0.0157152304866443,0.23081779305039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,28774,-0.00552393129081951,0.00460995183611556,-0.014559436889606,0.00351157430796698,0.230824809405335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.00728642719547718,0.00609253814866051,-0.0192278019668518,0.00465494757589742,0.231724109442541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.0063317289129148,0.00529697860232579,-0.00405034914764376,0.0167138069734734,0.231963146595732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00509776067890311,0.00426515357617277,-0.0134574616882017,0.00326194033039552,0.232016208700855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00564929346129549,0.00473247877625664,-0.0149249518627585,0.00362636494016753,0.232595702425981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.00621124310580674,0.00520864267370553,-0.0164201827462696,0.00399769653465609,0.233079615313695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00236721986353192,0.00198521430976905,-0.00152380018361543,0.00625823991067926,0.233106207343937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0213422713971336,0.0180904148050707,-0.0567994844150722,0.0141149416208049,0.238108946989419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,24195,0.00553340113890204,0.00469230714474313,-0.00366352086479449,0.0147303231425986,0.238310418883486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.00332542525664059,0.00282449022285662,-0.00221057558015839,0.00886142609343956,0.239063710604361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.00557359125187681,0.00475636551222258,-0.00374888515207944,0.0148960676558331,0.241281972733864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.00215350676747457,0.00184549381768839,-0.00146366111519469,0.00577067465014382,0.243261945113403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,24229,0.00280371076042159,0.00240790864540965,-0.00191579018458131,0.0075232117054245,0.244283187200944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,29466,-0.00316926099676448,0.0027266985776341,-0.00851359020892732,0.00217506821539835,0.245120179692561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.00777344683833653,0.00669315164517532,-0.0208920240628802,0.00534513038620711,0.245489152433341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,0.00374273043937041,0.00323420234532884,-0.00259630615747412,0.0100817670362149,0.247186042881393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00363986009191474,0.00316083861729888,-0.00255538359799107,0.00983510378182055,0.249517933551254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,24111,0.0038440096742125,0.00334925124323414,-0.00272052276252642,0.0104085421109514,0.251094698570605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,0.00264422296352886,0.00231467321630833,-0.00189253654043546,0.00718098246749318,0.253307830715624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.00335834644033935,0.00294750234669797,-0.00241875815918868,0.00913545103986738,0.254553023657716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,24101,0.00601835963412303,0.00529196051668224,-0.00435388297857416,0.0163906022468202,0.255438979997472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00572019730801431,0.00505248932105641,-0.00418268176125625,0.0156230763772849,0.257580856614944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.0033910329794779,0.00300596376090939,-0.0092827219508603,0.0025006559919045,0.259288186389539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,24845,0.00728616255340815,0.00648164272763674,-0.00541785719275986,0.0199901822995762,0.260971789099794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,29523,0.00422950762117533,0.00377335788385843,-0.0031662738311872,0.0116252890735378,0.262345106856053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00278856545064043,0.0025058964417263,-0.00770012247642398,0.00212299157514311,0.265804715222457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.00319604728924588,0.00287692444641325,-0.00883481920421585,0.00244272462572409,0.2666116592109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,24922,0.00224937501923267,0.00202693282025296,-0.00172341330846314,0.00622216334692847,0.267120392894871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,24805,-0.0196852386843193,0.0177533015923756,-0.0544817098053754,0.0151112324367369,0.267518042766485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,28626,0.00505469984613685,0.00458559252420541,-0.00393306150130575,0.0140424611935794,0.270340426853374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.00317606320653709,0.00288204548792658,-0.00247274594979902,0.00882487236287319,0.270465318457338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,-0.00376942999220166,0.00343551695017405,-0.0105030432145428,0.00296418323013948,0.272567668413345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.00462218901547807,0.00422472592713245,-0.0129026518326577,0.00365827380170154,0.27393043777772
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,24240,-0.0063964680288958,0.00588864402772192,-0.0179382103232308,0.00514527426543916,0.277384583458102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,28931,0.0103805418677645,0.00970950293793199,-0.00865008389058222,0.0294111676261112,0.285028325866049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,24867,-0.00261381316634944,0.0024476734495866,-0.00741125312753918,0.0021836267948403,0.285586557954791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.0018486926199104,0.0017364457142624,-0.0015547409800439,0.0052521262198647,0.287046752153148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.00310920964115349,0.00292923348502749,-0.00885050727180736,0.00263208798950039,0.288498005033663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,28931,0.00220268768334031,0.00207537678401772,-0.00186505081333443,0.00627042618001504,0.288542682434597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.00906285665336965,0.00854231727216133,-0.00768008520006656,0.0258057985068059,0.288727637495249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.00257349798305423,0.00242638332969261,-0.00218221334314328,0.00732920930925174,0.288867799354555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,29497,-0.00215176368046713,0.0020296714082255,-0.0061299196405891,0.00182639227965484,0.289083359462387
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.00204035040232737,0.00192465180934674,-0.00581266794864697,0.00173196714399224,0.289103295558265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.00401383430214111,0.00380270686503159,-0.00343947115332081,0.011467139757603,0.291196247348268
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.00566036910182747,0.00536608237916224,-0.0161778905649855,0.00485715236133051,0.291506450655259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00672678804911616,0.00641252408844854,-0.00584175916424299,0.0192953352624753,0.29418507198377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00217744567555741,0.00207810199330899,-0.00625052558244303,0.0018956342313282,0.294738621814712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,24381,-0.00244918338355894,0.00235040766675936,-0.00705598241040728,0.00215761564328941,0.297410459244986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00264150929292833,0.00254316769216366,-0.00762611796956911,0.00234309938371246,0.298967415551713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.00348582947711419,0.00337208978921604,-0.00312346650974924,0.0100951254639776,0.301271026219151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,0.00269340092113929,0.00260676498915723,-0.00241585845760889,0.00780266029988747,0.301504234014153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00184856255330198,0.00179175153266618,-0.0053603955573277,0.00166327045072374,0.30221970843486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.0019306756262866,0.00188362884696391,-0.00176123691376266,0.00562258816633586,0.305384149131663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.00633426116564221,0.00618629550932123,-0.0184594003639118,0.00579087803262741,0.305884145629068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.00243780572269234,0.00238708100745086,-0.00711648449729602,0.00224087305191135,0.307144457039417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,24229,-0.00118307985764036,0.00116263634881044,-0.00346184710130882,0.00109568738602811,0.308885978901942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.00257177968119947,0.00252837708683967,-0.00752739877140523,0.00238383940900629,0.309084477441551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.00738597892805207,0.00726710885867309,-0.0216295122910513,0.00685755443494719,0.309469439869139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,24111,-0.00263395912584666,0.0025970674753732,-0.00772421137757813,0.00245629312588481,0.310495069924357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,29594,-0.00322518897376164,0.00318126058279844,-0.00946045971604659,0.0030100817685233,0.310682437765739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.00229207019872725,0.00226146477138689,-0.00214040075319107,0.00672454115064556,0.310815547814195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,24229,-0.0034044952842503,0.00338482904313073,-0.0100387602087865,0.00322976964028593,0.314516971729796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00382740630892511,0.00381911510225617,-0.00365805929149698,0.0113128719093472,0.316271126133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00464116585409751,0.00463403056804823,-0.00444153405927701,0.013723865767472,0.316576025458577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,24111,0.00447002382836727,0.00446972874839967,-0.00429064451849608,0.0132306921752306,0.317288602438496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00257977712756215,0.00259891147343587,-0.00251408936037217,0.00767364361549646,0.320896588157574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.00288668313990187,0.00290945780414517,-0.00281585415622266,0.00858922043602639,0.321123460871771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,28931,0.0019368052883993,0.00195270567731695,-0.00189049783914191,0.00576410841594051,0.321275463614321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00175890594882066,0.00177979774442279,-0.00524730952788933,0.00172949763024801,0.323032651950352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.00419196971048536,0.00424413784664202,-0.0125104798899037,0.00412654046893299,0.3233054512402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00189622166261224,0.00192672056697854,-0.00567259397389018,0.0018801506486657,0.325041486142311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,24195,-0.00503903919332427,0.0051661992752852,-0.0151647897728833,0.00508671138623472,0.329378511152357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.00505241795903772,0.00518627541607685,-0.0152175177745483,0.00511268185647291,0.329971660702292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.00420198521471128,0.00432134942360425,-0.00426785965555305,0.0126718300849756,0.330872147418416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00249511726463265,0.00257238659149524,-0.00254676045469802,0.00753699498396331,0.332073542321679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.00340299781511782,0.00351997597097799,-0.00349615508799904,0.0103021507182347,0.333670055977601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00326877742135943,0.00338834701582093,-0.00337238272964959,0.00990993757236845,0.334699039842946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00295456413940367,0.00306555914043517,-0.00305393177584927,0.0089630600546566,0.33515930551475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,28774,0.00347593287933201,0.00361718479461699,-0.00361374931811728,0.0105656150767813,0.336585505495897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.00332584185481596,0.00347250994622785,-0.0101319613494226,0.00348027763979063,0.338191810822351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.00557000905735788,0.00583683413946167,-0.0170102039707027,0.00587018585598699,0.339946759997249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,28490,0.00171524755824882,0.00179775034376795,-0.00180834311553636,0.00523883823203399,0.340037196085305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.005658992729432,0.00594767037707675,-0.0173164266685024,0.00599844120963843,0.341378294890997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.00485586548499513,0.00511444202603666,-0.00516844088603672,0.014880171856027,0.342405307050169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.00291569457708784,0.00307341145048189,-0.00893958102003235,0.00310819186585667,0.342789414865975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.00272289487348821,0.00287655997536117,-0.00291516267821969,0.00836095242519611,0.343861939977564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00315157327431624,0.00332985850228801,-0.00337494939016825,0.00967809593880073,0.343924210250071
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00310161499127265,0.00327992902828164,-0.00332704590415935,0.00953027588670466,0.344344376031109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.00544104502107065,0.00575425079655062,-0.0167193765823099,0.00583728654016856,0.344376064484364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,24101,-0.00243280679649882,0.00257646735356236,-0.00748268280948104,0.0026170692164834,0.345055843011304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.0016838985911716,0.0017871004551554,-0.00518661548327618,0.00181881830093299,0.346073143357088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.00313982612256236,0.00334201795632304,-0.00969018131695552,0.0034105290718308,0.347483184038762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00217382201457062,0.00231478915183885,-0.00236316472303353,0.00671080875217476,0.347688035969882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.00214554697589727,0.00229336690467912,-0.0023494521572738,0.00664054610906833,0.34951713277719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00262705343539191,0.00281653623043568,-0.00289335757626203,0.00814746444704585,0.350971249692714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,0.00175205257697927,0.00187923247795175,-0.00193124307980616,0.00543534823376469,0.351177021712221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.0029076597149703,0.00312070451739149,-0.00902424056905763,0.00320892113911702,0.351484342133915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,-0.00172223873728479,0.00185073621379141,-0.00534968171631596,0.00190520424174638,0.352085326427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00486402940480138,0.0052398338415174,-0.00540604492457273,0.0151341037341755,0.353271712558174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.00378123054538664,0.00407542235292399,-0.0117690583571176,0.00420659726634438,0.353513782507991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,24793,0.00221422785549559,0.00238957356731073,-0.00246933633643344,0.00689779204742463,0.354132631782672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.00430101052879303,0.00465088891792933,-0.0134167528079345,0.00481473175034846,0.355092424656173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00290169735525715,0.00314116045884509,-0.00905837185459352,0.00325497714407921,0.355617390189723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,28916,0.00383902649606762,0.00415959365785333,-0.00431377707332491,0.0119918300654602,0.356049796159033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,0.00609740635207765,0.00662728353546971,-0.00689206937744299,0.0190868820815983,0.357557884341307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00471709728260255,0.00516395867019238,-0.0148384562761796,0.00540426171097452,0.361006947182359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00183928836336958,0.00201579394082298,-0.00579024448738263,0.00211166776064347,0.361546919070678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.0016916472791599,0.00186556916744747,-0.00196486828903714,0.00534816284735693,0.364534377808788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,-0.0114862625741175,0.0126677303347086,-0.0363150140301463,0.0133424888819114,0.364554895465308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.00493386110580975,0.00544445542916948,-0.00573727153536242,0.0156049937469819,0.364829808212766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.00229379830311442,0.00254799734551078,-0.00728787310031554,0.00270027649408671,0.368003553215693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.00214107091975919,0.00237921592768186,-0.00252219229849726,0.00680433413801563,0.368179221678002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00222522789130263,0.00247731547412106,-0.00263031043797465,0.00708076622057992,0.369065420253954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,28931,-0.00238639029685901,0.00266177611526528,-0.00760347148277895,0.00283069088906093,0.369971581720502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,24101,-0.00451321540510677,0.00503715428741868,-0.0143860378084474,0.00535960699823384,0.370269652097238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.00162655299632447,0.00182230816320915,-0.00519827699621441,0.00194517100356547,0.372090248643293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00286386992434708,0.00324657177251203,-0.00922715059847067,0.00349941074977651,0.377720045258364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00329568460068387,0.00375094634314937,-0.0106475394332566,0.00405617023188891,0.379611796736587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,29478,0.00459772723939758,0.00525486086683529,-0.00570180005959959,0.0148972545383948,0.381609618487105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,24195,0.00361023167027332,0.00412660458199109,-0.0044779133104292,0.0116983766509758,0.381654768066788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.00550175324673623,0.00629247590256685,-0.0178350060157672,0.00683149952229479,0.381942682239077
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00946905793073932,0.0108535742792137,-0.0307420635179982,0.0118039476565196,0.382978544499878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00378303843297923,0.00434448263951957,-0.00473214754047913,0.0122982244064376,0.383889301679043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.00251922559368023,0.00290016172613689,-0.00316509138954806,0.00820354257690853,0.385045785739355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.00541955127454803,0.00625296522295187,-0.00683626056243764,0.0176753631115337,0.386104155678434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00285872467903118,0.00330773940658547,-0.0093418939159387,0.00362444455787634,0.387457364004414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,24845,0.00156482356236838,0.00181487864053096,-0.00199233857307231,0.00512198569780907,0.388575125767638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,29820,-0.00114807114442225,0.00133542283220033,-0.0037654998955349,0.0014693576066904,0.389957990109691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,24445,0.00988991722227803,0.011551319248687,-0.0127506685051484,0.0325305029497045,0.391910991312758
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00174194177632467,0.00203769302812245,-0.00573582011144468,0.00225193655879534,0.392637258442912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00294053834786871,0.00344304685829572,-0.00380783349439091,0.00968891019012832,0.393085107133542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.00428697207242848,0.0050406083692628,-0.00559262033132662,0.0141665644761836,0.395062699840771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,24229,0.00277208387144545,0.00326618428127265,-0.00362963731984894,0.00917380506273983,0.396044150008671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.0026685842664476,0.00315566953060354,-0.00351652801353533,0.00885369654643053,0.397756320472349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.00352971253754898,0.00417925657422905,-0.0117210554230379,0.00466163034793996,0.39835406552294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00161990761160413,0.00192280638269171,-0.00214879289847162,0.00538860812167987,0.399531571649012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.00453437507084449,0.00540940191187457,-0.0151368028181186,0.00606805267642966,0.401902911984956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.00224800057845573,0.00268372065428518,-0.00750809306085468,0.00301209190394323,0.402239384065511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0035282001926868,0.00422144013150257,-0.0118022228504318,0.00474582246505825,0.403286155520073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,24101,0.00299611404752094,0.00362016938923411,-0.00409941795537791,0.0100916460504198,0.407895587071708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.00314057874095743,0.00379525685362495,-0.00429812469214747,0.0105792821740623,0.407960031015379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,24793,0.00153662472896281,0.00185799905119477,-0.00210505341137894,0.00517830286930457,0.408226870592649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,28830,-0.0027468354241813,0.00333200836938786,-0.00927757182818151,0.00378390097981892,0.409731459348864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.00521899612604215,0.00634263648213713,-0.0176505636310309,0.00721257137894662,0.410605267158944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.00220433576895513,0.00268233835910217,-0.00746171895279539,0.00305304741488513,0.411199609042051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.00311664473764876,0.00380082016976329,-0.00433296279508728,0.0105662522703848,0.412228160604444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.00128466762179784,0.0015677115873986,-0.00435738233309909,0.00178804708950342,0.412534061013357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.00580923220647122,0.0071319458966323,-0.0197878461638705,0.00816938175092808,0.415344179555729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00244313593065302,0.0030103668942734,-0.00345718318212284,0.00834345504342888,0.417043940179459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00342734456586644,0.00422605729983646,-0.00485572774181302,0.0117104168735459,0.417372040274246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,24229,0.00416404764227325,0.00514341439075202,-0.0059170445636007,0.0142451398481472,0.418184842375312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.00383832974426279,0.00475779777092131,-0.0131636133752686,0.00548695388674299,0.419821324740543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.00291280548263439,0.00361305261701112,-0.00999438861197619,0.00416877764670742,0.420141265126006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,28931,0.00264691479517775,0.00329072667353519,-0.00380290948495121,0.00909673907530672,0.421198183757663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.00421950139448481,0.00524735501656725,-0.00606531443798701,0.0145043172269566,0.42133557876843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.00263924804781839,0.00328533265857451,-0.00907850005862443,0.00380000396298766,0.421783316273679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,0.00186218906137029,0.00232636331817884,-0.00269748304226023,0.00642186116500081,0.423443853695595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.0021718651076492,0.00273341611285764,-0.00752936068885017,0.00318563047355177,0.426875535621605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,24938,-0.0049671716281282,0.00625459464682018,-0.0172261771358958,0.00729183387963936,0.427107736136628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.00338472059427234,0.00428934057676435,-0.0050223869361858,0.0117918281247305,0.430061063791279
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00327324719526653,0.00416212313793424,-0.00488451415508459,0.0114310085456176,0.431619271823331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00237884382580427,0.0030545982157053,-0.00360816867697813,0.00836585632858666,0.436119877205253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00376835126316775,0.0048555441924485,-0.00574851535403131,0.0132852178803668,0.43770201228592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00335636973047782,0.00434591795783851,-0.0118743689278413,0.00516162946688567,0.439942013640114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,29566,-0.00198470299187979,0.00257149833541824,-0.00702483972929955,0.00305543374553997,0.440234323328028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.00216557423998275,0.00281119445342795,-0.00334436688873602,0.00767551536870152,0.441104801174675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.00286506721108259,0.00372892181698309,-0.00444361955020428,0.0101737539723695,0.442294658829339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,29725,0.00153027590380243,0.00200960338896268,-0.00240854673856443,0.00546909854616928,0.446375538649649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.00214937542534843,0.00282948983432056,-0.00769517550061673,0.00339642464991986,0.447479842806464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.00205981391521328,0.00271397624547729,-0.00325957952592221,0.00737920735634877,0.447880465455069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.00137270518793008,0.00181823170467595,-0.00493643932909493,0.00219102895323478,0.450276107220469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,24229,0.00525984044681244,0.00697854042736614,-0.0084180987908252,0.0189377796844501,0.451026853766519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,24657,0.00153236551776082,0.00204440255649459,-0.00247466349296858,0.00553939452849023,0.453537767685798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.000900426102041,0.00120419422531788,-0.00145979457958205,0.00326064678366405,0.454622008776257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.00232530228357041,0.00311010443341686,-0.00842110697306746,0.00377050240592664,0.454672210154058
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,29820,-0.00370061821772943,0.00495131645504615,-0.0134051984696199,0.00600396203416103,0.454827517505377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.00273768077421507,0.00366414206575601,-0.00991939922309685,0.00444403767466672,0.454977406943324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.00179468132631344,0.00240585514467113,-0.00651015740986887,0.00292079475724198,0.455696238844956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.00162920415549998,0.00218602897843453,-0.00591382095323165,0.00265541264223169,0.456108394209891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.00211813824784409,0.0028422822658986,-0.00345273499331716,0.00768901148900535,0.456143285547996
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.00129261143044393,0.00173731596798389,-0.00211252786680448,0.00469775072769235,0.456866652531325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.00212793889846366,0.0028679109502653,-0.00774904436098364,0.00349316656405632,0.458105148321501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.00420639700720953,0.00566995670395422,-0.0153195121469598,0.00690671813254074,0.458170506320518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.00592312838544763,0.00799945468582335,-0.00975580279876613,0.0216020595696614,0.459039376185414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,0.00219708593572744,0.00296736348112874,-0.00361894648728488,0.00801311835873976,0.4590541102667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00337318055318758,0.0045980326867133,-0.00563896351277049,0.0123853246191457,0.463191144825907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.00226981919098565,0.00309421251777063,-0.00833447572581608,0.00379483734384478,0.463217247979134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0019682002362178,0.00270757557499014,-0.00333864789076288,0.00727504836319848,0.467279892647275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,24966,-0.00132482332907349,0.00183101819709029,-0.00491361899537045,0.00226397233722348,0.469352146179319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.00284440244590655,0.00393147576433427,-0.0105500949440017,0.00486129005218862,0.469381804660718
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.00359566001617429,0.00497262475513469,-0.0133420045362383,0.00615068450388969,0.469630783652464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.00242315242462631,0.00335369359702329,-0.00899639187479196,0.00415008702553934,0.469974164682056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.00581698884515906,0.00805864943914623,-0.0216119417458857,0.00997796405556755,0.47040377695683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00205401259054344,0.00284750110986533,-0.00352708958479261,0.0076351147658795,0.47070821229308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.00508633602384108,0.00709734092471056,-0.0189971242362738,0.00882445218859162,0.473594688566487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,23913,0.00169588667682293,0.00237147285863636,-0.00295220012610434,0.00634397347975019,0.474542141187792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,29599,0.00547378906457491,0.00765707008579053,-0.00953406830357452,0.0204816464327243,0.474696681521423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.00121962806343362,0.00170895563675901,-0.00212992498461404,0.00456918111148129,0.475438970873188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,24445,-0.00350915602095213,0.00492630887703124,-0.0131647214199334,0.0061464093780291,0.476267452222787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,29694,-0.00141899951420106,0.00199679395235667,-0.00533271566082013,0.00249471663241801,0.477313597454587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,24754,-0.00251158034396631,0.00354223249565351,-0.00945435603544719,0.00443119534751457,0.478307069183316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00300658258443342,0.00424515595545582,-0.0113270882571268,0.00531392308825998,0.478804058900377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00224118645031976,0.0031664910315441,-0.00844750887214619,0.00396513597150668,0.479086162217137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,24445,0.00255534541692633,0.0036165869594714,-0.00453316502363762,0.00964385585749029,0.479845018931279
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00304271449150647,0.00432801967504004,-0.005440204071572,0.0115256330545849,0.482045650605523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,29519,0.00146462493678198,0.00208874273521502,-0.00262931082423947,0.00555856069780342,0.483184178824151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00208843300729274,0.00299449164404709,-0.00795763662962503,0.00378077061503955,0.485543565678064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,28931,-0.00157620055823747,0.00226094808858912,-0.00600765881187214,0.0028552576953972,0.485719900195048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.00255930912092677,0.00369631702894285,-0.00980409049765475,0.00468547225580122,0.488695256867687
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.00398168721379826,0.00575653329392582,-0.0152644924698929,0.00730111804229634,0.489144048507089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.00156564805022718,0.00227354214059193,-0.00602179064578735,0.002890494545333,0.491057386363451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00165798271944243,0.0024332135981933,-0.0064270813719013,0.00311111593301644,0.495627356283013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.00225854382972758,0.00333698398157804,-0.00428194477416537,0.00879903243362053,0.49852545985052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,24111,0.00385848316128128,0.00573281565789046,-0.00737783552818402,0.0150948018507466,0.500920651018709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,24867,0.00170147522917183,0.00255927468194142,-0.00331470314743336,0.00671765360577702,0.50616723982602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00136589221049888,0.00206446917404464,-0.00541225179162638,0.00268046737062862,0.50822067235446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00223376759699899,0.0033837533516466,-0.00439838897222835,0.00886592416622632,0.509167055977233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,24793,-0.00171398392868407,0.00259737162002728,-0.00680483230393755,0.00337686444656941,0.509329475440395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,24229,0.00260361168882781,0.00394754722226619,-0.00513358086681392,0.0103408042444696,0.509547797048576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00182943764993909,0.00277514020183702,-0.00360983714566147,0.00726871244553965,0.50975857984883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,29434,-0.0024984834737766,0.00380776564137548,-0.00996170413087254,0.00496473718331934,0.51172969831491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.00148367880766169,0.00226704217791163,-0.00592708147636848,0.0029597238610451,0.512823337498885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.00177636775462829,0.00273236324414987,-0.00713179971316203,0.00357906420390545,0.51561901473489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00217121958059538,0.00334833428500035,-0.0043915156180053,0.00873395477919606,0.516701647164082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,0.00218087636732914,0.00336876656127558,-0.004421906092771,0.00878365882742929,0.517391182697499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00235643410885683,0.00364130045711452,-0.0094933830048013,0.00478051478708764,0.517546898437403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.00375674385545782,0.00580733848414295,-0.00762563957346237,0.015139127284378,0.517705439179401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,24195,-0.00185054074252691,0.00286719508967742,-0.00747024311829466,0.00376916163324084,0.518662144287845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00117184039439968,0.00181903837200484,-0.00473715560352916,0.0023934748147298,0.519446024489638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.00223860724876369,0.00348191854580829,-0.00458595310102056,0.00906316759854793,0.520279859140186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,29676,0.00190226013841514,0.00295968677014535,-0.00389872593106974,0.00770324620790001,0.520408519749666
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,29589,0.00149935306733173,0.00233318719680943,-0.00307369383841475,0.00607239997307821,0.520475597391953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.00285261281378128,0.00444529760609969,-0.00586017049417411,0.0115653961217367,0.521064550160217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,0.00321435930837793,0.00502119138401498,-0.00662717580429144,0.0130558944210473,0.522075524195222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00159887914513486,0.0025123607563013,-0.00332534793721569,0.00652310622748541,0.524518455216003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00215976289696983,0.00340161275912498,-0.00450739811091513,0.00882692390485479,0.525484526042072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,29349,0.00122626355441184,0.00193948856844061,-0.00257513403973176,0.00502766114855544,0.527221077931911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00241970049029425,0.00386175119162003,-0.005149331845281,0.00998873282586951,0.53093976540686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.00267568791945678,0.00429375266201363,-0.0110914431370035,0.00574006729808993,0.533185277411997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.00268923054621335,0.0043176256349535,-0.0057733156982955,0.0111517767907222,0.533388429049824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00208696463092502,0.00336151533939269,-0.00450160543428465,0.0086755346961347,0.534710513781229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,24229,0.00111424570588081,0.00179493759918649,-0.00240383198852472,0.00463232340028634,0.534755966838838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,0.00366022867037266,0.00593637079291038,-0.00797505808373168,0.015295515424477,0.537518759278562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.00478024740443169,0.00777776516461076,-0.0200246671270688,0.0104641723182054,0.538821757853836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00308405758126696,0.00502859139744603,-0.0129400967202612,0.00677198155772725,0.539680849915154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,24016,0.0025344972527088,0.00414395819745835,-0.00558766081430957,0.0106566553197272,0.54079985966586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,28916,0.00442478934877792,0.00733073602191432,-0.00994345325417415,0.01879303195173,0.546118242740551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00207439763421,0.00344543308023977,-0.00882744647147996,0.00467865120305995,0.547132079234188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.00343748718231964,0.00572105533864584,-0.00777578128142621,0.0146507556460655,0.547946510541369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00146618791604163,0.00244607861453283,-0.00332812616844272,0.00626050200052598,0.548909504872941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,24421,0.00404851925519735,0.00676308300152367,-0.00920712342778905,0.0173041619381837,0.549431623884258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.00241636229348092,0.00406795782357584,-0.0103895596276896,0.00555683504072773,0.552518476252987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.00283492755326251,0.00479631642392901,-0.00656585263763834,0.0122357077441634,0.554483540775165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00229615105094431,0.00388538398055988,-0.00531920155095305,0.00991150365284166,0.554545085395852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.00153075232259574,0.0025921206669261,-0.00354980418457942,0.0066113088297709,0.554833830255744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00205742434859527,0.00351754987446792,-0.0089518221025524,0.00483697340536185,0.558618613875914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00133260456654412,0.00228052438107432,-0.00313722322036155,0.0058024323534498,0.558995276355433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,24867,-0.000870878273095942,0.00150155670717507,-0.00381392941915907,0.00207217287296719,0.561930931302848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.00095645311038163,0.00165121741844395,-0.00419283925053178,0.00227993302976852,0.562430902269249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,0.00359379284731433,0.00621220809450019,-0.00858213501790604,0.0157697207125347,0.562928667695759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.00308635438287177,0.00533518291497202,-0.0135433128962169,0.00737060413047339,0.562937295509939
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.00127100447358466,0.00220244265694698,-0.00558779208120074,0.00304578313403142,0.563885021630931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.00210302577710583,0.00365101636948137,-0.00925901786128932,0.00505296630707766,0.564612916090529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,24016,-0.0016161632726794,0.00280939882608997,-0.00712258497181574,0.00389025842645694,0.565114001392222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.00174237738587655,0.00303421869720177,-0.00420469126063892,0.00768944603239203,0.56580908223309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.00129875150617121,0.00227982993859376,-0.00576721818581499,0.00316971517347257,0.568905635561566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,28916,0.00277589153863553,0.00487554625295034,-0.00678017911714714,0.0123319621944182,0.569123166262577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.000880338451303944,0.00155216187805285,-0.00216189882967965,0.00392257573228754,0.570603485088285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.00111368193702006,0.00197086797024538,-0.004976583158701,0.00274921928466088,0.572029303400593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,24111,-0.00227155236457148,0.00405680142641948,-0.0102228831603537,0.00567977843121071,0.575527758991382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,24195,0.00185498345934027,0.00331348298541605,-0.00463944319207518,0.00834941011075572,0.575601350350063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,0.00298550833875106,0.00536028336113503,-0.00752064704907359,0.0134916637265757,0.577554135513195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00229177574915834,0.0041322128283024,-0.010390912892631,0.00580736139431437,0.579164217242097
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.00410736719781411,0.0074204134748207,-0.0186513776084627,0.0104366432128345,0.579909770113902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00126843166221874,0.00230636000137574,-0.00325203394047771,0.00578889726491519,0.582344199441976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,0.00136733872302249,0.00248649864898033,-0.00350619862897895,0.00624087607502393,0.582389424970512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.00327874783807667,0.00598309921941636,-0.0150056223081327,0.0084481266319794,0.583695757686941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,-0.00178822206988158,0.00327208583029348,-0.0082015102972568,0.00462506615749364,0.584720888326625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00141033578119658,0.00258195787600479,-0.00365030165577281,0.00647097321816596,0.584914768095573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.00222798027024709,0.00409302376753081,-0.0102503068546075,0.00579434631411331,0.586214461032383
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,28797,-0.00511618867757808,0.00946594698115042,-0.0236694447606329,0.0134370674054767,0.588867781011011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.00195678629781507,0.00364046965150656,-0.00909210681476793,0.00517853421913779,0.590921057003491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,24016,0.00233079190023738,0.00435768094933643,-0.00621026276046203,0.0108718465609368,0.59274485341836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.0016546352995085,0.00309548788097952,-0.00772179154622835,0.00441252094721135,0.592978750868236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.00211154400245927,0.00396479361793041,-0.00565945148868433,0.00988253949360286,0.594332870681284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,27585,-0.00177694150522347,0.0033450340930453,-0.00833320832759225,0.00477932531714531,0.595272169197926
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.0020939266716361,0.00395989340077157,-0.00566746439387617,0.00985531773714836,0.59696042515381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00622967847914383,0.0118055900328703,-0.0293686349435697,0.016909277985282,0.597720021201114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00354185252649671,0.00672394233159936,-0.00963707444343804,0.0167207794964315,0.598370414764176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.00126471738982622,0.00241436091983603,-0.00346743001305239,0.00599686479270483,0.600400675909009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.00326410413391601,0.00626763443032813,-0.00902045934952712,0.0155486676173591,0.602519741825785
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,-0.00223430768380097,0.00429555658987336,-0.0106535985999528,0.00618498323235083,0.602968015113821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,28931,-0.00184627649167835,0.00357377800372214,-0.00885088137897374,0.00515832839561705,0.605427102062306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,0.00197235574079717,0.00384433125267581,-0.00556253351444742,0.00950724499604177,0.607917097351628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.00390085286984274,0.00760462832919959,-0.0188059243950739,0.0110042186553884,0.607985592944032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00101108505733922,0.00199501491021623,-0.00289914416668459,0.00492131428136304,0.612295105951826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.000976691076122791,0.00194624995117251,-0.00479134098042092,0.00283795882817534,0.61578924497087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.00271973581106693,0.00545887625391475,-0.00797966164660598,0.0134191332687398,0.618331602239777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,29165,-0.00162849393097921,0.00328185864774474,-0.0080609368805589,0.00480394901860047,0.619749384731181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,0.00164240021880122,0.00332149157712751,-0.00486772327236869,0.00815252370997114,0.620974085753855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00160428158887299,0.00324595918446189,-0.00475779841267232,0.0079663615904183,0.621141461273342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00250980621712722,0.00511237033708829,-0.0125300520778203,0.00751043964356582,0.62348177963672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00137449243213312,0.00280409375335624,-0.00412153132444511,0.00687051618871135,0.624015615974584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,24229,-0.00144014573503152,0.00294669722976403,-0.00721567230536902,0.00433538083530598,0.625035750402155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.00138946980126699,0.00284754221990831,-0.00697065255228729,0.0041917129497533,0.625586756961574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.0015722912174898,0.00323159877623736,-0.00790622481891502,0.00476164238393542,0.626591135585183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,0.0027966475216758,0.00575376583222552,-0.00848073350948621,0.0140740285528378,0.626932501162042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.00201931830185305,0.00415785836088217,-0.00613008408547601,0.0101687206891821,0.627209707109403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00144664885722166,0.00302236117262294,-0.0044771790411193,0.00737047675556263,0.632193001019818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,24195,-0.00115193899880124,0.00241923065519967,-0.00589363108299259,0.00358975308539011,0.633965246733325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00180811024197926,0.00381448570018207,-0.0056682817303776,0.00928450221433612,0.635495854413298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.00131225822319471,0.0027712066866315,-0.00674382332899246,0.00411930688260303,0.63583714817657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00107906760067712,0.00229860311815237,-0.00558432971225577,0.00342619451090153,0.638755865740924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00157835727262703,0.00337893131018963,-0.0082010626405987,0.00504434809534464,0.640420165862265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,24793,0.00141904099748379,0.00304020868126181,-0.00453976801778935,0.00737785001275693,0.640677302694249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,28931,0.00198245377256762,0.00426360353056078,-0.00637420914733152,0.0103391166924668,0.641955427225207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,0.00243460444247463,0.00524476731091815,-0.00784513948692494,0.0127143483718742,0.642510916083878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.00159937542710635,0.00344991586144302,-0.00516245966132198,0.00836121051553467,0.64293969784843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.000591632522460489,0.00127885721067157,-0.00191492761045579,0.00309819265537677,0.643636544201772
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.00187863894975084,0.00408347392570942,-0.00988224784414129,0.00612496994463962,0.645477893362333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.0010305193732323,0.00229283378355242,-0.00552447358899504,0.00346343484253043,0.65310946680259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.00465901366755351,0.0103997593564571,-0.0250425420062094,0.0157245146711023,0.654161928518285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.001256111703073,0.00282365504917554,-0.00427825219331106,0.00679047559945706,0.656429899075657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.000777229050389952,0.00174964727457757,-0.00420653770856199,0.00265207960778208,0.656887173758576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,29461,0.00567095191349821,0.0127968421694143,-0.0194108587385538,0.0307527625655502,0.657658727749812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,28931,-0.00272278202675888,0.00627113339990196,-0.0150142034905667,0.00956863943704896,0.664163136757528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,24381,0.00107276664750022,0.00247774352628363,-0.00378361066401569,0.00592914395901613,0.665046837592607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.00157164311860725,0.00363757691956867,-0.00870129388096184,0.00555800764374734,0.665703358284294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.00195322136229098,0.00454428714578638,-0.00695358144345032,0.0108600241680323,0.667331036500938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,0.00133409020232223,0.00310442899106692,-0.00475059062016892,0.00741877102481339,0.667389569284283
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.000874211209187915,0.00204451002307449,-0.00488145085441391,0.00313302843603808,0.66895314529106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.00138541927917432,0.00324712003415651,-0.00497893598777243,0.00774977454612107,0.669629499396966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.00064983479228132,0.00152600528922118,-0.00234113557459218,0.00364080515915482,0.670227263250802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.00245299014652085,0.0057853571053536,-0.0137922900730139,0.00888630977997222,0.671569744540341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.00200245497507733,0.00477976716228371,-0.00736588866299874,0.0113707986131534,0.675260047555266
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,28745,0.00160087293331581,0.0038445577198185,-0.00593446019752845,0.00913620606416007,0.677120610444593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.000916989668508134,0.00222421039345811,-0.00527644203968603,0.00344246270266976,0.680139846603929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,29434,0.00168669435313387,0.00411949441572638,-0.00638751470168984,0.00976090340795758,0.682218246400024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,24101,-0.00309039935373767,0.00759891767218418,-0.0179842779912187,0.0118034792837433,0.684239731957851
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.00163788019398776,0.00409618207038327,-0.00966639705193896,0.00639063666396344,0.6892659532533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,-0.000595788593458295,0.00152201588591757,-0.00357893972985673,0.00238736254294014,0.69546967320385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.00148815943546316,0.00387252819259447,-0.00610199582202201,0.00907831469294833,0.700769671538218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00097351909647877,0.00253335664901511,-0.00593889812854839,0.00399185993559085,0.700774099122402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,24445,0.00108638488836032,0.00283900578007996,-0.0044780664405964,0.00665083621731705,0.701972348713621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,0.0010356506396301,0.00273664356175983,-0.00432817074141916,0.00639947202067936,0.705108381035816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,0.00167093910549089,0.00442839984723172,-0.00700872459508328,0.0103506028060651,0.705936525313615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.000975506325719581,0.00259110418248681,-0.00605407052339373,0.00410305787195457,0.706561165841479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,24922,0.000968248645441154,0.00257567212533104,-0.00408006872020768,0.00601656601108999,0.706979001359397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,24101,0.00122876107138007,0.00327085012542827,-0.00518210517445934,0.00763962731721949,0.707165368711519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.00113387724568614,0.0030302043729452,-0.00480532332528646,0.00707307781665874,0.708264928383552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,0.00142313751466747,0.00381454553847295,-0.00605337174073952,0.00889964677007445,0.709090834303995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.00152105726598121,0.00408223427942461,-0.00952223645365344,0.00648012192169103,0.709446404232691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.000747755639860361,0.00201029752620595,-0.00468793879122403,0.00319242751150331,0.709923349947992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.00120074613651553,0.00323891286216406,-0.0075490153463571,0.00514752307332603,0.710845057930286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.000930813255080307,0.00252221318035979,-0.0058743510885855,0.00401272457842489,0.712096512043635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,24195,0.000576528304671208,0.00156777639239637,-0.00249631342442567,0.00364937003376809,0.713073082219676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.000579517161352974,0.00157898086889495,-0.00367431966438708,0.00251528534168113,0.713607466017018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,28797,0.000986879570252665,0.00269508790196187,-0.0042954927175926,0.00626925185809793,0.714235593010485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.00109784897989862,0.00300851700001439,-0.00699454229992682,0.00479884434012958,0.71517908017547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.00186758324134395,0.0051372621206879,-0.0119366169978922,0.00820145051520434,0.716207204445339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,29693,0.000798498022790113,0.00219659516055572,-0.00350682849189909,0.00510382453747932,0.716221869733017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.00135145494474914,0.00373171505271893,-0.00596270655857996,0.00866561644807824,0.717240234878197
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,0.00255654430819283,0.00707222389455305,-0.0113050145251312,0.0164181031415168,0.717735693646498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.0016107163956587,0.00449670934145792,-0.0104242667049162,0.00720283391359883,0.720197583428446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,28719,0.000849857998002191,0.00237339918373789,-0.00380200440212408,0.00550172039812846,0.720288847605452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.00226687929604771,0.00634056184530203,-0.0146943805128397,0.0101606219207443,0.720705480421931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00170089422582207,0.00477741059223279,-0.0110646189865983,0.0076628305349542,0.721822311867609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,29694,0.000726161464501083,0.00204104916969331,-0.0032742949080978,0.00472661783709996,0.722008960766127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,0.00145482787970716,0.00411606806515161,-0.00661266552798999,0.00952232128740431,0.723753540642262
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00102437206903327,0.00289821174668015,-0.00465612295445982,0.00670486709252636,0.723753923382178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00142416995187573,0.0040837089699922,-0.00657989962930899,0.00942823953306044,0.727284381715635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,0.000992527014550578,0.00285842181528102,-0.00460997974340023,0.00659503377250139,0.728422312808304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.000495349092567323,0.00143551095672294,-0.00330895056774428,0.00231825238260963,0.730045600917708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.00161038074024495,0.00466990130286594,-0.0107633872938622,0.00754262581337229,0.730215649942552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,0.000746724884130171,0.00217947954395041,-0.00352505502201263,0.00501850479027297,0.731890226704012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00235658341980979,0.00688954195423184,-0.0158600856501042,0.0111469188104846,0.732314506273218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.00180358247370103,0.00527435736902765,-0.0121413229169952,0.00853415796959316,0.732389213447179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.000678124910154034,0.00199736646919766,-0.00323671336947338,0.00459296318978145,0.734228878932812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,24229,0.00108484779561866,0.0032086736781994,-0.00520415261365218,0.00737384820488949,0.735291882982324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.00225095869433827,0.00668833762897143,-0.0153601004471223,0.0108581830584457,0.736458724195228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.00149959803076278,0.00448658542496295,-0.0072941094021646,0.0102933054636902,0.738201071948726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.000710747014268633,0.00214618994216531,-0.00349578527237538,0.00491727930091265,0.740520778419394
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.000669814260022361,0.00202578565293685,-0.00464035413977859,0.00330072561973387,0.740916122379825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.00192799196164756,0.00583875365568285,-0.00951596520349082,0.013371949126786,0.741247129231321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,0.00112876730245971,0.00344209709151075,-0.00561774299690136,0.00787527760182079,0.742967340733808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,0.00145663047412961,0.0044533312882498,-0.00727189885083999,0.0101851597990992,0.743603822666801
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,28931,-0.000993060320305801,0.00305742078195888,-0.0069856050529452,0.00499948441233359,0.745332306110698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.00136573198230227,0.0042830619325309,-0.00976053337006283,0.00702906940545829,0.749829256759035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,0.0018341132420926,0.00575689619182589,-0.00944940329388614,0.0131176297780713,0.750037079668051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,24454,-0.000541222458466033,0.00172051322252614,-0.00391342837461727,0.0028309834576852,0.753090574341047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.00172500490107501,0.00548878642090379,-0.0124830262860464,0.00903301648389641,0.753312538996147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.00274253571994467,0.00875285520073192,-0.0144130604734899,0.0198981319133792,0.754031849434257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.00102115844373349,0.00325933990392983,-0.00740946465543595,0.00536714776796897,0.75405377152991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.00122876982826165,0.00392891663023129,-0.00892944642351497,0.00647190676699168,0.754473099534212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.001656685145905,0.00530673029219557,-0.0120578765186083,0.00874450622679832,0.754902041814137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.00217700011828373,0.00706694262827255,-0.0160282076696979,0.0116742074331305,0.758043453257986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,0.00115934551959349,0.00377416213674802,-0.00623801226843262,0.0085567033076196,0.758709356535457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,0.000544904485518656,0.00178703451049528,-0.00295768315505209,0.00404749212608941,0.76042880820999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.00158608559900147,0.00525139293371865,-0.01187881574909,0.00870664455108709,0.762630698321777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,29454,-0.000461616691959246,0.00158774526933446,-0.00357359741985479,0.00265036403593629,0.771254328842847
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,29322,0.000716990919146486,0.00246658357043384,-0.00411751287890383,0.00555149471719681,0.771296759344629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,29632,0.00121939479192387,0.0041972835701102,-0.00700728100549212,0.00944607058933986,0.771420492132435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.00122068365587546,0.0042324186774708,-0.00951622426371823,0.00707485695196731,0.773033264409988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.00224778796409434,0.00791060564937051,-0.0177525750368605,0.0132569991086719,0.7762988279962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.00088906267383593,0.00315100324469142,-0.00706502903343112,0.00528690368575926,0.777828794437729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,24938,0.000844566910044071,0.00300648735749209,-0.00504814831064043,0.00673728213072857,0.778778051143348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,24101,0.00110852650431715,0.00394893662554029,-0.00663138928174182,0.00884844229037611,0.778931266284238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,-0.000582616558736133,0.00210465003371913,-0.00470773062482563,0.00354249750735336,0.781917988450931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.000691049541576426,0.00250240518841538,-0.00421366462771772,0.00559576371087058,0.782431978645977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.000606191326832192,0.00219676396031874,-0.00491184868905692,0.00369946603539254,0.782590439660754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.0015669441716388,0.00576257658482473,-0.00972770593461766,0.0128615942778953,0.785687925135122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,29349,0.000354690405222446,0.00130505935275549,-0.00220322592617831,0.0029126067366232,0.785792287084222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,0.00059133035907791,0.0021781903121665,-0.00367792265276843,0.00486058337092425,0.786025502855879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.000896755504753686,0.00336954451772864,-0.00750106275950183,0.00570755174999446,0.790137112914057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.00107656994149944,0.00408128197634704,-0.00907588261513963,0.00692274273214076,0.791949919812995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,29121,0.00100410843943467,0.00390742881680123,-0.00665445204149574,0.00866266892036509,0.797200497275867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.000760215222919975,0.00297584868494181,-0.00659287864540593,0.00507244819956598,0.798368374915562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,28774,0.0008269222706539,0.0032387591955646,-0.00552104575265271,0.00717489029396051,0.798477237755802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.000868658269290566,0.0034236891328822,-0.00584177243115855,0.00757908896973968,0.799713726482954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00100040542572389,0.00396390141561333,-0.00676884134887823,0.00876965220032601,0.800750293588157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.00200967210016286,0.00811677051484866,-0.0179185423092662,0.0138991981089405,0.804449861085278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,29434,0.000655248906261836,0.00265072704774906,-0.00454017610732633,0.00585067391985,0.804758329077035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.000638593254338685,0.00259156187259059,-0.00444086801593887,0.00571805452461624,0.805365018219806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.000778512220587484,0.0032063156409136,-0.00550586643560317,0.00706289087677814,0.808157475069017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.000686840024306152,0.00286122232642677,-0.00629483578410261,0.00492115573549031,0.810292553292721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000647209812092948,0.00275339852961502,-0.00474945130595249,0.00604387093013839,0.814165303031377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,29341,0.00114846920294268,0.00491954721552738,-0.00849384333949099,0.0107907817453764,0.81541347758677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.00196093439085074,0.00842510281046433,-0.0145522671176594,0.0184741358993608,0.815957959719622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00097064211161649,0.00417770145926749,-0.00721765274854779,0.00915893697178077,0.816276857856845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,0.00134034730890148,0.00582085937797751,-0.0100685370719344,0.0127492316897374,0.817886542584681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.000904029164607078,0.00393572082750021,-0.00680998365729333,0.00861804198650748,0.81832801905349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.000853939342507283,0.00372586345123567,-0.00644875302191463,0.00815663170692919,0.818721376103063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,29216,0.000803381608730784,0.00353097877314068,-0.00611733678662494,0.00772410000408651,0.820018079479267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,28931,0.00117935400839008,0.00523555241451602,-0.00908232872406133,0.0114410367408415,0.821779577157259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00129982727293338,0.00583970400691587,-0.0127456471264885,0.0101459925806217,0.823860804861932
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.000293909985088807,0.00133112600184241,-0.00290291694869994,0.00231509697852233,0.825251512200625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.00055333613968434,0.00252154756643326,-0.00549556936989354,0.00438889709052486,0.826306729880282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,-0.000998870341582851,0.0045832678489533,-0.00998207532553133,0.00798433464236562,0.827478898717703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,24793,-0.00162822908874176,0.00752407603196497,-0.0163754181113931,0.0131189599339096,0.828675775796944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.00162257544800116,0.00776401882918716,-0.0135949014572057,0.016840052353208,0.834460510999126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.000670921891615905,0.00325364718397192,-0.00570622658896905,0.00704807037220086,0.836631660352109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,28774,-0.000836087377732785,0.00407559496578992,-0.00882425351068104,0.00715207875521547,0.837460396639165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.000423042320401957,0.00206909766494029,-0.00447847374368493,0.00363238910288101,0.837997800205201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.000412660978454619,0.00203266562782929,-0.00357136365209079,0.00439668560900003,0.839124948181432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.000563198793251468,0.00279822272305283,-0.00604771533043501,0.00492131774393208,0.840489008278602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.00117996019751697,0.00599057622374775,-0.0129214895960626,0.0105615692010286,0.843853137924102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.000702792685562629,0.0036951536697124,-0.00794529387819894,0.00653970850707368,0.849159424090218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,0.000856366005329669,0.00455583605962249,-0.00807307267153041,0.00978580468218975,0.850900796955523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.000332511063497635,0.00178192211437417,-0.003825078407671,0.00316005628067573,0.851973858799243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,29443,-0.000659126109278544,0.00355987629186846,-0.00763648364134072,0.00631823142278363,0.853109353206489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,28931,0.000696395081798712,0.00380122404536782,-0.00675400404712222,0.00814679421071964,0.854640141994683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.000319940271455667,0.00175330794388908,-0.00311654329856693,0.00375642384147826,0.855209045365571
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.00133575108704274,0.00741258185082785,-0.0131929093405798,0.0158644115146653,0.856996698635372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.000665818506334211,0.00370733940985375,-0.00660056673697913,0.00793220374964755,0.857472282430303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.000870079636907231,0.00488888550868631,-0.00871213596011794,0.0104522952339324,0.858747274654527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.000620908889134984,0.00350203989443946,-0.00624308930396635,0.00748490708223632,0.859274871299943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,28931,0.000407777229739458,0.00233153178850073,-0.00416202507572198,0.00497757953520089,0.861162023089084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,24229,0.000569750118397243,0.00328011223370863,-0.00585926985967167,0.00699877009646616,0.862103977729496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.000822509359259462,0.00476693288288825,-0.0085206790912015,0.0101656978097204,0.863010708258381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.0010286560229881,0.00598411665956117,-0.012757524675728,0.0107002126297518,0.863519386583859
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.000724061280295292,0.00437510636666952,-0.00785114719837696,0.00929926975896754,0.868555229760215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.000878422369326343,0.00536184473139614,-0.00963079330421009,0.0113876380428628,0.869867613843133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.000649160243339015,0.00407363259229744,-0.00733515963756397,0.008633480124242,0.873389246642659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,29313,0.00073756105494726,0.00474755193926637,-0.00856764074601482,0.0100427628559093,0.876541677652929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.000272583591797953,0.00175802511306847,-0.00317314562981626,0.00371831281341216,0.876782353553667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,24229,-0.000335719848438574,0.00221695026659273,-0.00468094237096032,0.00400950267408318,0.879635271888289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.000401407195214757,0.00267805127234955,-0.00565038768901987,0.00484757329859035,0.880854359916866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.000555032909564275,0.00370551936742599,-0.00781785086971921,0.00670778505059066,0.880935120463824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,24867,-0.000333917277551936,0.00223948201377544,-0.00472330202455179,0.00405546746944792,0.881472232815121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.000228738314680386,0.00155253529448001,-0.00281423086250044,0.00327170749186121,0.882871076955976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,28931,-0.0003105369292193,0.00215688846452431,-0.00453803831968695,0.00391696446124835,0.885521612446752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.000546795938321657,0.00382425195612812,-0.00694873789568945,0.00804232977233277,0.886306248360825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.000427493933303384,0.00301225044564695,-0.00633150480677141,0.00547651694016464,0.88714559648012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,28797,0.00028718487160946,0.00212617728195267,-0.00388012260101777,0.00445449234423669,0.892556690609089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,0.000306279853375136,0.00231739753684751,-0.00423581931884599,0.00484837902559626,0.894854510072448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.000864369893578616,0.00665007414360108,-0.0138985152150367,0.0121697754278795,0.896584107482611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000282541415695372,0.00218647544085214,-0.00456803327976557,0.00400295044837482,0.897182823083598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.000420518168153839,0.00327973879986897,-0.00684880621589703,0.00600776987958935,0.897978341528278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.000467430376622486,0.00373214857096334,-0.00684758082246566,0.00778244157571063,0.900331177920465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.000484157809864393,0.00395553510794256,-0.00726869100170303,0.00823700662143182,0.902583200663751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,28774,-0.000308683189568428,0.0026110545693693,-0.00542635014553226,0.0048089837663954,0.905892858571834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.00032409718602101,0.00275426457353621,-0.00507426137810996,0.00572245575015198,0.906329278729514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,0.00053565690058643,0.004590461796521,-0.00846164822059472,0.00953296202176758,0.907107392879111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.000686040524138409,0.00592926217268048,-0.0109353133343153,0.0123073943825921,0.907887930059033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.000417013935344681,0.0036522470529813,-0.00674139028849866,0.00757541815918802,0.909095977936704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.000512071147840053,0.00450909920911314,-0.00934990559770181,0.0083257633020217,0.909584406812459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.000358615341218781,0.00321008324818571,-0.00593314782522522,0.00665037850766278,0.911050095854876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,0.000363940823793667,0.00327778319409052,-0.00606051423662375,0.00678839588421108,0.911591412101341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.000341066703296197,0.0030742903865018,-0.00568454245424733,0.00636667586083972,0.911663553378424
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,28916,-0.000203392970421845,0.00187502128413628,-0.00387843468732894,0.00347164874648525,0.913619648114094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,29434,-0.000480783389109851,0.0044496420879471,-0.00920208188148616,0.00824051510326646,0.913956845073316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.000428737434012351,0.00451252571255136,-0.00841581296258831,0.00927328783061301,0.924307254790049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,24381,0.000606447869054068,0.00639852566497194,-0.0119346624342909,0.0131475581723991,0.924490897769176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,24111,0.000255107587133354,0.0027430767646845,-0.00512132287164826,0.00563153804591497,0.9259039150004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,0.000245022085370753,0.00266064360356975,-0.00496983937762595,0.00545988354836745,0.926626268549401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.000408152272882127,0.00462750912046993,-0.00866176560323893,0.00947807014900318,0.929717285447706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00031635443624304,0.00372293047431239,-0.00698058929340925,0.00761329816589533,0.932282309710865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.000192007838405303,0.00228400582420283,-0.00466865925384285,0.00428464357703224,0.933004441390648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,28931,-0.000278411066613505,0.0033294004122267,-0.00680403587457783,0.00624721374135082,0.93335756661263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.000157104273194793,0.00194993473164376,-0.00397897634721655,0.00366476780082697,0.935785279952847
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.000192913847101224,0.00257976026010524,-0.00486341626270505,0.00524924395690749,0.940390561610317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,24101,0.000321157085682811,0.00434279568192343,-0.00819072245088712,0.00883303662225274,0.941049438778324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.000192416088785348,0.00277893192299885,-0.0052542904802924,0.0056391226578631,0.944798236894044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,28774,0.000245820188101333,0.00380134654509309,-0.00720481904028112,0.00769645941648378,0.948439899298713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.000113261713066674,0.00186671596776916,-0.00377202500989422,0.00354550158376088,0.951619088183352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.000151354130861738,0.00259975622905896,-0.0052468763398173,0.00494416807809383,0.953574913110393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,24195,-0.000162450740434922,0.00285467417486502,-0.00575761212317036,0.00543271064230051,0.954619804944418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,24203,0.000269023810822446,0.00478016782660983,-0.00910010512933282,0.00963815275097771,0.955119888443577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,24793,0.000184871967098344,0.00328546054046071,-0.00625463069220466,0.00662437462640134,0.955127388791841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,-0.000426311835812519,0.00759321516897974,-0.0153090135670128,0.0144563898953878,0.955227743495121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00022751983121227,0.00412665306234455,-0.00831575983340758,0.00786072017098304,0.956031978361367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.000231648059646726,0.00420686974547764,-0.0084771127607829,0.00801381664148944,0.956087670516722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.000233679559398313,0.00434719565382094,-0.00828682392209073,0.00875418304088735,0.957131525763343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,24445,-0.000308799729427938,0.00587266644330796,-0.0118192259583115,0.0112016264994557,0.958064957165316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,0.000160465359808094,0.00310961155105258,-0.00593437328025496,0.00625530399987114,0.958845425624424
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,24966,-6.7002925565355e-05,0.00133912658860059,-0.00269169103922252,0.00255768518809181,0.960095060391645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,29478,0.000127971112417873,0.00262146729809793,-0.00501010479185406,0.00526604701668981,0.96106578639743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.000108587422851267,0.00251842870127115,-0.00504470767734272,0.00482753283164018,0.965608453906751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.000119071914787452,0.00276234819386287,-0.00553327437475868,0.00529513054518378,0.965617922958737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.000201434428169873,0.00485601575692283,-0.00931635645539887,0.00971922531173861,0.966912384562844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.000167116179417864,0.00412100037566136,-0.0079100445568784,0.00824427691571413,0.967653117013184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-8.98599027313279e-05,0.00222977793499049,-0.00446022465531269,0.00428050484985004,0.967854340579228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,9.46584317683868e-05,0.00245185745478798,-0.00471098217961605,0.00490029904315283,0.969204122632491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,4.84336866292063e-05,0.001387344375526,-0.00267076128940175,0.00276762866266017,0.972150885182459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,-5.01259846598685e-05,0.00150073029017821,-0.00299155735340917,0.00289130538408943,0.973355038505499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,0.000307714982845245,0.00942758076973455,-0.0181703433258345,0.018785773291525,0.97396203881425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,5.17810128270221e-05,0.00159923833440801,-0.00308272612261267,0.00318628814826671,0.974170437760277
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.000108104112507463,0.00358619395686234,-0.00713704426795765,0.00692083604294272,0.975952037462043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.000124644354230453,0.00417191466024287,-0.00830159708830647,0.00805230837984557,0.97616534383604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,24445,0.000109324741814368,0.00367392122588168,-0.00709156086091372,0.00731021034454245,0.976261124334695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,24195,5.54035306556713e-05,0.00187259519617267,-0.00361488305384276,0.0037256901151541,0.976397079238425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-6.96299325832264e-05,0.00235910287062034,-0.00469347155899909,0.00455421169383264,0.976453712567223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-5.28604803776984e-05,0.00205109384046059,-0.00407300440768045,0.00396728344692505,0.979439492379796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,24229,0.00010774140130061,0.00420499111592143,-0.0081340411859054,0.00834952398850662,0.979558837254646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.000107495013491362,0.00426816661982582,-0.00847310158834996,0.00825811156136724,0.979907373031838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,24240,0.000112373958802474,0.00484082431134438,-0.00937564169143251,0.00960038960903745,0.981479916778826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.000152729290986595,0.00741904430979008,-0.0146940561381752,0.014388597556202,0.983575988159067
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.000107405477474552,0.00599561714220784,-0.0118588150762019,0.0116440041212528,0.985707605648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,3.58866223679205e-05,0.00271766339095864,-0.00529073362391102,0.00536250686864686,0.989464385906711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,24966,1.31915629825186e-05,0.0010375326292011,-0.00202037239025165,0.00204675551621668,0.989855783708039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-5.34624939528694e-05,0.00488289082555453,-0.00962392851203975,0.00951700352413402,0.991264269742989
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-2.36206425705049e-05,0.00366747561714581,-0.00721187285217628,0.00716463156703527,0.994861246925548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,29518,-1.87052747502397e-05,0.00308943507794137,-0.00607399802751532,0.00603658747801484,0.995169203461749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-3.1330847176813e-05,0.00984542632816743,-0.019328366450385,0.0192657047560313,0.997460943199894
